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Photodynamic Therapy 
Photodynamic tllel'apy (PDT) is a treatment modality for malignant (and 
benign) diseases that combines administration of a chemical compound 
(photosensitiser) and irradiation with (visible) light of the proper wave-
length and fluence to induce tissue necrosis. The mechanisms by. which 
PDT induces cell death are not yet fully understood. The basic principle 
is that the iIIumination of the sensitiser causes excitation of the oxygen 
present in the tissue to the very reactive singlet state that induces damage 
to the tissue. The oxygen supply in the treated tissue is therefore of para-
mount importance for the final damage induced. Two types of damage are 
thought to be most important for the induced necrosis. Firstly, important 
(tumour)cell structures such as mitochondrial and cellular membranes are 
damaged with consequent direct cell death. Secondly, through damage of 
the endothelium of the blood vessels vascular stasis occurs which causes 
tissue damage as a secondary process. 
The photosensitiser can be one single molecule like mTHPC (meta-Tetra-
Hydroxy-Phenyl-Chlorin) or a mixture of several photo-active compounds 
as is the case with Photofrin. Instead of using exogenous photosensitisers, 
photosensitivity can also be generated in the living tissue by the induc-
tion of the formation of an endogenous photosensitiser ProtoPorphyrin IX 
(PPIX). This is achieved by administering ALA (5-amino-levulinic-acid), 
which intervenes in a feedback mechanism of the cycle of haem synthesis, 
thereby inducing excess fOl'mation of PPIX, which can then be used for 
photodynamic therapy. 
The majority of the sensitisers is activated with red light ("" 630 nm for 
PPIX and Photofrin, 652 nm for mTHPC). Sometimes green light (514 nm) 
is also applied because some sensitisers (eg. Photofrin, PPIX) have stronger 
absorption at that wavelengtil. The penetration of green light in tissue is 
very limited ("" 1 mm) becanse of the strong absorption by blood. For the 
treatment of thick lesions this is a disadvantage but for the treatment of 
the superficiallesions in the oesophagus, however, the Iimited penetration 
depth of the green light is an advantage because it prevents perforations. 
In the ideal case, the photosensitiser accumulates preferentially in the target 
tissue, and selective treatment of the target (tumour) tissue is possible. 
U nfortunately, most photosensitisers do not show these ideal localisation 
properties. A drawback of the use of photosensitisers is the fact that the 
clearance of the compound from the body can take some time (up to months 
with Photofrin), and during this period precautions most be taken to avoid 
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exposure to bright daylight, because the drug can accumulate in the skin 
(especially Photofrin). In the development of new sensitisers for clinicaluse, 
much effort is put into reducing the clearance time, which is, for example, 
reduced to two weeks for mTHPC. 
Fluorescence 
In parallel with the generation of singlet oxygen, the photosensitiser may 
show fluorescence. This fluorescence light can be used to estimate the 
amount of sensitiser present. This can be used to study the pharmaco-
kineties of the sensitiser, which knowledge helps to optimize treatment pa-
rameters such as the interval between administration of the sensitiser and 
illumillation. Ouring illuminatioll the amount of sensitiser present can be 
reduced by photo-degradatioll, which can be monitored by a fluorescence 
measurement. 
In the case of a sensitiser with good selective uptake in the tumour it might 
be possible to use the fluorescence to find pre-malignant tissue that is not 
yet visible with conventional techniques. There is a great need for methods 
for early detection of malignant tissue, because this generally enhances the 
chances of a successful treatment considerably. 
AppJications 
The majority of the CUl'l'ent applications of POT concerns the treatment of 
malignant diseases. The light penetration in tissue is limited to a maximum 
of "" 1 cm, depending on the wavelength of illumination and the optical 
properties of the tissue. A consequence of this is that mostly superficial 
lesions are treated, although interstitial illumination of e.g. liver metastases 
is being investigated. In principle all tumours in areas that can be accessed 
either directly or by endoscopie techniques are eligible for treatment such 
as the skin, mouth, bladder, prostate, the digestive tract (oesophagus) and 
the upper respiratory tract. Sometimes intra-operative illuminations are 
performed e.g. in the thorax for treatment of malignant mesothelioma 
and in the peritoneum for treatment of ovariall cancel' mestatases. Also 
benign diseases can be treated with POT, for example warts and age related 
macular degeneration. Another intm'esting application is the disinfection 
of donor-blood with POT. 
POT is of ten used for recurrent tumors, because in sueh cases the maximum 
tolerabie radiation therapy dose has already been applied. The advantage 
of POT is that it can be applied more than once, if necessary several illu-
minations can be performed with one single photosensitiser dose. 
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This thesis foeuses on the treatment of cancel' of the upper respiratory 
tract. PDT is used with curative intent on early lesions (carcÎnoma in situ) 
as well as for palliative llleans in the case of (partly) obstructing tumours. 
Light delivel'Y 
Lasers are of ten used as a light souree for PDT treatment, because they 
offer the possibility to tune the wavelength to an absorption maximum of 
the sensitiser. A second advantage of a Laser as a light souree is that the 
light ean be easily transported through fiber-opties, so that the light ean be 
delivered at every plaee that is aeeessible by endoscopie teehniques. For skin 
lesions sometimes conventional (halogen) lamps are used in combination 
with filters. 
For the iIIumination of lesions three types of light delivery systellls are 
commonly applied (figure 1). In the case of a localised les ion on a flat 
surface sueh as the skin or inside a hollow stl'llcture sueh as the upper 
respiratory tract a mierolens is used that projeets a divergent bealll of light 
on the surface, eausing a circular homogeneous iIIulllination field if the 
be8111'S axis is perpendieular to the smfaee. In the case of the iIIulllination of 
a hollow organ the output charaeteristics of the light applieatOl' are adjusted 
to the geometry of the organ. For use in eylinder-like organs sueh as the 
trachea, the oesophagus and the prostate a linea I' (or cylindrical) diffuser 
is used that elllits diffuse light over some length that ean be chosen to fit 
to the dimensions of the treated lesion. For a sphere-like O1'gan sueh as the 
bladder a spherieal diffuser is used that acts as a diffuse point souree. 
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Figme 1.1: Overview of the light delivery systems used in PDT 
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Light dosimetry 
The applied light fluence is one of the important factors for the final effect 
of the treatment. The applied fluence ean be measured in situ with a 
fiberoptic isotropic probe. This detector measures the incoming light from 
al! directions (fluence rate), which is a measure for the amount of optical 
energy available for absOl'ption by the photosensitiser. This detector does 
not only measure the light incident on the tissue from the light delivery 
system, but also accounts for the light that is backscattered from the tissue. 
An isotropic probe is very similar to a spherical diffuser (figure 1), with 
this differenee that the light is col!eeted and sent through the fibre to a 
photodiode, instead of the light coming from the laser and being emitted. 
A fluence measurement is of vital importanee because large variations in 
the measured fluence can be observed for different patients treated with 
the same applicatol' with the same output. These variations are caused by 
inter-patient variations in the optical properties of the tissues. 
Aim of the study 
The aim of this study is wel! described by the title of this thesis, which 
was also the title of the project funded by the Dutch Cancel' Society that 
provided the financial means to perform these investigations. Besides the 
importance of understanding the bio-distribution of the photosensitiser and 
the oxygenation of the tissue, the other aspect of paramount importance 
for the therapeutic effect is to deliver the light to the right place in the right 
amount. By conforming the illumination field to the tumor and tumor bed 
dimensions through proper light delivery techniques, the disadvantages of 
less-than-ideal bio-distribution of the photosensitiser can be diminished. 
The absolute levels and distribution of the fluence rate in the target tis-
sues are highly dependent on the optical proper ties of the tissue leading 
to large inter-tissue and inter-patient variations. In order to perform wel!-
defined fluence-response studies that yield readily comparable results it is 
a necessity to combine in situ measurements with knowledge gained from 
experiments and mathematical and Monte Carlo modeis. 
This thesis focuses on light delivery and light dosimetry for PDT of the 
upper respiratory tracts, an area in which the light dosimetry was not very 
advanced until recently. Topics that are dealt with are: the influence of the 
quality of the Iinear diffusers used, of the optical properties of the bronchial 
tissue, of the position and length of the light source and of the diameter 
of the treated lumen. An applicatol' for the delivery and measurement of 
light was developed to put the knowledge to clinical practice. 
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Outline of the thesis 
Chapter 2 describes measurements in ex vivo plg traelleas in which we 
measured the fiuence rate in the tissue when t.he trachea was illuminated 
with a linear diffuser. The tot al fiuence rate in the bronchial mucosa is 
considerably more than the fluence rate incident on the tissue from the 
lilwar diffuser. This is caused by backscattering hom the tissue and multiple 
reflections in the cylindrical cavity of the trachea. Also the infiuence of the 
positioning of the light source was investigated. The measured fluence rate 
profiles are compared to the profiles simulated with a Monte Carlo model. 
In chapter 3 a device is presented that measures the output characteristics of 
the linear diffusers used for endobronchial PDT. The consequences of those 
characteristics for illumination in a cavity and for interstitial illumination 
are evaluated. Chapter 4 shows improved designs of linear diffusers that 
\Vere given to us aftel' the publication of chapter 3. 
In chapter 5 a design of an applicatol' for light delivery and light dosimetry 
is presented that incorporates a linear diffuser, a fixation system and an iso-
tropic probe for in situ light dosimetry. Also the first in vivo measurements 
with this applicatol' are discussed. 
The Monte Carlo model that is validated in chapter 2 is used to gain more' 
insight in the fluence rate profiles resulting from varying diffusers in varying 
lumen diameters in tissue with varying optical properties. In chapter 6 the 
results of the simulations are presented, \Vi th an attempt to extend the 
findings to rules of thumb for clinical use. 
The applicator for endobronchial PDT is used to perform a fluence-response 
study on the normal tissue of the pig trachea. In chapter 7 a short-term 
fluence finding experiment is described for maximum toIerabIe norm al tissue 
damage with the use of the sensitisers Photofrin and mTHPC. Also the 
long-term recovery of the bronchial mucosa is evaluated with the fiuence 
[mmd in the short-term experiment. 
An application of in in vivo, clinical use of light dosimetry is evaluated in 
chapter 8. The feasibility of intra-operative PDT of Malignant Mesothe-
lioma iu au eutire hemithorax with mTHPC is iuvestigated. Data of the 
first 5 patieuts are discussed. 
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Suggested reading 
A comprehensive overview of clinical and preclinical Photodynamic The-
rapy is given by Fisher et al (1995). Lam (1994) presents an overview of 
PDT for lung cancel'. Henderson and Dougherty (1992) provide infol'lnation 
about the mecllanisms involved in PDT tissue destruction. An overview of 
the clinical use of in vivo fluorescence can be found in Andersson-Engels 
and Wilson (1992) 
An overview of the principles and applications of in vivo light dosimetry can 
be fonnd in Star (1997). A complete overview of several aspects important 
for light dosimetry is offered by Welch and van Gemert (1995). In this 
book attention is paid to the mathematical modelling of light propagation 
in tissue and measurement of the optical properties of biological tissue. Also 
an overview is given of light delivery systems for PDT and other medical 
laser applications. 
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Abstract 
The light distribution dnring Photodynamic Therapy of the bronchial tree 
has been estimated by measnring the fluence rate in ex vivo experiments 
on dissected pig bronchi. The trachea was illuminated (630 nm) with a 
cylindrical difl'user and the fluence rate was measnred with a fiberoptic 
isotropie probe. The experiment with the diffuser on the central axis was 
also simulated with Monte Carlo techniques using the optical proper ties 
that were determined with a double-integrating-sphere setup. The results 
from ex vivo experiments and the Monte Carlo simulations were found to 
agree within the error of measnrement (15%), indicating that the Monte 
Carlo technique can be used to estimate the light distribution for varying 
geOlnetries and optical properties. The results shO\ved that the light fluence 
rate in the mucosa of the tracheal tract may increase by a factor of 6 
compared to the fluence rate in air (in the absence of tissue). This is due 
to the scat tering properties of the tissue and the multiple reflections within 
the cavity. F\trther ex vivo experiments showed that the positioning of the 
diffuser is critical for the fluence rate in the lesion to be treated. When 
the position of the diffuser was changed from the central axis to nearby 
the lesion, the fluence rate in the mucosa increased significantly by several 
orders of magnitude as compared to the initial (central) iIIumination. The 
inter- and intra- specimen variations in this increase were large (± 35 %) 
because of variations in optical and geOlnetrical properties and light source 
positiolling,respectively. These variations might cause under- or overdosage 
resulting in either insuflicient tumonr-necrosis or excessive normal-tissne 
damage. 
Introduction 
Light dosimetry in tissue is essential for the proper evaluation of the effect of 
PhotoOynamic Therapy (POT). For bladder, esophagus and skin, attempts 
have been made to perform dosimetry during treatment (Marijnissen et 
al 1993a, Overholt et al 1994, Hudson et al 1994). Except for the skin 
treatment, where it is possible to use invasive methods, light dosimetry is 
limited to measnrements of the fluence rate at the snrface. The penetration 
of light in the tissue has to be estimated with the aid of radiative transfer 
models (diffnsion theory) (Star 1995) and Monte Carlo simulations (Keijzer 
et al 1991). These methods rely on measurements of optical proper ties 
which shonld ideally be performed in vivo and non-invasively (Patterson 
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et al 1989). In the bronchus, the dosimetry during treatment is seriously 
hampered by the reqnirement of a measurement technique that does not 
block the air flow. The lesion is illuminated through a cylindrical difl'user 
of which the length (typically 2 cm) ean be adapted to the size of the 
lesion. In clinical practice, dosimetry has been limited to specification of 
the total output per unit length of the diffuser (typically 200 J/cm at 630 
nm). Few studies on the influence of the geometry and optical properties 
of the illuminated lumen of the broncIms have been published (Marijnissen 
et al 1993b). 
The first objective of this study is to assess the influence of the placement of 
the light source in the lumen. Even though most clinical protocols prescribe 
that the cylindricallight source be placed on the central axis of the lumen, 
clinicians are of ten tempted to place the souree close to the visible part of 
the lesiOll. The motive for this is to increase the light dose in the les ion and 
spare the normal tissue at the opposite side. The light dosimetry for such 
a geometry has never been evaluated. In this study PDT in the broncIms 
is mimicked by ex-vivo experiments on pig bronchi. 
The secOlld aim is to estimate the light distribution in the mucosallayer at 
the inside of the trachea during endobronchial PDT by combining ex-vivo 
experiments on pig bronchi with Monte Carlo simulations for the same op-
tical properties and geometry as the experiment. Once agreement between 
ex vivo and Monte Carlo data is reached, the lat ter can be used to estimate 
the light distribution for varying optical properties and lumen diameters. 
This provides a taal for evaluating light dosimetry during treatment. 
Materials and Methods 
Ex-Vivo Fluence Rate Measurements 
Experiments were performed in the trachea of a fresh, dissected pig-bronchus. 
The trachea was excised and mOlmted verticallyon a stand. For the deli-
very of light we used a 2 cm cylindrical difIusing light source (Quadra Logic 
Technologies, Canada) that was connected to all argon pumped dye-laser 
(Spectra Physics model 2040E/375B) that produced light of 630 nm. The 
light source was positioned in the trachea either on the central axis (cen-
tral) of the trachea, against (proximal) or opposite the site of measurement 
(dis tal) (figure 1) (in contact with the tissue). The output of the diffuser 
was measured with an integrating sphere power meter and adjusted to 800 
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mW, corresponding to the clinically used output of 400 mW lcm diffuser 
lengtil. 
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Figure 2.1: Schematic drawing of th1"ee possible positions of the light SOU1"ce. 
C=central, D=distal and P=proximal to the site of meaSU1"ement (probe 
position indicated). 
The light fluence rate was measured with an isotropic probe (accuracy 
± 15%) constructed with a smal! (diameter 0.9 mm) scattering sphere 
mounted on a quartz fiber (core diameter 200 Jlm), ofwhich the directional 
sensitivity showed a ± 15% deviation from mean for angles from -160 to 
160 degrees relative to forward incidence (van Stayeren et al 1995a). 
The probe was calibrated in air in a home-made integrating sp here with 
built-in laser diodes that provided a stabie diffuse light field at a wayelength 
of 680 nm. With an appropriate conversion factor this provided a reference 
light field of 7.0 mW Icm2 for calibration at 630 nm (van Stayeren et al 
1995a). When the probe is calibrated in air, the fluence rate measured in 
tissue has to be multiplied by a factor 1.7 to account for the losses due 
to the change of refractive index (Marijnissen et al 1987). This correction 
factor was determined empirical!y by comparing the detector response to a 
uniform beam in air and in water. Water serves as a phantom for tissue in 
th is instance because it has a refractive index close to tissue (water: n=1.33, 
--{) Ex-vivo meaSUl'ements and Monte Cal'lo simulatiolls 0- 15 
tissue (mucosa, see section Optical Properties): n=1.37). The correction 
for measurement while pressing the detector against the mucosa reduces to 
1.07 (sd 0.03) and was determined in a similar way by immersing the probe 
halfway into the water. 
The probe was placed either in the trachea on the mtlcosa or gradually 
inserted from the outside in between the cartilage rings lllltil the probe 
was positioned below the mucosa. Measurements \Vere made at 4 different 
positions, viz. (1) on the mucosa inside the trachea, (2) just below the 
mucosa on the edge of the cartilage, (3) in the tissue between the cartilage 
rings and (4) in the tissue just outside the cartilage rings (figure 2). The 
measurement made with the probe pressed against the mucosa yields an 
average value of the fluence rate in the mucosa and in air. Those fluence 
rates will be different because of the change of refractive index. 
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Figure 2.2: Places of measurement on and in the trachea wal!. (1) on the 
mucosa inside the trachea, (2) just underneath the mucosa, (3) in between 
the cartilage rings and (4) in the tissue ju st outside the crtrtilage rings. The 
mean depths (n=5) of positions 1..4 are 0, 0.9(0.1), 2.1(0.5) and 3.5(0.4) 
mm respectively (sd in parentheses), 
In some experiments the position of the probe in the tissue relative to the 
diffuser was varied to measure at the tip, the centre and the bot tom of the 
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diffuser. The influence af limited tissue thickness autside the trachea was 
investigated by camparing the readings at position 4 withaut and with some 
extra tissue added at that position. The variations found were only minor 
compared to the error in the measurement, and therefore the influence of 
the tissue thickness is only minor. 
Optical Properties 
The optical properties of the mucosa were determined with a double-inte-
grating-sphere set up eombined with an Inverse Adding Doubling (IAD) 
algorithm (Pickering et al 1993). This setup yields values for the scat tering 
eoefficient I-'s and the absorption eoefficient I-'a as weil as the anisotropy 
factor g. The index of refraction of the mucosa was found to be n=1.37 
(± 0.01 for 450 nm < À < 650 nm), by measurement of the critical angle 
of interface between tissue and glass (n=1.73, À = 630 nm (van Staveren 
1995b)). The optical properties were measured aftel' the ex-vivo experi-
ment. The mueosa was seperated from the eartilage and and the tissue 
samples were either measured immediately or aftel' keeping them refrige-
rated in saline overnight. The optical properties of the supporting eartilage 
rings were also measured. 
From I-'a, I-'s and 9 the other relevant optical properties ean be derived, 
aecording to I-'t = I-'s + I-'a, I-'tr = I-'a + I-'s(1- g) and I-'eff = ..J3I-'al-'tr. which 
are the total-, transport- and effeetive attenuation coefficients, respectively. 
Monte Cal'lo Simu\ation 
The Monte Cat'lo code was adapted from the code used to simulate whole 
bladder wall illumination (Keijzer et al 1991). The geometry of the expe-
riment was modelled as a cylinder of air (diameter typically r=18-20 mm) 
embedded in a cylindrieally symmetrie semi-infinite medium (height h=50 
mm, outer radius r -+ 00). The chosen height was typical for the length 
of trachea that is used in an experiment. Making the slab thieker resulted 
in no significant changes in light distribution and for the sake of spatial 
resolution the slab thickness was kept limited. The air in the cylinder 
has negligible absorption and seattering, and the index of refraction is 1. 
The semi-infinite medium has the optical properties of the mueosa layer at 
the inner side of the trachea at À=630 nm. The linear light source with 
a lengtIl of 2 cm is modelled as a eontillllOus distribution of ideal isotro-
pic point sources placed on the central axis of the cylinder (figure 3). An 
-<) Ex-vivo measurements and Monte Carlo simulations 0- 17 
estimate of the error in the simulation is calculated from the standm'd de-
viation of 5 consecutive runs of 25000 photons each. The total output (Le. 
the summed contributions of all point sourees) of the source was adjusted 
to fit the output of the source in the ex vivo experiment as measured with 
an integrating sphere. 
I 
i 
20.1~ mm 
I 
( I , 
I MUCOSA Il n, g, IJs. I-Is , , 5 cm 2~'" -
1 i AIR! ! 
G 
Figure 2.3: Schematic "epresentation of the cylindrical Monte-Ca1'lo model. 
One layer of mucosa was simulated, of thickness 5 cm and a mdius l' --+ 00. 
The 2 cm light souree consist of homogeneously dist"ibuted isotropie point 
sour'Ces. The cavity has a diameter of typically 18-20 mm and is filled with 
air as is the spa ce outside the slab of mucosa. 
In the tissue, the measured and simulated fluence rate may be readily com-
pared. The measurement at the surface (position 1) with the probe partly 
in the tissue is approximated by a volume element on the border of the 
tissue, with one surface facing the air in the cavity. In general however, the 
optical properties of the probe material differ from those of the tissue. This 
causes local changes in the light distribution and introduces inaccuracies 
(Marijnissen 1993c). 
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Results 
Ex vivo measurements 
The fluence rate measured in the mucosa and the tissue in between the 
cartilage rings for one trachea is shown in figure 4. The fluence rate in air 
was measured beforehand with an isotropic probe, at a distance from the 
diffuser equivalent to position 1 (figure 2) in the absence of tissue. This 
value <Po is used to define a fluence rate build-up factor (3 in analogy with 
earlier work in the bladder (van Staveren et al 1994). This factor relates 
the true fluence rate <Pfrue in the mucosa to the unscattered incident light 
coming directly from the lillear diffuser. 
(3 = <Plrue 
<Po 
(2.1) 
The measured <Po is in reason"ble agreement with calculations of simple 
models with either a linear light source that emits light only perpendicularly 
to its length Or a superposition of isotropic point sources (see below). In 
the first case <Po is descrihed by 
P' 
<Po (1' ) = (2nr) 
and in the second case 
P' 
<po(T, I) = -( -) arctan(lj21') 2n1' 
(2.2) 
(2.3) 
where l' is the radial distance from the diffuser [cm] and I is the length of 
the diffuser [cm]. P' is the radiant power per cm diffuser length [mWjcm]. 
For the experiments I = 2 cm, l' "" 1 cm and P' = 400 mWjcm, which 
yields a fluence rate of <Po"" 64mWjcm2 in the first, and <Po "" 50mWjcm2 
in the second case. On average (n=7), both formulas underestimate the 
measured (non-scattered) fluence rate by 7% and 22%, respectively, which 
is of the same order of magnitude (±15%) as the error in the measurement. 
The data in figure 4 are for a trachea with a diameter of 20(1) mmo The 
measured <Po was 56 m W j cm2 • The fluence rate in air as a function of 
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Figure 2.4: Fluenee mte measured on and in the tmehea wall, on positions 
1-4 described in the methads seetion. The linear diffusing light souree of 
2 cm length emits 800 m Watt of light at À =630 nm. The light souree 
was placed either centrally, distally 01' p1'Oximally. The estimated elTO?' in 
measurement is 15%, except for the measurement on position 1, p1'Oximai 
(see text). 
distance is also indicated for reference. It can be rollghly described by a 
1/1' relationship (1' = radial distance between diffuser and probe). When 
the diffuser was placed centrally, we observed a build up factor (J = 3.1 on 
the mucosa (position 1) and (J = 6.3 just underneath (position 2). F\n'ther 
in the tissne (positions 3,4) the fluence rate decreases, though not as rapidly 
as in air. 
The fluence rate build-up for the distal placement showed the same depen-
dency on distance in the tissue with an amplitude of about half that of the 
central illumination. The ratio (J on position 1 and 2 now is 2.0 and 3.7, 
respectively. 
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Proximal illumination increased the fluence rate considerably. (3 values 
of 21.4 and 33.4 are a factor 6.9 and 5.3 higher on position 1 and 2 as 
compared to the central iIIumination. The error in the measurement of the 
fluence rate on position 1 was rather large (35%) because small variations 
in diffuser postioning caused rather large variations in the measured fluence 
rate. This error implied an uncertainty in delivered fluence rate of a factor 
of", 2(35% x 6.9). These fluctuations were absent when we measured on 
position 2. Dceper in the tissue the fluence rate decreases similarly to the 
first two cases. 
Figllre 5 shows data from 6 tracheas. To make an inter-specimen compa-
rison to evaluate the influence of diffuser positioning, we normalized the 
fluence rates to a reference value, <Pref' This is the fluence rate observed 
on position 1 and central iIIumination. We chose this value for nor mali-
sation because this will be the only value that might be measured during 
treatlnent. 
The fluence rate was significantly lower in the dis tal case, as the average on 
position 1 is 0.64 (sd 0.02). Proximal positioning caused an increase of a 
factor 4.0 with a standard deviation = 0.9, indicating an overall fluence rate 
uncertainty of 90%. On average a slight, though not significant, increase of 
fluence rate could be observed just underneath the mucosa. The fluence rate 
measured just outside the cartilage rings (position 4) is still considerable. 
The measured fluence rates were 49(8)%,43(5)% and 137(29)% of <Pref for 
centra I, dis tal and proximal iIIumination respectively. 
The mean values 1'01' (3 1'01' central iIIumination are summarized in table 1. 
The truc flucnce rat es on positions 1-4 have been divided by <Po for each 
Position 1 2 3 4 
(3 4.9(1.7) 6.2(2.9) 4.9(3.1) 2.1(0.5) 
Table 2.1: Mean (n=6) (3 values (Eq. 1) fOl' positions 1-4 (figure 2) in the 
trachea wall, standm'd deviation in parentheses. 
individual specimen. The fluence rate tended to be built up to a maximum 
just below the mucosa (position 2). 
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Figure 2.5: Avemge of the measured fiuence rate in different tmcheas (n=6) 
with a diameter varying lram 18-20 mm. The fiuence mtes f01' each indivi-
dual trachea were normalised to the fiuence rate measured on position 1 for 
each specimen, centrally to correspond with the normal treatment protocol. 
Fluence rates were measured on positions 1-4 (see Methods) with the light 
source placed centmlly, distally 01' proximally. 
Monte Carlo Simulations 
Optical properties 
The averaged (n=5) optical proper ties of lung mucosa and cartilage are 
sllmmarized in table I1. The specimens were taken from 5 of the 6 tracheas 
used for the ex vivo dosimetry experiment. The mean thicknesses of the 
mucosa and cartilage layers were 0.9(0.1) mm and 2.6(0.4)mm. The inter-
specimen variatioll of optical properties is rather large which is reflected in 
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Tissue absorption scattering anisotropy 
type Pa (cm-I) Ps (ClU- I) g(-) 
lnucosa 0.22 (0.17) 113 (19) 0.80 (0.06) 
cartilage 0.10 (0.06) 43 (17) 0.56 (0.11) 
Tissue total attenuation transport attenuation efl'ective atteuuation 
type Pi (cm- t ) Pt,. (cm- t ) I'eff (cm- t ) 
lnucosa 113 (19) 22 (5) 3.9 (0.9) 
cartilage 43 (17) 19 (5) 2.2 (0.6) 
Table 2.2: Mean values of optical properties of bronchial mucosa and cw·ti-
lage for À =630 nm. Standard deviations for n=5 specimens in parentheses. 
high standard deviations. The variation of Pa is most prominent (77% and 
60% for mucosa and cartilage, respectively). 
Cartilage tends (though not significantly) to be less absorbing, and is signi-
ficantly less scattering than mucosa. On the other hand, cartilage is a more 
isotropic scatterer. This is reflected in the 9 value, which is significantly 
lower for cartilage. The 9 and Ps values combine to about equal transport 
attenuation coefficients (Ptr) for both tissue types. The low absorption of 
cartilage results in alowel' effective attenuation (lIef f). 
The optical proper ties for mucosa and cartilage of the trachea that was 
simulated are summarized in table lIl. These values were measured for a 
different trachea than that used for the data of figure 4. The values are com-
parabie to the average values in table Il within the error of measurement. 
The lumen diameter was 20(1) mm, the mucosa thickness was 1.0(0.1) mm 
and the cartilage thickness was 3.2(0.1) mmo 
Simulations 
The calculated and the measured fluence rate in this trachea are shown in 
figures 6 A and B. Generally speaking, the measured and simulated data 
were in agreement. This in spite of the fact that the trachea was modelled 
as consisiting only of mucosa without accounting for the cartilage. The 
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Tissue absorption scattering anisotropy 
type pa (cm-I) ps (cm-I) g (-) 
ll1ucosa 0.15 (0.02) 81.2 (0.9) 0.77 (0.01) 
cartilage 0.040 (0.006) 29.4 (0.5) 0.45 (0.01) 
Tissue total attennation transport attenuation effective attenuation 
type Pt (cm-I) l't1' (cm-I) I'eff (cm-I) 
lnucosa 81.4 (0.9) 18.7(0.5) 2.9 (0.2) 
cartilage 29.4 (0.5) 16.2(0.8) 1.4 (0.1) 
Table 2.3: Optical propeTties of branchial m1tcosa and caTtilage of sim1tlated 
trachea fOT À = 630 nm. StandaTd deviations fOl' n=4 spots on the specimen 
in parentheses. 
error in the l11easurement (15%) is larger than the statistical fInctuations 
in the sil11ulation (2-3%). 
In figure 6 A the fIuence rate in the tissue is presented. The measured and 
Monte Carlo data agree in the 111ucosa layer, but start to deviate in the 
cartilage region as is to be expected. The simulated fIuence ra te is 50% 
lower than the measured ftuence rate at the outer edge of the cartilage. 
In figure 6 B the fIuence rate inside the trachea on the l11ucosa surface 
is presented. The measurements were made opposite the tip (-lOmm), 
the middle (0 mm) and the tail (10 mm) of the difI·user. The measured 
fIuence rate opposite the tip was higher than that opposite the tail. This 
was probably caused by the (non-ideal) output characteristics of the linear 
diffuser. The effective length of treatment is langer than the diffuser lengtil. 
If the 37% (l/e) value of the maximum fIuence rate is taken as a measure, 
the treated length is "" 32 mm. 
We caleulated the inftuence of the error in the measurement of the optical 
properties on the outcome of the Monte Cm'lo simulation by performing 
simulations with the above used values plus or minus the standm'd deviati-
ons. We found that the infIuence of variations in g and Ps were only minor 
(5% and 2%, respectively). The infIuence of the variations in Pa were lar-
ger, especially when the value was lowered by 1 standm'd deviation. This 
yielded an error of 12 %. Varying the diameter of the lumen by 1 m111, 
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Figure 2.6: Comparison of measured fiuence mte (dots) and Monte C01·10 simu-
lated data (solid line) for central illumination with 2 cm linear diffuser· emitting 
800 m Watt of light at À=63Onm. MeasUl·ed data are ± sd (15%) and the Manie 
Carlo data ± sd calculated from 5 consecutiue runs of 25.000 pilOtons each. A: 
MeasUl·ements in the trachea waU, opposite the middle of the light sam·ce. Positi-
ons of measurement 1-4 with real distance, far mucosa thickness of 1(0.1) mm and 
carti/age thickness 3.2(0.1) mm. The stippled lines indicate tke borders between 
air, rn1ICaSa and cartilage in the ex vivo experiment, B: Measurements on the l1W-
COSa inside the trachea opposite the middle (0 mm), top (-10 mm) and bottom (10 
mm) of the diffuser. The diffuser position is indicated on the x-axis. 
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whieh is the estimated measurement error, resulted in a 6% variation. 
Discussion 
The light dose delivered to the tissue strongly depends on the positioning 
of the diffuser in the lumen. If the diffuser is fixed in the centre of the 
lumen a reproducible and rotationally uniform illumination can be achieved. 
Moving the diffuser towards the visible part of the les ion causes a high and 
variabie inc1'ease in the light dose in the les ion and is accompanied by a 
decrease of dose in the tissue at the opposite side. The disadvantage of such 
a procedure is that the light dose in the lesion is not controllabie, which 
hampers interpretation of dose-response data. Furthennore, the light dose 
is not distributed uniformly across the lumen, thereby underdosing possible 
pre-malignant cells at other sites. Therefore, we strongly reconllnend that 
during endobronchial POT the linear diffuser always be fixed at the centI'e 
of the lumen. 
The scat tering nature of the tissue helps to broaden the treated area and 
increases the light dose by a maximum factor of 6.2 just underneath the 
mucosa (tabie I) when compared to the incident unscattered illumination. 
This factor is of the same order of magnitude as observed in pig bladder 
((3 = 5.0) (van Staveren et al 1994), which has approximately the same 
optical properties but a different geometry. Lesions that invade between 
the cartilage rings mayalso be treated, as the fluence rate decreases only 
slowly with increasing depth (figure 5). 
The measured optical properties (tabie II) for the mucosa were different 
from the f1.eJ J = 9.1 cm- 1 for human mucosa reported by Cheong et al 
(1990). Nevertheless, with our set of optical proper ties we were able to 
obtain agreement between the Monte Carlo simulation and the ex vivo 
experiment, especially in the mucosa. 
The measurent of f1.a is the most critica!. The outcome of the simula-
tion strongly depends on the value of f1.a, and table II shows a large inter-
specimen variation of the absorption. This indicates that there is a great 
need for non-invasive in vivo methods for the accurate determination of 
optical properties (e.g. Patterson et al 1989). 
The measured fluence rate outside the mucosa, in between the cartilage 
rings, is higher than the simulated fluence rate. This is caused by the in-
adequate modelling of a semi-Î11finite medium consisting of only mucosa. 
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The underestimation of the true fiuence rate can be understood qualitati-
vely by taking the properties of the cartilage into account. The cartilage 
of the example trachea is less absorbing and more isotropically scat tering 
than the mucosa (see table UI), which may result in a higher light dose. 
An additional factor is the change of refractive index from tissue (n=1.37) 
to air (n=1.00) outside the cartilage, which causes internal refiections and 
thereby an increase in light dose. 
On average, we observed an increase in fiuence rate just below the mucosa 
(figure 5, table I) in the ex vivo experiment. This phenomenon did not occur 
in our Monte Carlo simulations. This observation might be explained by the 
same arguments as above. Indeed, on average the cartilage is less absorbing 
and more isotropically scat tering than the mucosa (tabIe U). Despite the 
inadequate modelling we were able to predict the light dose in the mucosa, 
and we expect that further improvement of the model wil! allow prediction 
of the fiuence rate in the cartilage region. 
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Abstract 
The distribution of the light emitted by Iinear light diffusers commonly em-
ployed in PhotoDynamic Therapy (PDT) has been investigated. A device 
is presented which measures the angular distribution of the exiting light 
at each point of the diffuser. With these data the fluence rate in air or in 
a cavity at some distance from the diffuser can be predicted. The results 
show that the light is scattered from the diffuser predominantly in the for-
ward direction. Experiments and calculations show that the fluence rate in 
air and in a cavity of scattering tissue at some distance from the diffuser 
has a maximum near the tip of the diffuser, instead of near the middle. 
However, the fluence rate resulting from an interstitial diffuser in a purely 
scat tering tissue phantom shows a maximum in the bisecting plane of the 
diffuser as would be predicted when the diffuser emitted light isotropically. 
The scat tering nature of the tissue is expected to cancel the anisotropy of 
the diffuser. 
Introduction 
Linearly diffusing light sources are commonly employed for PhotoDynamic 
Therapy (PDT) in cylinder-like hollow organs such as the broncIms (Ma-
rijnissen et al 1993) and the oesophagus (Overholt et al 1994). Interstitial 
iIlumination is also employed, e.g. in the brain (Ji et al 1992) and more 
frequently in animal models (e.g. Cairnduff et al 1995). The dosimetry 
in these treatment modalities is Iimited to the specification of the radiant 
power per cm diffuser length, without specification of the angular power-
distribution of the emitted light. Monte-Cat'lo simulations and radiative 
transfer theories for these treatments mostly employ a model of a Iinear 
light SOUl'ce that consists of a row of ideal isotropic point sources (e.g. 
Murrer et al 1995). The present study investigates the influence of the 
expected non-isotropy of these point sources. 
In clinical practice, during treatment of a hollow organ Iike the trachea, the 
output of the diffusers is assumed to be a cylindrically symmetrie, uniform 
field along the length of the diffuser, which is too simple an approach. 
Indeed, measurements of the fluence rate at some distance from the diffuser 
have shown a forward directed scat tering from the diffuser (Feather et al 
1994), with a non-uniform distribution parallel to the diffuser. During 
interstitial application, the scat tering and absorbing properties of the tissue 
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wil! also determine the light distriblltion in the tissue. 
In this paper we present a device that provides a means of checking the 
qllality of a linear light diffuser by measllring the angular distriblltion of the 
emitted light from the diffuser, and an algorithm to determine the fluence 
rate in air at some distance from the diffuser. Also the influence of the 
presence of scat tering tisslle (bulk or a cavity wall) has been investigated. 
Materials and Methods 
The anglliar distribution of the light emitted by a linear diffuser is measured 
by the apparatlls shown in figure 1. A (black) measuring head is mounted 
on a rail and ean be moved by computer-control. In t.his head 5 detectors 
are mounted at different angles with respect to the surface that will be 
measured, viz. at 30, 60, 90, 120 and 150 degrees. The augles are defined 
relative to the direction of the incoming light from the libre. The detector 
at 30 degrees therefore measures light that is emitted in a forward direction. 
The detectors are constructed with a lens (diameter 2 mm) mounted at a 
fixed distance from a cleaved bare fibre, in such a way that an image of the 
measured surface is formed on the fibre surfaee. The light is then trans-
ported through the fibre to photodiodes (PhotopT 455, United Detector 
Technologies), and the signalof the diodes is A/D-converted and stored 
on the PC's hard-disk. The light source we used for all experiments and 
calibrations is a HeNe-laser (,\ = 632.8), with an output. ofseveral mWatts. 
The setup with 5 fixed angles offers a quick method for measurement of the 
outpllt of a linear diffuser, which is desirabie for clinical llse. 
We used a lens with a focal distance of / = +3.5 mm, fixed on the image 
distance of di = 7 mm (2/) of the fibre (figure 1). Using the lens-formula 
(1// = l/d; + l/do ) this means that the fibre surface has to be placed 
at the object distanee (do = 7 mm (2/)), while measuring the output 
of the fibre in air. Such a set up measures the radiance at a point of the 
surface (Watt/(sj' m2)). The detectors are calibrated relative to each-other 
by measuring the radiance of an isotropic spherieal diffuser, whieh should 
yield the same reading for each detector (see figure 1). 
The 5 detectors sample one common point on the diffuser sm'faee. By mo-
ving the head parallel to the diffuser the entire diffuser surface is sampled. 
The surfaee is divided into sections by making measurements at 0.5 mm 
intervals. The diffuser is also rotated 90 degrees along its axis, and the 
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Figure 3.1: Schematic represenlation of the measurement device. The light 
ellters the dij)'user from the dght side (arrow) through a supply fibre. The 
side where the light ellters the diJfuser is delloted as the taiJ, the distal end 
of the diffuseris de/wied as the tip. These conventions are maintained in 
all figures. One point of the diffusing surface is sampled from 5 angles 
(3{f',,15{f') by 5 lenses. The measuring head can be moved parallel to the 
dijfuser. The stop reduces scaftered light from other parls of the dij}'user 
sU/jace. The dashed circle indicates the position of the isotropie spherical 
diJfus€/' for ca{ibration. 
measurement is repeated to check for cylindrical symmetry of the emitted 
radiation patten!' To check for intra- and inter measurement variations we 
performed a series of measurements with and without. removing and repo-
sitioning the tibre be.tween measurements. Influence of scat te red light from 
other than the sampled part is minimized by putting a stop (diameter 2 
Olm) over the diffuser surface which leaves only the sampled part visible 
(figure 1). 
The radiance measured at 30,,,,150 degrees is used to estimate the radiance 
in the directions that we re not measured by fitting a sixth-degree Lagrange 
interpalation polynomial (Abramowitz and Stegun, 1970) through the me-
asurements at 5 angles and asstllning that the radiance at 00 and 1800 is 
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zero. This yields a curve for each element n of the surface that is measured 
for eaeh angle a, denoted as L6,n(a) (figure 2, part B). This polynomial 
does oecasionally result in small negative values for the radiance, whieh is 
not realistic. In sueh a case, the absolute value of this radianee is used, but 
this does not represent a large contribution to the tota!. 
From the results of the diffuser-tester the measured fluenee rate r/>(d, z) 
(Watt/cmZ) at a certain distanee d from the linear difftlHer and a distanee 
z from the tip of the diffuser can be predieted. This is aehieved by summing 
the contributions r/>n(d, z) of the N separate sections that are measured (Eq. 
3.1). 
N 
r/>[d, zJ = L r/>n[d, zJ (3.1) 
n=l 
These seetions have the co-ordinate X n as indieated in figure 2 (part B). The 
contribution of one seetion to the fluenee rate is the irradianee eaused by 
this seetion on the surface perpendieular to the direct ion of the ineoming 
light. The radianee in this direct ion is determined by the interpolation 
polynomial L6,n(an[d, zJ) (figure 2, part A). 
The irradianee in the direct ion of the measurement is then determined by 
firstly multiplying the radianee by the eosine of the angle CYn (Eq.3.2) with 
the normal to the surface and by the projection of the diffuser surface An of 
eaeh element (in a plane perpendieular to the plane of figure 2 B). Assuming 
a eylindrically symmetrie emission pattern, this projeeted surface becmues 
equal to the surface of the seetion parallel to the axis of the linear light 
souree which is the length of the section (L/N) multiplied by the diameter 
of the diffuser D (Eq. 3.3). Seeondly, the radianee is divided by the square 
of the distanee r n (Eq. 3.4) from measurement site to seetion surface to 
go from power per solid angle (W /sr) to power per surface area (W /mZ). 
This leads to a contribution of eaeh seetion aeeording to Eq. 3.5. 
cyn[d, zJ = aretan((z - xn)/d) 
L 
An= N D 
(3.2) 
(3.3) 
(3.4) 
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Figure 3.2: A : Example of a sixth-degree polynomial fit through the measu-
rements at 5 angles (3(J' .. 15(J' ) and the assumed values of 0 f07' (J' and 18(J'. 
Measu"ements are from a section in the middle of a typical diffuser with 
strongly forward scattering. B : Definition of the geometry f07' calculating 
the fluence mte in air at a perpendicular distance d from a diffuser of length 
Land a distance z from the tip of the diffuse,'. X n is the center-coordinate 
of one section, which is at a distance "n from the point of measurement. 
"'n represents the angle of the vecto,' 1'n with the normal to the surface of 
the section n. The light enters the diffuser from the right side (arrow). 
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1 
tPn(d,z) = L6,n(a,,[d,zJ) cos(an[d,zJ) 2[d J A" (3.5) 
rn ,z 
The error introduced by the assumption that the radiance at 0 and 180 
degrees is zero is reduced by the fact that the eosine of a is small in this 
region. Therefore the contribution to the total fluence rate at these angles 
is smal!. 
The calculations of the distribution of the fluence rate are verified with a 
measurement of the actual fluence rate at a distance cl from the diffuser 
on an axis parallel to the diffuser (figure 3, part A). The fluence rate is 
measured with a fibre-optic isotropie probe, of which the construction and 
calibration have been described by Marijnissen and Star (1987, 1996) and 
Van Staveren et al (1995). The influence of the presence of a eavity-wall 
of scat tering tissue has been examined by repeating the same procedure as 
above inside a dissected pig trachea with a radius 7' "" cl (figure 3 part B). 
Interstitial treatment was simulated by immersing the linear diffuser in a 
liquid phantom (water with IntralipidT ). This 33 mI/I 10% IntralipidT in 
water solution has a scat tering coeflicient Jls = 16 em- 1 and an anistropy 
factor 9 = 0.768 with very small absorption (van Staveren et al 1991). This 
phantom served as an example to look at the influence of scattering only, 
whieh serves as an indieation for the phenomena that can be expected in 
real tissue. The influenee of added absorber is beyond the scope of this 
article. The fluenee rate was measured with an isotropic probe which was 
also immersed in the phantom at a distanee cl from the diffuser. Before 
the Intralipid was added, the fluenee rate was also measured to investigate 
the influenee of the refraetive index of the surrounding medium (water, 
n = 1.33). 
Results 
The diffusers we tested were kindly provided by PDT Systems (Santa Bar-
bara CA, USA), Quadra Logic Technologies (Vaneouver, Canada) and Rare 
Earth Medical (Dennis MA, USA). Their diameters varied from 0.5 to 2.5 
mm, and their lengths from 1.0 to 3.4 cm. A typical example of the radi-
anee pattern from a eommercially available diffuser is presented in figure 4. 
This diffuser has a diffusing tip that is emitting light from a length of 34 
mm long (PDT System's specifieation: 30 mm) and has a diameter of 1.2 
mm. We wil! use this diffuser throughout this paper, as it is representative 
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Figure 3.3: A: Geometry for the measurement of the fluence rate at 1 cm 
perpendicular distrmce from a linc([1' diffuser of 3.4 cm length. The isotropic 
probe is mooed parallel to the diffusE/', with the light. entering from the right 
side (a rrow). This setup is employed for measurement in air, water and 
a /.issue sim ulating phantom where both difj'lIser and detector are in the 
medium. B: The measurement in the trachea is performed with the linear 
dijJuser in air (at the ceilIre of the lumen) and the isotropie probe embedded 
halfway in tlre mucosa of the trachea, as shown in the cross-section drawing. 
for most diffusers beeause it shows strongly forward seattering. 
The most striking feature of t.his and other diffusers is that the radianee 
in the forward directions (30 0 and 60°) is mueh higher than in the other 
direetions. The radianee in the 90°, 1200 and 150° directions are mueh alike. 
Diffusers are aften tested by moving a photodiode or a bare libre with a stop 
parallel to the diffuser surfaee and then measuring the (ir)radianee. This 
more or less eorresponds to our 900 measurement. Compared to the 90° 
radianee, the 30° radianee is ,,"10 times higher. This and other diffusers were 
also rotated aroUlld the libre axis and measured again. The readings then 
showed differenees that were as large as the measurement error, therefore 
it is reasonable to assume rotational symmetry. 
The diffuser appears to have a part (27 to 34 mm) wh ere the radianee for 
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Figure 3.4: Radiance in 5 directions on the surface of a linear diffuser that 
is a typical example f01' commercially available diffusel's. The detectors are 
only ealibrated relative to each-other, therefore the radiance units are arbi-
trary (a. u.). Error bars indicate the standard deviation f01' 5 measw'ements 
with removing and repositioning between measurements, the average SD is 
in the order of 10 %. For clm'ity, only the error bars in the 3(f' direclion 
are indieated. Light is entering the diffuser /rom the right side (arrow) and 
the solid vertieal lines denote the ends of the diffuser. 
all angles is relatively low. In the region 5 to 25 mm the radiance is more 
or less constant within one direct ion. The modulation that is seen on the 
radiance profiles of all directions and most prominent at 600 and can also be 
observed with the naked eye. This particular diffuser consists of parts with 
different concentrations of scattering particles, visible as slightly darkeI' and 
brighter areas. The 300 radiance also shows a non-zero reading at points 
beyond the tip of the diffuser. This reading was minimized by using a stop, 
but there still remains a component which is probably caused by reftections 
off the end-mirror that most diffuser-designs have at the tip. 
The distribution of the ftuence rate that was measured at 1 cm distance 
from this diffuser in air is depicted in figure 5, together with the ftuence rate 
that was predicted by the algorithm described in the methods section. The 
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Figure 3.5: Comparison between meas!l1'ed (soliriline) anri calculateri (dash-
dotted line) fiuence mte at 1 cm distance from a 3.4 cm linear diffuser. Bath 
curves have been nonnalised to their maximum va!!te. Bolid vertical lines 
denote the ends of the diff!lse7'. Light enters the diffuse,> from the right side 
(arrow). 
distance of 1 cm was taken becanse this is a typical diameter for a human 
trachea, a possible area of application for such a diffuser. The figure shows 
that in bath the measurement and the calculation the forward scattering 
results in a lIuence rate pattern with a maximum value at 5.5 mm from 
the tip. The calculation is not fully in agreement with the measurement, 
but gives an adequate prediction of the place of the maximum and a good 
impression of the shape of the curve. The maximum of the lIuence rate 
that was measured in air was 0.44 mWatt/cm2 with a total dill>user output 
of 3.4 mWatt (1 mWatt/cm diffuser length). 
Figure 6 shows what happens to the lIuence rate if bath diffuser and detec-
tor are immersed in a liquid scat tering phantom (IntralipidT ). This setup 
mimics an extreme case of interstitial treatment. The lIuence rate in air is 
also shown as a reference. The lIuence rate increases strongly (by a factor 
of 5.6) because of the multiple scat tering, and the position of the maximum 
shifts to 18(±1) mm, which is close to the middle of the diffuser at 17 mmo 
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Figure 3.6: Fluence mte measurements in the geometry depicted in flgure 
3. Bath diffuser and detector are immersed in the same medium, ai1·, water 
and an Intralipid! solution, ,·espectively. The standard deviation in measu-
rement for repeated measurements is 5% (n=5). Arrows indicate the spot 
of maximum ftuence mte at 1 cm perpendicular distance from the diffuser 
with an error of ±1.0 mmo The ftuence rate in all curves is normalized 
to the maximum ftuence rate in air, which is located at 5.5 mmo Fm· the 
Intralipid! the maximum is at 18 mm with a relative value of 5. 1. In water 
the maximum is located at -2 mm with a relative value of 0.9. Light ente,·s 
the diffuse,· from the rigM side (arrow). BoUd verticallines denote the ends 
of the diffuser. 
The fluence rate profile is now almost symmetric relative to the bisecting 
plane of the diffuser. When the difl·user and detector are immersed in water 
then the maximum flueuce rate can be found even further forward than in 
air, at -2(±1) mm with a relative value of 0.9. 
Finally, the fluence rate in the mucosa of a dissected pig trachea (diameter 
19(±1) mm) was measured as shown in figure 3. The output of the diffuser 
was 3.4 mWatt (i.e. 1 mWatt/cm diffuser length). The maximum in fluence 
rate is 2.8 mWatt/cm2 at 8.0 mm, which is a factor of ",,7 higher than the 
maximum found in air. When figure 5 and 7 are compared, the shape of 
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Figure 3.7: Fluenee rate measurement in the mueosa of a pig tr·aehea, ge-
ometTy as depieted in figure 3. The diameter- of tlte tmehea is 19(±1)mm, 
tlte leng th is 'lO(±l) mm. Output of the diffuser- is 3.4 m Watt, equivalent 
to 1 m Wattj cm diffuser- length. Light enters the diffuser- f1'Om the right 
side (ar1'01O), solid vertieallines denote the ends of the diff!lser. The sm all 
ar-r-01O indieates the maximum of 2.8 m Wattjem2 at 8 mm f1'Orn the Up. 
the curve in the trachea stays almast the same compared to the curve in 
air. For example, the fluence rate at 0 mm is 91% of the maximum in air 
and 82% of the maximum in the trachea. At 34 mm this is 16% and 20%, 
respectively. 
Discussion 
We have presented a device that tests the quality of a linear difl·user by 
measuring the angular distribution of the radiance at each point of the 
diffuser surf ace. The radiance in all the diffusers we tested was strongly 
forward directed, a feature that is not generaIlO' known,. but was also re-
ported bO' Spigulis et al (1994) who onlO' investigated the light Cll1itted bO' 
the dis tal end of a linear diffuser. In the case that manufacturers supplO' a 
proof of qualitO' it is a 900 measurement. The lat ter procedure measures the 
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radiance distribution within one direction along the leng th of the diffuser, 
which can be constant and might give the impression that the diffuser has 
a good performance. The procedure fails to measure in other directions, 
which might have a different distribution of emitted power as a function of 
position on the diffuser surface, and more importantly a very different mag-
nitude. We found no depence of the radiance on rotation aroUlld the axis 
of the libre. Diffusers that employ end-mirrors tend to have peaks in radi-
ance near that mirror. We only tested small diameter (0.5 - 2.5 mm) linear 
diffusers which can be used with an endoscope or interstitially. The small 
diameter limits the amount of scat tering bulk, and therefore the number of 
scat tering events before the light leaves the diffuser. The limited scattering 
Illight be insufficient to deflect the incoming light to largel' angles. 
The consequence of the forward scat tering for treatment in a cavity sueh 
as the trachea is that the maximum of the fluence rate on the cavity wall 
is fouud more uear the tip of the diffuser than at the middle, as would 
be expeeted from symmetry arguments. This phenomenon was reported 
earlier by Feather et al (1994) for measurements in air. In previous \Vork we 
already observed the asymmetry in the fluence rate pattern on the trachea 
wall (Murrer et al 1995). During treatment, the light souree should be 
positioned near a les ion with this phenomenon in mind. The algorithm we 
presented to predict the fluence rate distribution in air from the results of 
the radiance measurement also gives a good qualitative impression of the 
fluence rate distribution in a cavity in a practical situation (trachea). If 
an absolute value for the fluence rate is required, one measurement of the 
fluence rate on a lixed distance from the diffuser can be used to seale the 
fluence rate distribution calculated with the algoritlnll. This in spite of 
the fact that the algorithm does not account for the presence of scat tering 
tissue. The presence of the tissue increases the fluence rate (Murrer et al 
1995), but appears not to alter the shape of the distribution. 
Snell's law predicts a more isotropic emission of the light when the refractive 
index outside the diffuser increases (from nair = 1 to nwater = 1.33). This is 
because for a lixed entrance angle inside the diffuser, the exiting ray will be 
deflected more towards the normal (assuming ndiJ Juser ~ 1.5), resulting in 
less forwardly scattered light. In water, however, the maximum in fluence 
rate moves even further forward, implying more forward seattering. This 
ean be explained by the fact that aeeording to Fresnel's law the reflection 
eoefficient deereases (as the differenee between the refraetive indexes drops 
between diffuser bulk and surrounding medium). On average, the light 
will exit the diffuser aftel' fewer reflections and therefore fewer scat tering 
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events, resulting in more forwardly scattered light. This effect turns out to 
be dominant in this case. 
The experiment in the liquid tissue phantom shows that the scat tering by 
tissue ean eliminate the shift in maximum value of the lIuence rate cau-
sed by the forward scat tering of the diffuser and the refractive index ellect 
described above (nussue "" 7l water)' The lIuence rate shows a symmetric 
pattern, with a maximum near the middle of the diffuser. The inlluence of 
added absorber has to be investigated to evaluate the lIuence rate distribu-
tion in real tissue. For interstitial treatment it seems most important that 
the light exits the diffuser homogeneously along the length of the diffuser, 
il'l'espective of the angular distribution. 
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Abstract 
The angular radiance distribution of several linear diffusers used for Pho-
toDynamic Therapy (PDT) was measured. The forward scat tering found 
previously was not observed in these designs. The impl'Oved isotl'Opy leads 
to a better agreement between intended treatment site and actual maxi-
mum of the flnence rate profile when the Iinear diffuser is used in a hollow, 
cylindrical, organ. 
Introduction 
Linear (or cylindrical) diffnsers are commanly emplayed for PhatoDyna-
mic Therapy (PDT), either for interstitial treatment or far intracavitary 
iIIumination of hollow organs sueh as the trachea or the oesophagus. 
In a previous publication we reported (Muner et al 1996) that commercially 
available Iinear diffusers often show a strongly forward directed radiation 
pattel'll. When employed in hollow organs, this causes a forward shift of 
the maximum fluence rate (parallel to the diffuser) on the organ wal!. This 
might result in underdosage of the target area. This pl'Oblem was not 
generally recognised, becanse the appropriate measuring methods were not 
available and the diffusers were designed predominantly for interstitial (or 
'contact') use in tissue. During interstitial use the directional distribution 
of the radianee is not important, because the diffuser surface is in direct 
contact with the tissue. The highly scat tering nature of the tissue cancels 
the anisotropy of the radiance (Muner et al 1996). 
New designs of Iinear diffusers have become available sinee. This note 
presents radiance scans of these designs, focusing on the improved isotropy 
of the radiance. 
Materials and Methods 
The device we used to measure the radiance at each point of the Iinear 
diffuser surface is described in MUITer et al (1996). The device is presented 
in figure 1. It measures the radianee in 5 directions, viz. at 30°, 60°, 
90° 120° and 150° angle with the direct ion of the incoming light from the 
supplying fibre. The detectors consist of a small lens (diameter = 2 mm) 
mounted on a fixed distance from a c1eaved, bare fibre. The radiance of 
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60' 
Figure 4.1: Schemalic represelliatioll of Ihe measurement device. The light 
enters Ihe dij)'user f/'Om the right side (arrow) Ihrough (/ supply fibre. One 
section of the dijj'usillg swface is sampled f/'Om 5 allgles (30' .. 150') by 5 
lenses. The measuring head can be moved pa/'llllei/o the diffuser. The stop 
reduces scaUered light from a/her parls of the diffuS€7' surface. The dashed 
circle indic(des the positiOI! of the isotropic spherical diffuser for calibratiol!. 
the diffuser surface is measured by forming an image of an element of the 
diffuser surface on the fibre slll{ace. The entire diffuser surface is scanned 
by moving the measuring head parallel to the diffuser. The detectors are 
calibrated relative to each other by measuring the radiance of an isotropic 
spherical diffuser, which shOldd yield the same reading for all detectors (see 
figure 1). 
Diffusers of 3 manufacturers IVere tested using 5 m Watt of red light (632.8 
nm) from a HeNe laser. The diffusers were kindly provided by Pat riek 
Thielen Microtechnique (PTM, Geneva, Switzerland), Rare Earth Medical 
(REM, West-Yarmouth MA, USA) and Pion eer (through QLT PhotoThe-
rapeuties Inc, Vancouver, Canada). The dimensions of the diffusers are 
summarized in table I, together with their flexibility. The REM diffuser is 
a rnodified diffuser for interstitial use. For use in hollolY organs an additio-
nallayer of scattering material (white tubing) is used to make the radiance 
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Matmfacturer 
Patrick Thielen Microtechnique 
Rare Earth Medical 
QLT /Pioneer 
LelJgth 
diffuser 
(mm) 
30 
15 
25 
Outer 
diameter 
(mm) 
1.0 
0.6 
1.7 
Flexibility 
Flexible 
Flexible 
Rigid 
Table 4.1: Length, outer diameter and indieation of flexibility of diffusing 
part of the linea!' diffusers 
isotropic. This addition increased the diameter of the diffuser from 0.5 to 
0.6 mmo 
Results and Discussion 
The radiance measurements of the three tested linear diffusers are presented 
in figure 2. In general, the diffusers presented here show a fairly isotropic 
radiance of light emitted from the diffuser surface. The highly forward 
seattering radianee we reported earlier (Murrer et al 1996) ,i.e. relatively 
high 30° and 60° radiances, is absent in these diffuser designs. The isotropy 
of the radianee can be checked roughly with the naked eye, as the observed 
brightness of the diffuser should not vary with the angle under which it 
is observed. Both REM and PTM provide a total output versus position 
plot with each diffuser, that agrees with the average profile measured at 
5 different angles within the errOr of measurement. Both REM and PTM 
diffusers are flexible and thin (tabIe I), which makes them fit for many 
applications. 
The overal! output of the PTM difl'user shows a decrease from the proximal 
to dis tal end, w hich is consistent for al! directions. The radiance profiles 
for the individual angles show a gradual overall decrease of magnitude from 
forward (30°) to backward (150°) scat tering, with the latter still at an 
acceptable level (eg. ~ 80 % of the 30° level at 20 mm). 
The REM diffuser has a better ratio of proximal to distal output, but shows 
some leakage of light outside the intended difl'usillg area. Some smal! peaks 
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Figure 4.2: Radianee in 5 directions on the sUlfaee of three makes of linear 
diffuser·s. The detectors are only calibmted relative to each-other, there-
fore the radiance units are arbitrary (a. u.). The standar'd deviation in the 
measurements is 10 %. For the sake of clar·ity error bars have not been 
indicated. The light enters the diffuser from the right side (arl'Ows) and 
the solid vertieal lines denote the ends of the diffuser. The dimensions of 
the diffuser's are indieated in table J. (A) Patriek Thielen Mieroteehnique 
(PTM) (B) Rare Earth Medical (REM) (e) QLT/Pioneer (QLT) 
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can be observed at the distal end, probably cause by reflections of!' the 
end mirror. The additional layer of scat tering material on the REM difl'u-
ser functions weil to make the radiance of the forward scat tering diffuser 
isotropic. The radiance at shallow angles (ie. 30° and 150°) has alowel' 
magnitude compared to the other 3 angles that are more perpendicular to 
the diffuser surface (eg. the 30° radiance is ab out 80% of the 90° radiance 
at 5mm). This leads to a narrower distribution of incident light on the 
organ wall compared to an isotropic diffuser. 
The QLT /Pioneer diffuser is less consistent in the proximal to distal output 
ratio for different directions (cf. 60° and 150°). Also, the ratio between the 
radiances at different angles is less favourable (eg. the 150° radiance is ~ 
50 % of the 60° radiance at 20 mm). The fact that this diffuser is rigid and 
relatively thick makes it perhaps less versatile for other applications than 
the ones it is used for now (in the bronchial tree). 
The good isotropy of the diffusers presented here will benefit the dosimetric 
evaluation of treatment in hollow, cylindrical, organs because the maximum 
of the fluence rate willnow be located on the wàll of the organ opposite the 
middle of the diffuser, where it is expected to be. There is no longel' a shift 
of the location of the maximum parallel to the diffuser caused by forward 
scat tering of the diffuser. 
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Abstract 
A design of an applicatar for light delivery and light dosil11etry during Endo-
Bronchial PhotoDynamic Therapy (EB-PDT) is presented. The design in-
corporates a linear diffuser that is fixed in the centJ'e of the lumen by a steel 
spring basket that does not block the air flow. An isotropic light detector is 
a part of the design, to measure the light fluenee actually delivered to the 
bronehiallllucosa surface. The applicatol' is designed for use with common 
bronchoscopy equipment, and can be used with bronchoscopes with a large 
biopsy channel (::oó 3 mm). The first clinicalmeasurements were performed 
and caused no additional discomfort to the (noll-photosensitized) patiellts. 
The data showed a cOllsiderable inter-patient variability of the light fluence 
l'ate measured as a result of a fixed output power of the difl·user. This 
fact and the expected strong dependellce of the fluence rate on the lumen 
diameter stress the importance of in situ fluellce rate measurement for a 
proper evaluation of the relationship between light fluellce and biological 
response of EB-P DT. 
Introduction 
To date, light dosimetry in endobronchial PhotoDynamic Therapy (EB-
PDT) has been limited to specifying the total output of the linear diffusing 
light source or an es ti mate of the incident il'l'adiation (in some cases also 
a micro-lens is used). This limits the possibility of interpreting fluence-
response data because the true light dose in the tissue is not known. The 
fluence rate in tissue during EB-PDT depends on the diameter of the lumen 
and on the optical proper ties of the mucosa aml underlying cartilage which 
are generally unknown. It is therefore essential to measure the fluence rate 
during treatment. Few studies on the dosimetrie aspects of EB-PDT have 
been published (Murrer et al 1995, Marijnissen et al 1993). 
In clinical EB-PDT the light source is introduced through a bronchoscope 
and the position during treatment is monitored and adjusted by either 
direct or video mediated visual inspection. It is difficult to avoid move-
ment of the light source due t~, e.g., coughing and the intense laser light 
reduces visibility. Fixation of the light source in the treated lumen is there-
fore required, and central placement in the lumen will ensure homogeneous 
iIIumination on the circumference. Non-central iIIumination induces uncon-
trollabie variations in the light fluence received by the mucosa (Murrer et 
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al 1995). 
For application in the oesophagus, applicators have been developed based 
on a balloon for position fixation of the Iinear diffusing light SOUl'ce and 
unfolding of the mncosa (PanjehpoUl' et al 1992). A design based on a 
rigid cylinder has been published by Van den Bergh et al (1995). These 
authors also developed a balloon method for application in the bronchial 
tree. A drawback of the latter constrnction is that the air 'flow is (partly) 
blocked, which is undesirable for use in patients that already have a reduced 
respiratory capacity. 
This paper preseJlts a design for an applicatol' that incorporates a Iinear 
difl'using light SOUl'ce, a fixation system that does not block the air flow and 
an isotropic pl'Obe that allows for on-Iine meaSUl'ement of the true delivered 
fluence rate and resulting total fluence. The first experiences and dosimetry 
results in humans and animals are presented. 
Materials and Methods 
The design of the applicatol' is presented in figUl'e 1. It is based on a basket 
made out of foUl' flat steel springs (A), that unfold when moved out of a 
catheter (D). The width of the steel springs is 0.3 mm and the thickness 
is 0.1 nun. The applicatol' is unfolded by retracting the catheter from the 
basket at the handpiece. The outer diameter of the catheter (2.6 mm) is 
such that it can be introduced through most flexible bronchoscopes with a 
large biopsy channel (so-called t1'eatment scope). This way the positioning of 
the applicatol' can be performed under visual control. The baskets (MTW 
Fujinon Medical Holland) are normally used to e.g. fix kidney-stones to 
vaporize them with intense laser light. The basket construction offers the 
possibility to have a Iinear diffuser (B) at the centre of the basket, that wil! 
then be fixed in the centre of the lumen in which the basket is unfolded. A 
fibre-optic isotropic light detector is also part of the applicatol' (C). 
The basket 
The advantage of the basket construct ion is that it does not block the air 
flow in the lumen. Variabie diameters of the unfolded basket are available 
to fit to the various lumen diameters that can be encountered. The springs 
cau easily adjust to the local shape of the lumen, and the fixation force 
is spread over the enth'e length of the spring, thereby avoiding local high-
preSSUl'e points on the mucosa. This is of importance, because the diseased 
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Figure 5.1: Applieator for light delivery and light dosimetry in the bmnehial 
tree. (top) Schema tic drawing of the folded applicator in the catheter, and of the 
applicator unfolded in a eylindrieal lumen. The cmss-seetion shows the posiUon 
of the deteetOl' b1llb that is pressed against the wall. (bottorn) Photogmph of the 
unfolded applieatOl'. Clearly visible are the light-diffusing fiber at the eentl~ (E) 
the white bulb of the isotrop;e detector (C) and the steel springs of the fixation 
basket (A). The outer diameter of the nylon tubing (D) that con ta ins the folded 
applicator is 2.6 mm. The blaek dot shown near the pro,"imal end of the applicatol' 
indieates where the detector fibre is attached to the steel spring. 
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tissue tends to bleed easily. Bleeding introduces dark spots that absorb light 
that is then lost for therapy in the target tissue, and generally causes the 
light distribution to be less homogeneous. The width of the steel springs is 
such, that the light from the source is minimally shadowed. AIso, the light 
scat tering by the tissue will even out the shadowing, because the surface 
spread of the light is approximately equivalent to the penetration depth of 
the light in the tissue. The peneü'ation dep th is given by 1htef f and is 
in the order of several millimeters for bronchial mucosa at a wavelength of 
630 nm (Murrer et al 1995) , which is largel' than the width of the springs. 
(/leff = V3/la(/la + fLs(1- g)), with I'a the absorption coeflicient [cm-I], 
l's the scat tering coeflicient [cm-I], and 9 the anisotropy factor [-J). The 
1/ /lef f for green light (514 llln) in bronchial mucosa is in the order of 1 mm 
(unpublished data), which is also largel' than the spring widtll. 
The linear diffuser 
We used a thin linear diffuser (outer diameter 0.5 mm, libre core diameter 
200 fLm, Rare Earth Medical, West Yarmouth MA, USA), with a diffusing 
leng th of 16 mm. The small diameter is necessary to lit the applicatol' 
in the catheter. Diffusers with different lengths (e.g. 20 or 25 mm) arc 
available. 
The isotropic detector 
The detector is attached to one of the springs of the basket. When the 
basket is unfolded the detector is pressed against the mucosa of the tre-
ated lumen, positioned between two springs to avoid erratic readings from 
reflections ofl' the springs. The detector is mOllllted in such a way that 
the bulb is pressed against the mucosa at the location where the maximum 
fluence rate is to be expected. Because the detector libre extends beyond 
the lumen radius, a lateral bend is introdllced in the libre during unfolding. 
This bend acts as a spring and presses the detector against the mucosa. 
The maximum can be predicted by measuring the fluence rate in air along 
the diffuser at a radial distance equal to the radius of the lumen that is 
to be treated (before assembly of the applicator), and the position of the 
maximum depends on the lumen diameter and the output characteristics of 
the linear diffuser (Murrer et al 1996). The detector bulb is placed on the 
les ion to be treated, serving as a reference for positioning of the applicatol'. 
The detector bulb will not introduce a shadowing effect, as the material of 
which the bulb is made has a very low absorption. Also, the penetration 
depth for red (630 nm) and green (514 nm) light will be sufficient to over-
come possible shadowing, as argued above in the case of the springs of the 
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basket. 
The detectors in this study are home made, const1'llcted with a bulb (dia-
meter 0.9 mm) of scattel'Ïng material (HeliosealT Vivadent, Schaan, Liech-
tenstein) mounted on a 100 Ilm diameter quartz core fibre. This small core 
diameter has the disadvantages of being fragile and having a relatively low 
light output. The reason we chose this libre was twofold. The first was 
to have as little friction as possible in the catheter (lengtIl 1 m), to allow 
smooth unfolding of the applicatol'. Secondly, the isotropy of the probe 
improves with a smaller ratio of the bulb diameter to the libre core diame-
ter. So in order to minÏInize the bulb diameter, a small core diameter is 
required. 
The manufacturing procedure of the detectors is patented by Henderson 
(1991) (European Patent, applications no. 90302852.0 and 90309797.0). 
Their isotropy is checked by measuring the response to a parallel beam 
coming from different directions (-160 to 160 degrees angle hom forward 
incidence). The normalized response of the detector has to be within 15% 
deviation from mean van Staveren et al 1995) to be able to measure with 
an accuracy of 15%. A force of 2.5 N (250 gr.) is applied axially to the bulb 
to check the bulb-to-libre connection (van Staveren et al 1995, Hudson et 
al 1993). 
The light output of the isotropic detector libre is coupled to a photodiode 
(Photop UDT-455, Graseby Electronics, Orlando FL USA), and the signal 
is pre-amplilied, A-D converted and stored on a PC. This enables us to do 
real-time monitoring of the fluence rate and the totallight fluence delivered 
to the mucosa. 
Calibration 
The output of the linear difl'user is measured in an integrating sphere, by 
inserting and unfolding the applicatol' in the sphere. Typical output powers 
used are 400 mWatt per cm diffuser length (Photofrin, À =630 nm). The 
integrating sphere has built-inlaserdiodes, that provide a difl'use calibration 
field for the isotropic detector of the applicatol' (6.4 mWattjcm2 for À = 
630 nm, (van Staveren et al 1995)). The calibration voltages are stored 
on the PC for the real-time conversion from photocliode voltage to fluence 
rate. The dosimetry-software is also able to switch the laser on and off, by 
opening and dosing a valve that is placed in the resonator of the dye-laser 
(Spectra Physics 373). 
For the measurement with the detector pressed against the mucosa a correc-
tion factor of 1.07 (±2%) for change of refractive index from air to mucosa 
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has to be introduced (Murrer et al 1995, Marijnissen et al 1996). Note that 
th is correction factor increases to 1.7 (±2%) in the case that the probe is 
fully in the tissue (Murrer et al 1995, Marijnissen et al 1996). With this 
correction, the detector measures the /luence rate in the top layer of the 
mucosa with an accuracy of ± 15% (Marijnissen et al 1996). Because the 
refractive index mismatch causes a jump in the /luence rate going from air 
to tissue, it is very important that the probe is in good contact with the 
tissue. 
If the probe is fully covered with liquid (mucus), the above mentioned 
correctioJl factor of 1.7 must be used, because the liquid has a refractive 
index close to that of tissue. In case of doubt it is preferabie that the 
applicatol' is retracted, cleaned and inserted again. With the bronchoscope 
still in place this is a simple and fast procedure. Also in the presence of 
blood, the applicatol' (and the lesion) must be cleaned, either by rinsing it 
through the bronchoscope or retracting, rinsing and inserting. The presence 
of blood wil! in/luence the light distribution negatively by creating local 
dark spots (especially with green light) and' reducing the total amount of 
backscattered light. 
Measurements 
Measurements with light with a wavelength of 630 nm were performed in 
three (non-photosensitized) volunteers, during a routine bronchoscopy in 
parts with normal, healthy tissue (Laser System: Spectra Physics Argon-
Dye System 171/373). Informed consent was obtained from all volunteers 
before the experiment. An additional measurement was performed in nor-
mal, healthy tissue of a live pig, to relate the previously published ex-vivo 
results (Murrer et al 1995) to measurements in the presence of an intact 
blood-circulation, as this might cause additional absorption of the light. 
The animal experiment was approved by the University Animal Experi-
ments Ethical Committee (DEC: protocol 605-93-03). 
A useful measure for the increase of the /luence rate in the mucosa due 
to multiple scattering is the ratio of the measured /luence rate (<Ptrue) and 
the /luence rate at the same position relative to the diffuser in the absence 
of tissue (<Po), which we called the backscatter factor (3max (Murrer et al 
1995). 
(3 - <Ptrue max - <Po (5.1) 
The /luence rate in the absence of tissue is approximated by (Murrer et al 
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1995): 
'" Pout 
'ro = 2 7f Riumen Ldif fuser 
(5.2) 
where Pout is the output of the linear diffuser (mWatt), LdiJ Juser the length 
of the diffuser (cm) and RIomen the radius of the lumen (cm). 
Results 
Use of the applicator 
The applicatol' was introduced and unfolded in the bl'Onchus of human 
volunteers on four occasions, on three of which the laser was connected 
and a measurement was made. The applicatol' was unfolded in the trachea, 
the bronchi and the sub-bronchi, the main target areas for this device. The 
unfolding went smoothly and was not hampered by the bends in the flexible 
bronchoscope. 
The patients were only anaesthetized locally, and experienced no additional 
discomfort from the procedure. The procedure eould be entirely controlled 
from one PC, which made it fast and simple to perform a measurement. 
The linear diffuser was fixed weil in the lumen of one of the bronchi, and 
no bleeding was observed as a result of manipulations with the applicatol'. 
During positioning of the applicatol', care was taken to keep the detector 
weil in touch with the tissue, which was checked visually through the bron-
choscope. A picture of the unfolded applicatol' in a bronchus of a volunteer 
is presented in figure 2. 
First dosimetry results 
The dosimetry results for the volunteers are presented in table 1. The 
measurements are made in the bron eh us, which has an average diameter 
of 1.2 cm, which we use 1'01' calculation of <Po. The resulting fluence rat es 
show a considerable variation. f3max values range from 2.7 to 7.1 with an 
avel'age value of 4.7 (sd 2.2). 
The dosimetry results for the animal experiment are presented in table 2. 
In these experiments, the placement and measurement were repeated on 
the same location, and the standard deviation of the measured values was 
15%. The measurements were made in the trachea of a pig, with light of 
630 nm and 652 nm. These wavelengths are used for PDT with PhotofrinT 
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Figure 5.2: Unfolded applicator during measurement in the bronchus of 
a (non-photosensitized) volunteer. (A) springs of the fixation basket (B) 
linea)' diffuser (C) detector. 
Voluuteers 
Subject lll'. Pout <Ptrue <Po f3max 
(mWatt) (mWattjcm2 ) (m Wattjcm2 ) (- ) 
±5% ±15% ±1O% ±20% 
1 242 117 43 2.7 
2 241 304 43 7.1 
3 239 183 42 4.3 
Table 5.1: Output of the diffuser Pout , measured fluence mte <Pt,.ue, fluence 
mte in a;,'<po and backscatter factor f3max JOl' 3 volunteers. Wave/eng th = 
630 nm. The mdius of the treated lumen (bronchus) Rlume" is 6 mmo The 
length of the diffuser Ldiffuser = 1.6 cm. Indicated are the estimated eITOI'S 
in the measuTements. 
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Pig Experiment 
Wave\ength Pout <Ptrue <Po (3max 
(nm) (mWatt) (m Watt/ cm2 ) (m Watt/ cm2) (-) 
±5% ±l5% ±10% ±20% 
630 210 61.0 20.9 2.9 
652 179 46.0 17.8 2.6 
Tab\e 5.2: Output of the diffuser Pout, measured fluence rate <Ptrue, fluence 
rate in ai>' <Po and backscalter factor (3max for the trachea of a pig, for 
wave/engths 630 and 652 nm. The radius Rlumen for the trachea is 10 mmo 
The length of the diffuser Ldiffuser = 1.6 cm. Indicated are the estimated 
errors in the measurements. 
and lll-THPCT , respectively. The trachea was cxcised aftel' the experiment, 
and the diameter was then measured with calipers. 
The lllcasured (3max va\ues are lower than thc average fotllld in human vo-
\unteers, but these values are not readily comparabie because they were 
found at different lumen diameters. In the pig, there is no significant dif-
ference in the (3max values fOlmd for 630 and 652 nm. The trachea was 
excised aftel' the experiment, and the diameter was then measured with 
calipel's. 
The total output of the diffuser used in the experiments ranges from 179 to 
242 III Watt, which is in the same order of magnitude as e.g. the PhotofrinT 
protocol (QLT /Lederle P 503/504) for a 16 mm difillser (output 400 m W / cm 
x 1.6 cm = 640 mWatt). 
Discussion 
We have presented a design that improves the methad of light delivery and 
light dosimetry during endo-bronchial PhotoDynamic Therapy (EB-PDT), 
suited for use for the treatment of early stage (non-obstructing) cancel'. 
For (partially) obstructive cancel' and treatment of segments be\ow the 
sub-bronchi an interstitia\ illumination or an illumination with a balloon 
methad seems more appropriate. The CUlTent protocols for EB-PDT have 
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paid very limited attent ion to complicating factors like the influence of 
optical properties, the lumen diameter and positioning of the linear diffuser 
in the lumen that is treated. Currently, the dosÎlnotry in EB-PDT is only 
defined by the output of the light source. 
D'Hallewin et al (1992) and Marijnissen et al (1993) have shown that consi-
derabie variations in diffuse light backscattel' factors can be found in whole 
bladder wal! PDT with light of 630 nm wavelengtil. Huds'on et al (1994) 
shOlved the similar variations in backscattering from skin lesions at the same 
wavelengtil. They observed that whitish lesions, as aften observed in early-
stage bronchial carcÎnoma showed a significantly increased backscattel' fac-
tor. Our first results also show considerable variations in the backscattel' 
factor (3max. These variations are mainly caused by variations in the optical 
properties of the (nonnal) mucosa, perhaps caused by differences in blood 
contents. Errors in the estimation of Rl",,,en and therefore cpo also have 
an influence. Small variations in the tissue absorption can have a large 
influence on the tissue backscatter factors, as we previously showed with 
the help of Monte-Carlo simulations of the light distribution of an ex vivo 
pig trachea (MuiTer et al 1995). 
The position of the isotropic probe should be monitored, to make sure it is 
in contact with the tissue. If mucus is present, the probe should be cleaned 
or an appropriate correction factor should be used. It is important to keep 
the ilIuminated area free from bleeding, to avoid underilluminated spots 
and to profit maximally from the enhancement of the fluence rate through 
backscattering. Care must also be taken to keep the probe free from blood, 
to avoid faulty (too low) readings of the fluence rate. 
The diameter of the lumen that is treated is also an important factor for 
the total light dose in the tissue. The magnitude of the incident light 
dose is roughly proportional to the inverse of the lumen diameter, and that 
factor alone causes a considerable variation (67%) when moving from eg. 
the trachea (Diameter = 20 mm) to the broncIms (Diameter = 12 mm). 
Furthermore we have shown that the positioning of the linear diffuser in 
the lumen (on- Ol' off-axis) is crucÎal for the resulting light fluence (Murrer 
et al 1995). 
All these factors taken together prove that it is difficult to perforlll a wel!-
defined fluence-response study without in-situ measurement of the fluence 
rate. The design we present here offers a possibility to do so, alboit with 
only one measurement site. For an applicator design that can be used with 
,tandm'd bronchoscopy equipment this seoms the m~xilllum achievable. 
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The EB-PDT applicatol' published by Van den Bergh et al (1995) has 
the advantage of homogenizing the light by the scat tering material at the 
surface of the fixation balloon. A disadvantage of this method is that the 
air flow in the treated lumen is blocked, so that it cannot be used in, e.g. 
the trachea. Fritz et al (1991) published a design th at was intended for 
use in brachytherapy which employs a catheter for feeding the iridium wire 
with a largel' concentric secOlid catheter with glits at the distal end that 
unfold when pushed up at the pl'Oximal end. This design might prove a 
useful concept also if e.g. an isotl'Opic detector would be incorporated. The 
data from the pig experiment show a lower f1ma,,-value for 630 lUll illumi-
nat ion of the trachea in-vivo (2.9) than found during a series of ex-vivo 
measurements (average 4.9, sd 1.7)) (Murrer et al 1995). This may weil be 
attributed to the additional absorption intl'Oduced by the blood flow that 
is absent in the ex-vivo material. 
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and eccentric light sources. 
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Abstract 
A Monte Carlo model is presented for the illumination of a cylindrical ca-
vity by a linear diffuser, which is employed to compute the fluence rate 
distribution during endo-bronchial PhotoDynamic Therapy. The influence 
of geOlnetrical parameters such as the diameter of the treated lumen, the 
length of the linear diffuser and the possible off-axis position of the diffuser 
on the fluence rate have been investigated, as weil as the consequences of 
varying output characteristics of the diffusel's. For on-axis isotropic dif-
fusers some simple practical rules are derived to estimate the fluence rate 
profile on the wall for varying diffuser length and lumen diameter. With 
linear diffusers that can be modelled as a row of isotropic point sources, a 
constant fluence rate build-up factor can be employed for varying diffuser 
lengths and lumen diameters. Extreme off-axis placement of the diffuser 
causes a highly variabie, considerable increase in the maximum fluence rate 
as weil as a highly asymmetrical fluence rate profile on the circumference 
of the illuminated lumen. The measured radiance profiles of real diffusers 
can be implemented in the model, which provides a means of evaluating 
the fluence rate distribution resulting from realistic (non-ideal) light sour-
ces. The influence of the optical properties of the bronchial mucosa on the 
fluence rate build-up factor was also investigated. The changes in fluence 
rate could be accounted for by diffusion theory. 
Introduction 
Few studies have been published on the light dosimetry during EndoBron-
chial Photodynamic Therapy (EB-PDT) (Murrer et al 1995, 1997a, Marij-
nissen et al 1993). These studies show that the light dosimetry in the upper 
respiratory tract strongly depends On light source positioning, optical pro-
perties of the tissue and the diameter of the lumen that is illuminated. We 
showed that the fluence rate distribution calculated with Monte Cm'lo simu-
lations provides accurate absolute values for the fluence rate as measured 
e.'C vivo in a pig trachea (Murrer et al 1995). 
Monte Cm'lo simulations offer the possibility to vary the geometry and 
optical properties (Saponal'o et al 1996) to asses the influence of those 
parameters on the fluence rate distribution. Especially in complex geome-
tries where analytical radiative transport calculations are not feasible the 
Monte Carlo simulations prove particularly useful to achieve more insight 
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(qualitatively as weil as quantitatively) in the role of geometry and optical 
properties. 
The present paper seeks to describe the fluence rate distributions as aresuit 
of different illumination conditions and to inter-relate the different conditi-
ons by rules-of-thumb. The issues that will be addressed are the influence 
of the length and emission profile of the light source, the on- or ofl~axis 
positioning of the light source, the diameter of the treated lumen and the 
influence of the optical properties on the fluence rate build-up. 
Methods 
Monte Carlo Model 
The Monte Cm'lo code was adapted from the Pascal code used to simulate 
whole bladder wall illumination (Keijzer et al 1991, Van Staveren et al 
1995). The simulations were run on a Pentimn PC. The geometry of the 
experiment was modelled as a cylinder of air (diameter D) embedded in 
a cylindrically symmetric semi-Î1Ifinite medium (thidmess T, outer radius 
,. --+ (0) (figure 1). T was chosen 5 cm, which was the length of the trachea 
specimens used in previous experiments (Murrer et al 1995). Making the 
slab thicker generally resulted in no significant changes in light dis tri but ion 
and for the sake of spatial resolution the slab thickness was kept limited. 
The air in the cylinder has negligible absorption and scat tering, and the 
index of refraction is 1. 
The semi-infinite medium has the optical properties of the mucosa layer at 
the inner side of the trachea at the chosen wavelength (À = 630 or 514 nm). 
The optical properties Ita(cm- I ) the absOl'[Jtion coefficient, Its(cm- I ) the 
scat tering coefficient and g ( -) the anisotropy coefficient for the mucosa of 
pig tradleas were measured ex vivo with a double-integrating sphere setup 
combined with an Inverse Adding Doubling (rAD) algorithm (Pickering et 
al 1993) The average values (630 Uln (n=6), 514 IllIl (n=4)) as weil as the 
value for one individual trachea (630 nm) that were used in the simulations 
are shown in table 1. The refractive index of the mucnsa is 1.37 (± 0.01) 
for the wavelengths used (M urrer et al 1995). 
The !inear !ight SOUfce with a length L is modelled as a continuolls dis-
tribution of isotropic and equally strong point SOUl'ees or with strength 
varying with position and anisotropie radianee (see below) . The quality of 
linear difl'users available now is sueh that they can be accUl'ately clescribed 
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Figure 6.1: Monte Cado model geomet.ry, with L the length of the diffuser, 
D the diameter of the cavity, T the Ihickness of the slab, x Ihe eccenlricity 
of the ti!!ht sourcc, r Ihe deplh in the tissue and z the hei!!ht, q, azimuth"l 
angle 
with isotropie point. SOli rees (lv[urrer et al 1997), The diffusers si1l1ulated 
in this paper will consist. of equally st.rong and isotropic point sourees, un-
less otherwise stated, The light sou ree was placed either on the central 
axis or eccent.rkally with a distance ~, from the central axis, In the case 
of cent.ral placement of the light sou ree a 2-dimensional grid was employed 
t.o store the dat.a, In t.he case of oft~axis placement of the light sou ree the 
cylindrical symmetry is violated and a 3-dimensional grid was employed, 
In the 3D case, more photons (N ~ 250,000) were needed to obtain a good 
signal-to-noise ratio, as opposed to the 2D case where only one tenth of 
t.his number (N ~ 25,000) was requireel, Several runs were performeel (N 
= 3,,5) to calculate the standard deviations on the simulated values for the 
ftuence rate, The resolution in the z, I' anel q, direction was 1 mm, 0,2 mm 
anel 6 degrees, respectively, 
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Wavelength absorption scat tering anisotropy remark 
(nm) i'a (cm-I) i's (cm-I) g (-) 
630 0.22 (0.17) 113 (19) 0.80 (0.06) n=6 
630 0.15 (0.02) 81.2 (0.9) 0.77 (0.01) single trachea 
514 1.83 (1.01) 119 (19) 0.77 (0.08) n=4 
Table 6.1: Optical properties of bronchial mucosa. Measured ex vivo 
with a dauble-integmting sphere setup. The data on 630 nrn were published 
beJare (Murrer et al 1995), the 514 nrn data are similar ta thase Jaund 
bU Van Staveren et al (1995) JOl' bladder rnucasa. (Standard deviatians 
between parentheses). 
Theoretical Considerations for cylindrical symmetry 
The geometry parameter Q is defined as: 
Q=L/D (6.1) 
With L (cm) the length of the diffuser and D (cm) the diameter of the 
lumen. The incident fluence rate (m W /cm2 ) at a certain point is defined 
as the fluence rate in air at that point as a result of the light emitted by 
the diffuser, without contributions of backscattering by the tissue. The 
incident flllence rate on the wall of the cavity calculated from a radially 
e!llitting (perpendicularly to the diffuser's axis) line source is: 
{ 
P/(1fLD) f-- I z I S L/2 
<Pinc,radia/(Z) = 0 f-- I Z I > L/2 (6.2) 
with P (m W) the total output power of the difl'user and z (cm) the position 
on the wall relative to the middle of the diffuser (figure 1). This source 
funttion does not describe tbe actual situation, but is sometimes used as a 
rough estimate by dividing the output of the diffuser by the estimated area 
of illumination (the surface area of a cylinder witb radius D and length L). 
If, more realistically, a superposition of isotropic point sources is consiclered 
as a model for the linear diffuser, the incident fluence rate on tbe wall 
(mW /cm2 ) is described by: 
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PiL - 2z L+ 2z 
<Pillc,isotropic(Z) = 1f LD 2" (arGtan[ D ] + arctan[ D]) (6.3) 
which is equatian 6.2 corrected bya factor describing the geometry. 
In the case of isotropic point sOUl'ces, the ratio R between thc incident flu-
ence rate at z=O and z=±L/2 (opposite middle and endings ofthe diffuser, 
respectively) yields: 
R = <Pinc(Z = ±L/2) = arctan[2Q] 
<Pillc(Z = 0) 2 arctan[Q] (6.4) 
The fluence rate build-up factor (3 is defined as the ratio of the incident flu-
ence rate on the cavity wall at z=o divided by the measlU'ed (Ol' simulated) 
fluence rate at that position (<Ptrue(z = 0)) in the case of on-axis position 
of the diffuser (M urrer et al 1995). 
(3 = <Ptrue 
'P;llc(z = 0) (6.5) 
For the two different source terms (radial and diffuse) (3 is: 
1fLD 
fJradial = ----p- qJlrue,radial (z = 0) (6.6) 
and 
(3. . - 1f LD <Ptl'ue,isotl'opic(Z = 0) 
IsotrOptc ~ P arctan[Q] (6.7) 
The expression for (3 derived from diffusion theory (Star 1995) for an in-
finitely long, radially l'adiating, diffuser in an infinitely long cylindrical 
(air)cavity in an infinite medium yields: 
l'eff ( ) (3diff.th. = - - 2 6.8 
Jla 
with l'ef f (cm-I) the effective attenuation coeflicient, defined as: I'cf f = 
)3Jla(llo + (1 - g)Jls). 
Realistic light sources 
Using a uniformly distributed random variabie, the distribution of the site 
and elevation angle of emission e of the photons from the linear diffuser 
is generated for Monte Carlo simulations (See Appendix). The azimuthal 
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angle <p is taken randomly !i'om the interval [0,27f). The distribution of 
the place of 8mission is deseribed by the total probability of light 8mission 
at each posi tion of the diffuser, estimated by suml1ling the radiance in all 
directions at that position. The measnrement of these profiles was deseribed 
in detail by Murrer et al (1996). Furthermore, the angular distribution of 
the light cmitted from the diffuser at a particlIlar position on the diffuser 
is generated. Here the distribution of the 8lnission angle of the photon is 
described by a 6th degree interpolation polynomial as described by Murrer 
et al (1996). The diffuser used as an example in (Murrer et al 1996) is used 
again in the present paper. 
In figure 2, a comparison is made between the original dis tri but ion and the 
random number generator counts when the above procedure is applied. An 
example for both the place and the angle of emission are shown. The power 
distrilmtion of this particlIlar diffuser shows a peak near the end, whieh 
is caused by relleetions off the end-mirror in this diffuser. The angular 
distribution of the radiance shows a forward directed pattern (maximum 
at 30°). The angle indicated is the angle between the direction of the light 
entering the diffuser and the light emitted by the diffuser. Because of the 
cylindrical symmetry around the diffuser axis a 2-dimensional simulation 
can be applied. 
Results 
Radial versus Isotropie souree terms 
Figure 3 presents the Iluence rate profiles generated by an on-axis linear dif-
fuser that consists of either radially or isotropically radiating elements. A 2 
cm diffuser in a cavity of 2 cm diameter was simulated and the average opti-
cal properties for 630 nm (tabIe 1) for the mucosa were used. The resulting 
Iluence rates at z=O and 1'=0 are 680(12) 1 mW Icm2 (radial) and 487(16) 
mW Icm2 (isotropic). The calculated incident Iluence rates (see methods) 
are 79.6 (radial) and 62.5 mW Icm2 (isotropic), corresponding with f3 values 
of 8.5(0.2) and 7.8(0.3), respectively. The depth profiles at z=O diller only 
a by constant factor of 1.47(0.02) (average of all depths), and both reach 
the level of the incident Iluence rate at 5 mm deptIl. The rectangular radial 
incident Iluence rate pattern as indicated in figure 3 causes a Iluence rate 
pattern on the cavity wall that is much narrower than the profile caused 
by the bell-shaped incident Iluence rate profile of the isotropic source. The 
lstandard deviations between parentheses 
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Figure 6.2: Random number distributions desc1'ibing the pTobability distri· 
bution of the site of emission (top) alul the elevation angle e of emission 
(bottom) (on position 15 mm) of the linear diffuser. The bars represent the 
counts of the random number generatm' per bin, the solid lines represent 
the measured dist1'ibutions 
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Figure 6,3: Fluence rate profiles resldting from illumination by a 2 cm dif-
Jusel' (total output of 1000 m W) with both radial (solid lines) and isotropic 
(dashed lines) emission patterns. Diameta of the cavity is 2 cm, optical 
properties: avemge values for 630 nm (tabie 1), E1T01' bars calculated Jrom 
5 simulations of 25000 pholons each. For clm·ity, error bars only on radial 
curves. Left: fluence rate in tissue at z=O. Incident fluence rale for mdial 
and isotropic sow'ce function indicated by solid and open square, respecti-
vely. Righl: fluence rate al Ihe wall (1'=0), Incident fluence mte profiles 
for both S01l1'ce terms are also indicated on the bottom of Ihe graph (solid 
and dashed tines fOl' mdial and isolropic emission pattenlS, respectively). 
resulting radial profile reaches 10% of the maximum value at 13 mm from 
the center, while the isotropie profile reaches th is level at 24 mm [rom the 
center. 
Non-ideal light souree 
In figure 4, the fluence rate profile on the waIl of the trachea as simulated 
with the measured souree characteristics (see methods) placed on-axis is 
compared with the profile measured in an ex vivo pig trachea with unk-
nown optical properties. For the simulations the average optical properties 
for À=630 nm are used (tabie 1). Although the profiles for measurement 
and simulation do not coincide, the figure shows that the positioll of the 
maximum of the fluence rate on the wall is the same (within measurement 
and simttlation accuracy) for both curves. 
The calculated (2.1 mW Icm2 ) and measured (2.8 mW Icm2 ) fluence rates 
at the maximum are of the same order of magnitude, but do not agree wit-
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hin error ranges. This is to be expected, because the simulation uses optical 
properties different from those of the measured trachea. However, the dis-
tinct asymmetry in the measured profile is reproduced in the simulation. 
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Figure 6.4: Fluence rate profile on the waU of an ex vivo pig trachea with 
a diameter of 19 mmo The length of the diffitser is 3.4 cm, the total output 
power is 3.4 In Watt.. Vertical lines 'denote the beginning and ending of 
the diffusing part. Dashed line: as measured wilh an isotopic probe (tal.,en 
from Murrer et al 1995), solid line: Monte Carto simulation, auemge of 5 
rUlls of 25000 photolls each, average optical propert.ies at 630 Ilm, sec table 
1 . Bath cl/rves are Ilormalised 10 tile maximum value, located at 8 mm 
for the measurement. (2.8 m W /cm2 ) and at 7 mm for the simulatioll (2.1 
m W/cm2 ). 
Variations in Land D: the geometry parameter 
In figure 5, the (3radial-estimate and f3isotropic va.lues are shown, calculated 
from the simulated value for <Pt,.ue, using both the incorrect, estimated 
radial sou ree function 4>inc"'adial and the correct isotropic 1>inc,isot"opic souree 
function. The relationship {3isofropic = f3radial-estimate/ ~,rctan[Q] conneets 
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the two fI-values. The fJ-values are plottecl as a function of the geometry 
parameter Q for bath 630 and 514 nm light. 
The values of Land D were varied from 1 to 5 cm in steps of 1 cm. The 
figure shows that the geometry parameter is useful to describe fI in difIerent 
geometries. In the left part of the figure the fI vallles calclliated with 
the incorrect(roughly estimated) radial source function show a one-to-one 
corrcspondence between fI and the geometry parameter. vVhen the corrcct 
source term is used to calculate the fI value (right part) fI is almost constant 
with a slow decrease with increasing values of Q. A Iinear curve-fit yields: 
fl630(Q) = 8.36-0.34Q (1' = 0.78) and fl514(Q) = 3.32-0.15Q (1' = 0.83) 
in which l' is the correlation coeflicient. A first-order estimate of fI for all 
geOllletries can be made by taking the average vaille of fI for all values of the 
geometry parameter, which is 7.7(± 11%) for 630 nm and 3.0(± 11%) for 
514 nm. The slow decrease of fJ with increasing Q is probably callsed by the 
finite leng th of the cylindrical cavity. High Q values occur lal' long diffusers 
(4 and 5 cm) in the set of Land D values that were simulated. These 
diffusers lose relatively much light out of the ends of the cavity because 
their lengths are close to the thickness of the slab (T = 5 cm). 
The fluence rate at z=±L/2 and 1'=0 (opposite the ends of the diffuser) can 
be estimated roughly using eq. (6.4), assuming that the shape of the total 
fluence rate profile does not differ toa much from the incident profile. The 
fluence rate is then estimated by taking the fluence rate at z=O, and mul-
tiplying it by the factor of eq. (6.4). The simulated flucnce rate is 86%(22) 
of the vaille estimated for 630 mll and 90%(16) for 514 nm. This indicates 
that, on average, the total fluence rate profile is somewhat narrower than 
the incident profile. 
Varying lumen diameter 
In figure 6 the fluence rate at z=O and 1'=0, 2 and 5 mm is plotted for va-
rying lumen diameter. The light source is 2 cm long, on-axis and consisting 
of isotropic point sources with a totalontput of 1000 mW. Thc average 
optical proper ties for 630 nm are used (tabie 1). 
The curves for 0, 2 and 5 mm differ only by a constant factor, which means 
that the penetration depth (when related to the fluence rate at 0 !lun) is 
the same for all lumen diameters. The fluence ra te at 2 and 5 nun is 41(2)% 
and 11(1)% of the fluence rate at 0 mmo The average fI value for all lumen 
diameters is 7.2(0.5), in agreement with figure 5 (same optical properties). 
The regl'ession line is given by: fl630(Q) = 8.21 - O.53Q (1' = 0.94). 
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Figure 6.5: MOllie Cm'lo simulatiolls of {3 for varying diffuser lenghts and 
lumen diameiers plotted agl/inst Ihe geometry parameter. Optical properties 
I/re Ihe I/"erage for 6.10 Ilm (tI/biel). Ellch point is calculaled by one run 
of 25.000 pholons, the statistical slandard deviation of these values is ~ 
7%. Left: {3,·adial-esUmatc for (incorrect) assumption of radially emitting 
source, Right: {3isotropic for correct light sou ree consisting of isotropic point 
sOUrees. +: À = 514 nm, 0: À = 6.10 nm. The dashed lines indicate the 
average "alucs of {3isotropic, 7.7 (sd 0.8) and .1.0 (sd 0 . .1) for 6.10 and 514 
nm, respecti"ely. 
VarÎation in optical properties: Relation with diffusion theory 
vVhen the optical properties for the individual trachea (tabie 1) are used 
the value for {3diff.th. is 17.3. A lvIOllte Carlo simulation that uses these 
optical properties and an (isotropic) diffuser of 2 cm (on-axis) in a lumen 
with a diameter of 2 cm yields a {3m.c. of 8.4 (±5%). The reason for this 
difference is that the diffusion theory farm uia is derived for a different geo-
metry (see methods). In order to investigate if the diffusion theory formula 
can qualitatively describe the dependence of {3 on the optical properties, 
the value for bath {3m.c. and {3dif f.th. were normalised by setting them at 
unity at this set of optical properties. From there, the value for both Pa 
and Ps were varied in the Monte Carlo simulations and the diffusion theory 
formuia. The results are presented in figure 7. 
The normalised {3 values for varying scat tering found for bath Man te Carlo 
and diffusion theory ag ree weil (mean deviation 2%). For varying absorp-
tion (Pa) the agreement is less good. For increasing Ila the agreement is 
still acceptable (mean deviation 15%), but for decreasing II'a the discrepancy 
increases (mean deviation 32%), as is clear from the figure. 
The lvlonte Carlo data show less increase in {3 with decreasing absorption 
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Figure 6,6: Fluence mte at z=O mm and 1'=0, 2 and 5 mm dep th in 
tissue for varying lumen diameter, The simulated .(gn-axis) diffuser has a 
length of 2 cm, and a total output power of 1000 m W, Optical prope,'ties 
are the avemge values for 630 nm (see table 1). M ean v~lues and error bars 
calculated !rom 5 runs of 25000 photons each. 
than eliffusion theory. With lower absorption the photons travel along op-
tical paths that penetrate eleeper in the tissue. Becallse of the fini te length 
of the simulateel cavity, photons escape anel cause less build up of flllence 
rate compared with the infinitely extended difrusion theory geometry. 
The variations in 1"8 cause changes in (J from a decreasc of 34 % at 40 cm-I 
to an increase of 26% at 120 cm-I. When I"a is decreased to 0.05 cm-1 
the (J value increases by 65%. lncreasing the I"a to 0.30 cm-I elecreases (J 
by 30%. Variations in I"a may be expected when the blood content of the 
tissue changes. 
The (J values fOUlld for 514 anel 630 nm light in the section about the 
geometry parameter can be inter-related with eliffllsion theory in the above 
mannel'. The ratio of (Jdij j,th,,630 (= 15.6) anel (Jdij j.th,,514 (= 4.92) is 3.2, 
while this ratio for (Jm,c,,630 and (Jm.c,,514 is 2.6 (0.6). These ratios agree 
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Figure 6.7: Variations in f3 vallles from difji/sion theory (dashed lines) 
arul Monte Carlo simlilations (symbols) when I'a (+, boltom x-axis and left 
y-axis)) Ol' l's (0, top x-axis and right. y-axis) are va ried. The f3 values are 
normalised to the f3 va lues for di.fJusion theory and Monte Cm'lo at mUa 
= 0.15 cm-i, l's = 81 cm- 1 and g = 0.11. Statistical variations on the 
klonte Carla data: ~ 7%. 
within simulatian error. 
Alsa, the above procedure can be used 1.0 estimate the unknown absorption 
coeffident of the pig trachea in which the fluence rate profile resulting from 
a realistic light souree was measured. The simulatian with 1'.=0.22 cm- 1 
resulted in a maximum fluence rate that was 75% of the measurecl value. 
Assuming constant scattering properties, the abave procedure yields a I'a of 
0.13 cm- 1 far the trachea, which is a realist ic value, cansidering the ave rage 
value in table 1. 
Eccentric light sourees 
The optical prop er ties of the single trachea (tabie 1) were used ta investigate 
the influence of the off-axis placement of the light souree, A trachea with 
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Figure 6.8: Fl1tence mte on z=O ar"l 1'=0 "esulUng from i!lumination of a 
eavity (D = 2 cm) with an off-axis isolmpic diffuser of 2 cm length, optica I 
In·ope,·ties of single trachea (tabie 1). Total output powe1' of the diffuser 
is 1000 mW. Solide line indicates the fiuence rate al l' = (f', dashed line 
indicates the fiuence mte at the opposite side (q,=18(f'). Mcal! values ar"l 
erro1' bar's calculated of 3 runs of 250000 photons each. 
D = 2 cm with a diffuser (output 1000 m W) of 2 cm length was simulated. 
Thc rcsulting /luence rate at z=O, 1'=0 and q,=00 am! 1800 is shown in 
figure 8. When the di/l'user is placed on-axis, the /luence rate is 548(27) 
m W /cm2 , cOl'l'esponeling to a (3 of 8.8(0.4). Moving the diffuser away from 
the center to the wal! increases the /luence rate to 1174(57) mW /cm2 at 5 
mm anel 6110(130) mW /cm2 at 9.9 mm off-axis, which is a 2- and l1-fole! 
increase of the /luence rate, respective!y. 
The pOSitiOllillg of the diffuser close to the wal! is critical lol' the /luence 
rate. Moving the diffuser to 9 mm off-axis decreases the /luence rate by 
41% to 3602 mW /cm2 . Moving the diffuser 1 mm olf-axis to either side 
causes a 10% change in the /luence rate. The /luence rate at 1800 gradual!y 
decreases with increasing off-axis position to a value of 169(10) mW /cm2 
at 9.9 mm o/l~axis placement. This is 31% of the on-axis level, and 3% of 
the level at 00 • 
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Figure 6.9: Fluence rate profiles on Ihe wal! (,'=0) of a cavity (D = 
2 cm) resulting from iUumination with a 2 cm isotropic diffuse?', optical 
properlies fo1' a single tmchea at 630 nm (tabie 1). Numbe1's indicate tlte off-
,,";is pasition (mm) of tlte diffuser. Positive and negative numbe1's indicate 
that the diffuse?' is !noved towards and away fram tlte site, respeciively. 
Top: Fhlence rale profiles at qJ=(J', for varying aff-axis posilio11S. Botiom: 
Fluence rate profiles at z =0, fo1' varying off-axis posilions. For clarily, 
error bars are only indicated once in the top graph. M ean values and error 
{,""S calculaled of 3 runs of 250000 photons each. 
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Figure 9 presents the flneHce rate profiles on the wall of the cavity (1'=0) 
in the z- and the q\-direction. The closer the light source is positioned to 
the wall, the narrower the profile in the z-direction (top) becomes, which 
is a consequence of the fact that the incident fluence rate pattern is also 
narrower, because the difl'use light has less distance to expand befare hitting 
the wall. 
The figure shows that the relative increase between different off-axis po-
sitions is largel' for positions close to the surface (cf. 9 and 9.9 nun) as 
eompared to those far away from the surface (cf. -9 and -9.9 mm). This 
indicates that the fluence rate for ofl~axis light source positions close to the 
surface is relatively sensitive to small displacements of the light souree. 
The profiles in the q\ direction (bottom) show that profiles narrow conside-
rably for extreme off-axis positions. In the q\ direction we define the area of 
treatment for different off-axis positions as that area with a fluence ra te of 
more than 50% (arbitrary) of the maximum. For 5, 9 and 9.9 mm off-axis 
this area is 23.0, 6.2 and 3.1 mm, respeetively. 
Discussion 
The Monte Carlo Model 
Although the model of the trachea is simpie, we showed previously (Murrer 
et al 1995) that it is suitable to simulate absolute values of the fluence rate 
in the bronchial mucosa (thickness "" 1 mm) and to a eertain extent in the 
eartilage ("" 3 mm) by use of the optical prop er ties of the mucosa only. This 
is because the absorption and redueed scat tering of the cartilage (Murrer et 
al 1995) are very similar to those of the mucosa at 630 nm. With the use of 
green light the penetration depth is such, that in practice only the mucosa 
layer needs to be considered in the model. The incorporation of realistic 
light sourees in the model facilitates the interpretation of the consequences 
of the use of light sources with varying output characteristics. In the fut ure 
we hope to expand the model with a multi-Iayer structure to incorporate 
the cartilage and with local spots of different optical properties to simulate 
lesions. 
Souree term 
In practice aften a first estimate of the fluence rate on the wall is made 
by dividing the total output of the diffuser by the surface of the cylinder 
with the radius of the lumen and the length of the diffuser. This incident 
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fluence rate can not be used for inter-patient camparison, as the fluence rate 
build-up is highly variabie between patients. An otller aspect of the above 
estimate is the underlying assumption of a radially emitting diffuser. The 
incident fluence rate profile of a real (isotropic) diffuser is not rectangular 
but bell-shaped. Therefore a largel' margin around the lesion should be 
illuminated to ensure proper treatment of the tumour and the tumour bed. 
Influence of optical properties 
The analogy between the f3 values calculated with diffusion theory and 
those found with Monte Carlo can be used to estimate the variations in 
f3 that can be expected w hen the inter-specimen variations in the average 
optical properties for 630 nm in table 1 are taken into account. The largest 
change in f3 occurs when /1a and gare lowered by one standard deviation 
and /1s increased by one standar'd deviation (maximum reduced scattering). 
The f3 for the average optical proper ties (7.7 figure 5) then increases by a 
factor of 2.8 to 21.3. The lowest f3 is 4.0 (52%), for maximum absOl'ption 
and minimalreduced scat tering. This shows that considerable inter-patient 
variations can occur in the applied fluence rate due to variations in optical 
proper ties as reported previously by Marijnissen et al (1993a) for bladder 
and Hudson et al (1994) for skin at 630 nm. 
The influence of blood content of the mucosa can be directly estimated from 
figure 7. Changes in the order of 1 total volume percent introduce changes 
in the order of the average absorption at 630 nm (Cheong et al 1990), an 
increase in absOl'ption of 0.15 cm- 1 introduces a decrease of 30% in the 
fluence rate, and a decrease of the absOl'ption causes even largel' increases 
in the fluence rate. The latter may occur when vascular simtdown occurs, 
one of the possible effects of Photodynamic Therapy. 
Practical use 
Several rules of thumb can be derived for use in clinical practice, provided 
that diffusers with good characteristics are used (Murrer et al 1997). For 
practical use, the f3 value can be assumed the same for all lumina in one 
patient, and then the maximum fluence rate on the wall for on-axis illu-
mination can be calculated according to cp = f3. P' /(-rrD) . arctan(L/D). 
This relation can be used to es ti mate that the maximum fluence rate in-
creases by a factor of 2.2 when going from the trachea (D=20 mm) to a 
bronchus (D=12 nun) with a 2 cm diffuser. A protocol written to cover 
different areas in the bronchi should incorporate these large diflcrence in 
dosimetry. 
For on-axis isotropic diffusel's, as a first-order estimate the fluence rate 
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profile on the wall can be described as the incident fhwnce rate pattern 
enhanced by a factor (3, like we observed with an ex vivo measuremcnt in 
a pig trachea (Murrer et al 1996). 
The geometry parameter in humans can vary between 0.25 and 7.5 because 
of the length of the applied diffuser (0.5 to 3 cm) and the diameter of 
the treated lumen (20 to 4 mm). The corresponding term correcting for 
the geometry (arctan(Q)) then varies from 0.24 for L = 0.5 cm and D 
= 2 cm (Q = 0.25) to 1.44 for L = 3 cm and D = 004 cm (Q = 7.5). 
The illumination of even smaller lumina or obstructing tumours beCOlnes 
comparable to interstitial treatment and is beyond the scope of this paper. 
The fluence rate opposite the ends of the diffuser is 95% of the maximum in 
the case of the smallest Q (0.25) and 52% for the largest Q (7.5), as ean be 
estimated with the help of eq.6A. This is important to know when choosing 
a diffuser length for treatment of a lesion of a certain length. For treatment 
with a large Q it may be wise to use a diffuser that is longel' than the lesion 
to avoid under-illumination of the edges of the tumour. The length of the 
diffuser can be chosen such that the incident fluence rate (eq.6.3) on the 
lesion perimeter is eg. ? 80% of the fluence rate at z=O. 
Penetration depth 
The data in figure 7 show that, for varying lumen diameter and constant 
optical properties, the penett'ation depth is a constant. The definition of 
penetration depth is somewhat arbitrary. If the penett'ation depth is defined 
as the depth at which the fluence rate has decreased to a certain percentage 
of the fluence rate at the wall, then the penetration depth is indeed constant. 
This, however, implies knowledge of the fluence rate at the wall of the lumen 
through either calculation or preferably measurement. 
Another definition of penetration depth is the maximum depth at which the 
fluence rate exceeds a certain threshold value needed for the photosensitiser 
to induce tissue damage. When this definition is used, the penetration 
depth can be interpreted as depth of necrosis or treatment dep tIl. With 
the latter definition the penetration depth increases with decreasing lumen 
diameter. This is not a practical definition, because it requires lmowledge 
of the fluence rate in deptIl. In practical use, only a measurement at the 
surface is possible and therefore the first definition seems more appropriate. 
Eccentric illumination 
When the diffuser is placed off-axis in the lumen, large dose variations 
can occur. Slight deviations from the on-axis position pro duce only minor 
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variations in the fluence rate at the wall, but positions close to the wall cause 
an increase in dose rate at the wall of several orders of magnitude, which 
is very sensitive to small displacements, as we reported eadier in ex vivo 
measurements (Murrer et al 1995). The fluence ra te at the wall opposite 
the site toward which the diffuser is moved decreases to one third of the 
on-axis value. A very narrow region (3 mm for total 9.9 mm eccentricity 
in a 2 cm diameter lumen) receives the same (within 50%) fluence, which 
in general is smaller than the lesion plus a margin of surrounding tissue. 
In case of unknown extension of pre-malignant tissue we advocate uniform 
illumination (Murrer et al 1995) as in the bladder (Marijnissen et al 1989) 
to make sure a large enough margin is treated. Therefore we strongly advise 
to always use an on-axis illumination if possible. 
General conclusion 
The data shown here c1eady demonstrate the considerable variations in the 
fluence rate levels and patterns as a consequence of varying geometries and 
optical properties. Protocols for Photodynamic Therapy in the bronchi 
shOlIld therefore be designed with special attention to the dosimetry in 
order to achieve reproelucible results. 
The relationships derived above to estimate the fluence rate should be re-
lated to an in vivo measurement of the fluence rate (Murrer et al 1997a). 
F\'om this measurement a value for f3 can be calculated, and then the dosi-
metry in another lumen can be based on this f3 value anel the knowledge of 
the lumen diameter and diffuser length. This, however, assumes the same 
optical properties in every lumen. In the case of a dearly visible lesion, an 
in situ measurement should be attempted. If possible, an in situ measure-
ment of the optical properties might be performed (Bays et al 1996) which 
could then be compared with an extended set of Monte Cat'lo simulations 
with varying optical proper ties to estimate the fluence rate distribution. 
Combination of light dosimetry and a measurement of the fluorescence of 
the sensitiser present in the tissue (Braichotte et al 1996) might prove a use-
ful tooi for optimising the treatment parameters. Monte Cat'lo simulations 
can be very useful in investigating the excitation and escape of fluorescence 
from the tissue. 
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Appendix 
Construct ion of a non-uniformly distributed random variable 
ç is a random variable, uniformly distributed between 0 and 1 (Pu (8) = 1 
for 0 <:: s <:: 1, and 0 otherwise). We llsed Ran3 from Numerical Redpes 
(Press et al 1989). 
To generate a random variable distributed aceording to p(s) using the uni-
form distribution Puts), a function f(s) has to be foune! 8ueh that the follo-
wing condition is obeyed (Lnx and Koblinger 1991): 
{' J;' p(s)ds 
Jo Pu(s)ds = ç = J~ p(s)ds = f(stl (6.9) 
The integral in the denominator normalizes the distribution which is neees-
sary beeause the distributions used are of ten obtained from (generally not 
normalized) measurements. The random variable 81 is sampled through 
(6.10) 
Here we have a p(s) that is either no analytical function (measurement of 
output power versns position), or a function (6 th degree polynomial) t.hat 
has no analytical inverse function f-l. Therefore, a discrete description of 
the functions is used, viz. a series of N x and y values (lIi, Xi)' The x-values 
are equally spaeed by ~x. Equation 6.9 is rewritten as: 
(6.11) 
The function is normalised such that f(XN) = 1. For each Xn! value a Çn! 
value is calculated. The inverse function 
(6.12) 
is obtained by linear interpolation between the X n ! values paired to the two 
Çn! values that are dosest to the ç value generated by the uniform random 
number generator. 
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Abstract 
The damage to normal pig bronchial mucosa caused by PhotoDynamic 
Therapy (PDT) using mTHPC and Photofrin as photosensitisers was eva-
luated. An endobronchial applicatol' was used to deliver the light with a 
Iinear diffuser alld to measure the light fluence in situ. The applied flu-
ences were varied, based on existing clinical protocols. A fluence finding 
experiment with short-term (1-2 days) response as an endpoint shO\ved eon-
siderable damage to the mucosa with the nse of Photofrin (fluenees 50-275 
J /cm2, drug dose 2 mg/kg) with oedema and blood vessel damage as most 
important features. In the short-term mTHPC experiment the damage 
found was slight (fluenees 12.5-50 J/cm2 , drug dose 0.15 mg/kg). For both 
sensitisers atrophy and acute inflammation of the epithelium and the sub-
mueosal glands was observed. The damage was confined to the mucosa and 
submucosa leaving the cartilage intact. A long-term response experiment 
showed that fluences of 50 J/cm2 for mTHPC and 65 J/cm2 for Photofrin 
treated animals eaused damage that recovered within 14 days, with spo-
radic slight fibrosis and occasional inflammation of the submueosal glands. 
Limited data on the pharmacokinetics of mTHPC show that drug levels in 
the trachea are similal' at 6 and 20 days post injection, indicating a broad 
time window for treatment. The importance of in situ light dosimetry 
was stressed by the inter-animal variations in fluence rate for comparable 
illumination conditions. 
Introduction 
PhotoDynamic Therapy (PDT) for treatment of lung cancel' has been in-
vestigated extensively with the use of Photofrin as a photosensitiser (Mc-
Caughan et al 1988, Hayata et al 1996, Lam 1994) for palliation, as weil as 
with eurative intent for treatment of early-stage lung caneer. Cortese et al 
(1997) showed that PDT with hematoporphyrin derivative (HpD) ean be an 
alternative to sUl·geIT. Currently also the use of meta-TetraHydroxyPhenyl 
Chlorin (mTHPC) as a photosensitising agent is evaluated experimentally 
and c1inically for the treatment of cancel' of the lungs, oesophagus and 
larynx (Grosjean et al 1996, Lofgren et al 1994, Abramson et al 1994). 
Thc common method of light delivery in this application of PDT is the 
use of a Iinear (01' cylindrieal) difl'user, whieh is suited to illuminate hollow, 
ey Iindrical orgalls sueh as the trachea 01' the bronchi. The light dosimetry 
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af this treatment cansists af a measurement af the tatal output of the linear 
diffuser anly, and the applied 'light dose' is defined as the tatal amaunt of 
light energy emitted per unit of length af the diffuser (J/cm). Little is 
known abaut ather important factors that determine the light fluence rate 
(and fluence) distributian in the tissue, which is the appropriate 'light dose' 
to evaluate PDT effects. 
In previous work we showed that the in situ fluence rate resulting from 
illumination of the bronchi with identical diffusers and output ean vary 
considerably between individuals (Murrer et al 1997). This is related to 
the inter-individual variations in optical properties of the bronchialmucosa. 
Similar variations in fluence rate caused by variations in optical properties 
(with red light of 630 nm) are found in the bladder (D'Hallewin et al 1992) 
and in the skin (Hudson et al 1994). Also the positioning of the difl'user 
in the lumen (Marijnissen et al 1993, Murrer et al 1995) and the output 
characteristics of the Iinear diffuser used (Murrer et al 1996) have great 
influence on the fluence rate distribution in the tissue. 
Because so many, sometimes unknown, parameters can influence the fluence 
rate in the mucosa, it is necessary to perform an in situ measurement of the 
fluence rate to quantify the applied fluence. An applicator which makes it 
possible to perform such a measurement together with a controlled way of 
light delivery has been developed in our group (Murrer et al 1997). With 
the help of this applicatol', the present study seeks to find a l'elationship 
between the applied fluence (true 'light dose') and the short-term (1-2 days) 
damage found in the normal (healthy) tracheal mucosa resulting from PDT 
with Photofrin and mTHPC. Consequently, the long-term damage resulting 
from an applied fluence that results in potentially recoverable short-term 
damage is investigated to determine the tolerance of normal tissue to PDT. 
Methods 
General Protocol 
The study was performed in two parts. In the first (acute) part the normal 
tissue damage of the bronchial mucosa caused by PhotoDynamic Therapy 
in the trachea of healthy pigs was assessed visually as weIl as histologically 
24 and 48 hours aftel' illumination. Both mTHPC and Photofrin were used. 
The photosensitiser dose was kept the same in all experiments and the total 
light fluence was varied (with constant fluence ratel in three areas in the 
92 Light delivery nnd dosimetIy [or EndoBronchi<~l PDT 
trachea of each pig. This part served as a fluence-finding experiment for the 
second part. In the seeond part one single total light fluence was applied 
and the bronchialmucosa damage was followed visually during the 2 weeks 
follow-up period and histologically aftel' termination of the experiment. 
The totallight fluence applied in the second part is the fluence that showed 
potentially recoverable damage in the first part for each drug applied. The 
experimental protocol (nr. 604-96-02) adhered to rules laid down in the 
Dutch Animal Experimentation Act and was approved by the Committee 
on Animal Research of the Erasmus University Rotterdam. 
Animals and anesthesia 
The animals used in this study were female pigs of a cross breed of Da-
nish Landrace and Yorkshire pigs (""30 kg). The animals were kept on a 
standat'd diet. The day before treatment as well as the day before follow-
up bronchoscopy they were kept fasted. For all procedures the animals 
were sedated with Ketamine (im, 10 mg/kg), and intubated. They were 
ventilated artificially with a mixture of nitrous oxide: oxygen (1:2 V:V) 
and 1.5% isoflnrane. During ventilation, anesthesia was maintained with 
pancorium (iv, 4 mg) and fentanyl (iv, 0.1 mg). Aftel' the experimental 
procedures the animals were hand-ventilated until independent breathing 
was restored. During the treatment the artificial ventilation dm'ation never 
exceeded 45 minutes, during drug delivery and follow-up bronchoscopies 
the duration was less then 15 minutes. During drug delivery the animals 
were ventilated with a mask only and received no additional ivo anesthesia. 
The animals were sacrificed with a bolus injection of pentobarbital (iv). 
Drug delivery 
In both the acnte and follow-up part 6 animals were used. In each part 2 
animals received Photofrin™ and 4 animals received mTHPCTM (meta-
tetrahydroxyphenyl chlorin). The Photofrin was kindly provided by Qua-
dra Logic Technologies (Vancouver, Canada) and the mTHPC was kindly 
provided by Scotia Quantanova (Guildford, Great Brittain). 
The Photofrin was dissolved in a 5% dextrose solution and administered 
intraveneously by a slow-push injection 48 hours before treatment accor-
ding to the Lederle/QLT protocol (P 503/504) for endobronchial PDT. The 
applied dose was 2 mg per kg bodyweight. The mTHPC was dissolved in 
a mixture of ethanol, polyethylene glycol and water that was supplied with 
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the drug, and injected intraveneously by a slow-push injection 96 hours 
beforc treatment. This drug delivery-illumination interval is alao used by 
other groups for mTHPC-PDT (eg Grosjean et al 1996). The applied dose 
was 0.15 mg per kg bodyweight. The animals were housed separately in 
subdued light conditions during the entil'e study. 
Light delivery and dosimetry 
The light was delivered using an applicatol' that was specifical!y developed 
for endobronchial PDT. The applicator incorporates a linear diffuser for 
light delivery, a fixation system that ensures the central positioning of the 
diffuser in the trachea and an isotropic probe for in situ measurement of 
the fluence rate on the trachea wal! (Murrer et al 1997). 
The design has been improved with a 1.5 cm diffuser with isotropic instead 
of forward scat tering properties (Murrer et al 1997a) manufactured by Rare 
Earth Medical (West Yarmouth MA, USA). The isotropy of the diffuser 
causes the ll'aximum of the fluence rato to be located on the trachea wal! 
opposite the middle of the diffuser. The isotropic probe measures the flu-
ence rate at this maximum. 
With the aid of a Monte Carlo model for the geometry of a linear diffuser 
in a trachea (Murrer et al 1995) we estimated an overlap of less than 5% 
of the maximum fluence rate between separate fields when a diffuser of 1.5 
cm is used with an inter-lesion spacing of 5 cm. This is possible in the pig's 
trachea which is general!y langer than the 15 cm (3 times 5 cm) needed for 
the experiment. 
Thc diameter of the isotropic probe fibre care has been increased by a factor 
of two compared to our first design, which causes a higher light output of 
the isotropic probe, enabling a more sensitive measurement. The isotropic 
probe (bulb diameter 0.8 mm) mounted on a 200 Itlll quartz core fibre was 
produced by Rare Earth Medical (West Yarmouth MA, USA). 
The light source used was a KTP /Nd:YAG laser with a dye unit (KTP /YAG 
832 and Dye module series 600, Laserscope, San JOSG CA, USA) that was 
tuned to a wavelength of 652 Ol' 630 nm for mTHPC Ol' Photofi'in, respec-
tively. Thc output of the linear diffuser is measured with an integrating 
sphere. The applicatol' is inserted in the sphere and unfolded and the laser 
is switched on. The voltage reading of a built-in photodiode is converted 
to the total output in m W with appropriate calibration factors for the two 
wavelengths used. The same integrating sphere is used to calibrate the iso-
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tropic probe in air (van Staveren et al 1995). Built-in laser diodes provide a 
stabie diffuse light field, which is calibrated with the same photodiode that 
is used for the output measurement. The output voltage of the photodiode 
is multiplied by an appropriate calibration faetor to calculate the diffuse 
light field in the sphere for both wavelengths used. 
When in contact with tissue, the reading of the isotropic probe calibrated 
in air has to be corrected because of the difference of refractive index (n) 
between air (n=l) and tissue (n=1.37). When the probe is pressed against 
the mucosa, the reading of the probe calibrated in air has to be multiplied 
by a factor 1.07 (± 2%) (Murrer et al 1995, Marijnissen aml Star 1996). 
It is important that the isotropic probe is kept free of mucus and blood to 
ensure correct calibration. This can be checked through the bronchoscope 
and if necessary the probe must be rinsed through the bronchoscope or 
the applicatol' must be retracted, cleaned and inserted again (Murrer et al 
1997). The light output of the isotropic probe is coupled to a photodiode 
inside a home-built dosimetry device, that displays the fluence rate as weil 
as the integrated fluence rate in time (total fluence). The dosimeter is 
calibrated by inserting and unfolding the applicatol' in the sphere with the 
laserdiodes switched on. 
Applied Fluences 
The fluence rates and the total fluences that were applied for the different 
sensitisers in the acute experiment were derived from either au existing 
protocol (Photofrin) or from protocols for eg. skin or ENT application 
(mTHPC) in humans. 
The mTHPC-treatment fluence and fluence rate was derived from the inci-
dent fluences and fluence rates in protocols for eg. skin, where an incident 
fluence ra te of 100 m W Icm2 is used to a tot al incident fluence of 10 J/cm2 . 
In a pilot experiment on rats, we observed that the incident fluence rate 
on a shaved spot of skin (2 cm diameter) increased to 250% by backscat-
tering. This factor serves as an approximation of the trans lat ion between 
the measurement of the incident fluence (irradiance) with a flat detector 
and the actual fluence rate measured with an isotropic probe touching the 
skin. Therefore we decided to take 2.5 times 10 J/cm2 (flat detector) = 
25 J/cm2 (isotropic probe) as the central fluence and half and twice that 
fluence (12.5 and 50 J/cm2 ) for the other 2 illumination fields. The highest 
total fluence was used on the field most distal to the animal's head, and the 
fluence decreased with more proximal location, thereby ensuring minimal 
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relative overlap between illumination fields. 
To rule out ftuence rate effects, the ftuence rate was kept constant and the 
illumination time was varied to achieve difterent tot al ftuences. The ftuence 
rate was set at 400 mW jcm2 as measured on the isotropic probe because 
this is the ftuence rate we expected to find in the Photofrin treatment, 
based on ex vivo llIeasurements (Murrer et al 1995). Using the 2.5 times 
build-up factor described above, this ftuence rate is equivalent to an incident 
collimated il'1'adiance of about 160 m W jcm2 , cOluparable to incident ftuence 
rates commonly used in mTHPC and Photofrin protacois. Treatment times 
were 62.5, 125 and 250 seconds for the three fields. 
The protoeol for Photofrin (QLTjLederie P 503j504) prescribes a light 
output of 400 m W pel' cm diffuser length used for a duration of 500 seconds, 
yielding a total of 200 J pel' cm diffuser lengtll. In the acute experiment we 
applied this protocol in one of the three fields illuminated. The other two 
fields were illuminated with half and twice this energy viz. 100 and 400 J 
pel' cm diffuser length with the same output in m W of the diffuser. Thc 
variation in energy applied was achieved by varying the time of exposure, 
leading to treatment times of 250, 500 and 1000 seconds. 
Again the field with the highest total ftuence was chosen most distally to 
the head of the animal and the resulting ftuence rate and tot al ftuence on 
the probe were recorded. The measured total ftuence was used to determine 
a total ftuence for the follow-up part of the experiment. In the follow-up 
part, the fluence rate on the probe was set at "" 400 mW jcm2 (the sallle 
as the mTHPC experiment) and then the illumination was continued until 
the desired total ftuence was reached. 
Build-up factor 
Because of the scat tering properties of the illuminated tissue, the ftuence 
rate resulting from the illumination with the diffuser will be higher than the 
the incident ftuence rate on the mucosa. For diffusers with good isotropic 
proper ties (as used in our applicatol') the maximum incident ftuence rate 
for central placement in the lumen rPo (m W jcm2 ) can be calculated from 
(Murrer et al 1995): 
p 
rPo = 'lrLD arctan(LjD) (7.1) 
with P the total output power of the diffuser (mW), L the length of the 
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diffuser (cm) and D the diameter of the trachea (cm). The build-up factor 
(3 is defined as the ratio of the measured fluence rate <Ptrue and the incident 
fluence rate, 
(7.2) 
and depends on the optical properties of the mucosa. 
Treatment 
The respiration tube (diameter 9 mm) was fixed just below the larynx to 
leave a maximum length of trachea exposed to be used for iIlumination. A 
fibre bronchoscope with a large working channel (diameter 2.8 mm, Fuji-
non Medical Holland) was introduced through the tube, and the applicatol' 
was fed through the working channe!. During this procedure the artificial 
ventilation was maintained through the open space between the broncho-
scope and the tube. Aftel' unfolding of the applicatol' the positioning of 
the detector was checked through the bronchoscope to ensure good contact 
with the mucosa and to ensure that there was no blood or mucus on the 
probe. The relative position of the applicatol' in the trachea was measured 
by the markings on the bronchoscope relative to the teeth of the anima!. 
The larynx served as a reference for the zero position. 
The applicatol' was fixed in the trachea such that the most proximal position 
was not too close to the tube to avoid reflections off the tube. In the case 
of the acute Photofrin treatment, the output of the diffuser was preset to a 
fixed output of 600 m W defined by the Photofrin protocol (1.5 cm diffuser 
x 400 mW lcm) and the time of exposure was measured. The resulting 
fluence rate and total fluence were recorded. In the other cases the laser was 
switched on and the output was adjusted such that the probe reading was 
400 mW/cm2 , and kept at that level by adjusting the output if necessary. 
The treatment was halted when the desired total fluence was achieved. 
Aftel' the treatment the output of the applicatol' was measured, and the 
calibration of the probe was checked. 
In the acute experiment half of the animals (1 Photofrin, 2 mTHPC) were 
sacrificed at 24 and the other half at 48 hours. In the follow-up experiment 
the animals were sacrificed aftel' 14 days. On day 1, 3, 7, 10 and 14 the 
animais' tracheas were examined by bronchoscopy. In the case of excessive 
damage, the experiment was to be terminated eadier. 
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Precautions 
Several precautions were taken to avoid damage related to non-treatment 
light. During transport to and from the operating theatre the animals were 
shielded from light with dark cloth. In the operating theatre only necessary 
lights were left on, and those were not directed at the animais. Also here the 
animals were covered with dark cloth. The bronchoscope's light source was 
operated on the 100vest setting allowing good visual control of the situation. 
During treatment the light source was switched off entirely. The duration 
of of bronchoscopy with the light source on was kept to a minimum (1-2 
minutes). During recovery aftel' the experiments the animals were kept 
warm by cloth instead of using an infrared lamp. 
Tissue damage assessment 
The damage to the normal mucosa was inspected both visually and histolo-
gically. The appearance of the mucosa was either photographed or recorded 
on videotape in the live anima!. Images of the mucosa before treatment were 
made to serve as a reference. In the acute experiment, images were made 
aftel' 24 or 48 hours. Images were taken during each bronchoscopy in the 
follow-up experiment. The damage was scored according to: none/normal 
= 0, some/slightly increased = 1, much = 2. 
Aftel' the experiment, the tracheas were excised and fixed in buffered for-
maldehyde (4%). Aftel' fixation, the material was cut and Heamatoxylin 
Eosin (HE) stained for histological analysis. Longitudinal strips of the 
whole trachea as weil as rings from the centre of the treated areas were 
examined. The histological effects of the treatment were judged partly 
qualitatively (for example the nature of the inflammatory eells) and partly 
quantitatively (for example the number of inflammatory cells and the num-
bel' of mucus producing cells in the epithelium). The damage was scored for 
a panel of histological characteristics according to no/none = 0, light/few 
= 1, severe/much = 2. Of these, the most relevant are discussed in the 
results. 
mTHPC tissue level determination 
Tissue samples were taken from the mTHPC treated animals after they were 
sacrificed at 6 and 20 days aftel' injection (2 and 14 days aftel' treatment). 
Samples were taken from the skin, trachea (cartilage and mucosa in one 
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sample) and oesophagus and were snap-frozen in liquid nitrogen for further 
processing. The methad of determining the mTHPC tissue levels with High 
Performance Liquid Chromatography (HPLC) is described by Wang et al 
(1993). 
Results 
In table 1 an overview is given of the treatment parameters. The treatment 
sites are coded dist (distal) mid (middle) and prox (proximal) indicating 
their position relative to the larynx of the animal. For each animal the 
output of the applicator's diffuser is specified as weil as the measured fluence 
rate and the total fluence as measured by the isotropic probe. 
General Comments 
The treatment and follow-up in the acute part of the experiment was con-
ducted as planned without problems. In the follow-up experiment one 
animal (nr. 3) was excluded from the study because of technical problems 
during the illumination that led to uncertainty about the actual light dose 
delivered. Furthermore, animal 2 from the follow-np group had to be sa-
crificed eadier (day 10) because of damage to the skin of the belly of the 
animal. To the best of our knowiedge, this damage was not PDT related 
because 3 other animals with the same drng dose that were housed and tre-
ated under exactly the same conditions showed no signs of this skin damage. 
Moreover, the mTHPC tissue levels of damaged and undamaged skin sam-
ples were not excessively high (10-50 ng/g, see section on mTHPC levels). 
Probably the animal was accidentally exposed to concentrated, alkaline de-
tm·gent. Except for this incident, the general condition of all animals was 
good during the experiments. 
Dosimetry 
In the case of the acnte Photofrin experiment the diffuser output was fixed 
and the flnence rate was measured and found to be stabie within 5%, indi-
cating good fixation of the diffuser and the isotropic probe. The output of 
the diffuser was checked afterwards and was found to be stabie within 5%. 
In the other situations were the output was varied to achieve a fluence 
rate of"" 400 mW /cm2 the output of the diffuser could be adjusted within 
dist mTHPC 4 1 400 796 50 1.0 2.6 
1 mid mTHPC 4 1 400 796 25 1.0 2.6 
prox mTHPC 4 1 400 507 12.4 1.3 5.4 
dist mTHPC 4 1 400 859 50 0.9 2.0 
2 mld mTHPC 4 1 400 979 25 1.0 2.1 
prox mTHPC 4 1 400 919 12.7 1.0 2.1 
dist Phot°trin 2 1 270 600 274 1.0 2.1 
3 mid Photofrin 2 1 257 600 133 0.8 1.6 
prox Photofrin 2 1 330 600 79 0.9 2.4 
dist mTHPC 4 2 400 1350 51 1.2 1.8 
4 mid mTHPC 4 2 400 l480 25 1.0 1.3 
prox mTHPC 4 2 400 1220 12.6 1.2 2.0 
dist mTHPC 4 2 400 1474 50 1.2 1.6 
5 mld mTHPC 4 2 400 1288 25 1.2 1.8 
prox mTHPC 4 2 400 1165 12.7 1.2 2.0 
dist Photofrin 2 2 188 600 190 1.2 2.0 
6 mid Photofrin 2 2 178 600 90 1.0 1.4 
prox Photofrin 2 2 195 600 50 0.9 1.4 
------- -
follow-up 
1 mTHPC 4 14 400 584 50 -~ 4.1 
2 mTHPC 4 lOt 400 605 50 1.1 3.7 
3 Photofrin 2 -t 
4 mTHPC 4 14 400 468 50 1.1 4.7 
5 mTHPC 4 14 400 620 50 1.2 4.1 
6 Photofrin 2 14 375 450 65 1.0 3.9 
Table 7.1: Summary of the treatment parameters and light dosimetry. mTHPC dose was 0.15 mg/kg bodyweight, 
Photofrin dose 2 mg/kg bodyweight. tSacrificed earlier because of non-PDT skin damage. tExcluded from the 
experiment because of uncertainty of the light dose applied. Por jurther explanation see text. 
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seconds aftel' the start of the illumination to reach the desired level. Gnce 
this level was reached, only minor adjustments of the output (s 5%) were 
needed to have a stabie (within 5%) reading on the isotropic probe. 
The diameters of the traclleas were measured in the microscopie slides and 
c01'l'ected for the 10% shrinkage due to fixation. The diameters were used 
to calculate the incident fluence rate and the build-up factor for every field 
illuminated. The average trachea diameter in the acute experiment was 
1.06 (0.141) cm and in the follow-up experiment the average diameter was 
1.12 (0.08) cm, which is not significantJy different despite the 12 or 13 days 
age difference between the two groups of animals. 
There was no deal' difference in f3 values between 630 (f3 = 2.1(0.9)) and 
652 nm (f3 = 2.6(1.2)). There was a pronounced difference, however, in f3 
values between the acute (f3 = 2.1(0.9)) and the follow-up group (f3 = 4.1 
(0.4)), whieh also existed for the two separate wavelengths. The overall 
average f3 value found was 2.5(1.2) for all animals and wavelengths. 
VisuaJ damage score 
During each bronchoscopy, an image of the treated areas was taken and 
the damage was described qualitatively by specifying the amount of red 
and white discoloration, oedema and increase of mucus formation on the 
mucosa. The scores indicated in table 2 give an indieation of the entÎl'e 
field treated. 
In the acute experiment, the most pronolmced damage is found in the ani-
mals treated with Photofrin (3 and 6). All three fields illuminated showed 
redness and oedema in both animais, with slightly less damage at the proxi-
mal site were the lowest fluence was applied. There was no deal' difference 
between the damage observed aftel' 24 and aftel' 48 hours. The mTHPC-
treated animals (1,2,4 and 5) showed very little effect in all animals with all 
applied fluences. Some whitish discoloration of the tissue was found aftel' 
48 hours (animal 4 and 5), whieh was not seen at 24 hours. In animal 1 
(aftel' 24 hours) some mucus was observed. 
In figure 1 bronchoscope images are shown of the areas treated with the 
highest fluences for both sensitisers, taken 24 hours aftel' treatment. In the 
image taken in the Photofrin treated animal the red discoloration (hemor-
rhage, see histology), swelling (oedema) and some excess mucus formation 
are dearly visible (fluence 274 J Icm2). The image of the mTHPC trea-
lstandard deviation in parentheses 
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acute 
sacrificed 1 day 2 days 
after 
animit\ 1 2 3 4 5 6 
scns itiser mTI-I PC mTIIPC Photofrin IIlTHPG rnTHPC Photofrin 
site D M P D M P D 1 ... 1 P D ivl P D M P D M 
redness 0 0 0 0 0 0 2 2 I 0 0 0 0 0 0 2 2 
whitcncss 0 0 0 0 0 0 0 0 0 I I 1 I 1 I 0 0 
OedellH\ 0 0 0 0 0 0 2 2 I 0 0 0 0 0 0 2 2 
n11lCil S I I I 0 0 0 1 I I 0 0 0 0 0 0 I I 
follow-up 
auilJla l 1 21 31 
sCllsitiser mTHPC mTHPC Photofri n 
(Iay 1 3 7 10 1,1 I 3 7 10 1,1 1 3 7 10 14 
redllcss 0 0 0 0 0 0 I 0 0 - - - -
whiteness 0 0 0 1 0 0 0 0 0 - - - -
ocdcma 0 0 0 0 0 0 0 0 0 - - - -
IllIl CUS 0 0 I 1 0 0 0 I 0 - - - - -
animal 4 5 6 
sensitiscl· IlITHPC mTIIPC Pholofrill 
dal' I 3 7 10 14 I 3 7 10 14 I 3 7 10 14 
rc(II1CSs 1 0 0 0 0 0 0 0 I 0 0 I 0 0 0 
whiteness 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
ocdcma 0 I 0 0 0 0 I 0 I 0 0 0 I 0 0 
IIlUCIIS 0 I 0 0 0 0 1 0 0 0 0 I 0 0 I 
Table 7.2: Visual da11l.age score for acute a.nd fol/ow-u]! expeTi11l.ent. 0 
= nonc/1IOnnal, 1 = s01uejslight increase, 2 = m:llch, - = not (L'Uailable. 
D = distal, 111 = middle, P = 117'O:cimal. t Saaificcd on day 10 bec(wse of 
(non-PDT) skin dmnage . iExcllUled f7'Om eXpe7';'/lent beCl!lIse of 1t1t1ûiable 
dosilll etl'y. 
teel animal (fl uence 50 J/cm2 ) shows IIl11Casa. with the same appearance as 
before treatment . 
An ovcrv iew of the trac/ICas treatcel with three Iluences and excised anel 
fixeel 48 hou l'S aftel' t reatment is presentcd in figl\l'e 2. T he Photofrin 
treateel t.rachea shows three baneIs of dark rliscolouration , indicating areas 
were helllOrrhage has occul'l'eel. Thc width of the dark arcas is (Icft to 
right) 2.5 , 2 anel 1.5 cm 1'01' Ruences of 100, DO anrl 50 J/<:m2 , respect.ivel,l'. 
The trachea of the Photofrin treateel an imal t hat was sacrificeel aftel' 24 
P 
I 
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Photofrin 
mTHPC 
Figure 7,1: B1'Onclwscope image oJ the part oJ tlIC tmchca illuminated with 
the highest ]luence J07' both sellsitisers taken 24 Iwu,'s rtf ter tre(dme1lt. Top: 
Photojl'in t,'eatment with 2'14 Jlcm2 (6301/m), Bol,tom: mTHPC t,'catment 
with 50 Jlcm2 (65211111). The block dots in bol,h l,ict",'es m'e b1'01Ichoscol'e 
i1ll",9i1l,9 arteJacts, 
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hams also showed dark discolomated areas for the middle (133 J/cm2 ) and 
high (271 J/cm2 ) fluences, although not as sharply demarcated as in the 
animal sacrificed aftel' 48 hours. No deal' region of damage was observed 
for the lowest fluence (79 J/cm2). The mTHPC treated tracheas showed 
no macroscopical treatment effects, the appearance is quite comparabie to 
that of a nonnal, untreated trachea (see figure 2). 
In the follow-up experiment the overall damage observed visually was mild 
(as intended). The mTHPC-treated animals showed same whitish discolo-
ration and mucus on different days of the follow-up varying from day 3 to 
day 10. On day 14 the situation was normal again. The Photofrin-treated 
animal showed same redness on day 3 and some oedema on day 7 (probably 
non-specific because of the long time span aftel' illumination). On day 14 
the situation had retul'l1ed to nonnal, apart from some mucus formation. 
Histology 
The major changes in histology are summarised in table 3, and same 
examples of the histology are shown in figure 3. No systematic inter-animal 
variations were observed. A slight chronic inflammation was present di-
rectly beneath the epithelium (iamina propria) in all animals and was con-
sidered as non-specific. For all experiments the changes were limited to 
the trachea lining epithelium (iamina propria) and the submucosa. The 
cartilage Ol' deeper tissues were not affected in any of the groups, except for 
fluence independent circumscript mononuc1ear infiltrates that were found 
inthe oesophageal glands in 2 of 3 mTHPC and 0 of 1 Photofrin treated 
animals in the acute experiment (of 1 mTHPC and 1 Photofrin animal na 
oesophageal tissue was available in the acute part). In the long-term study 
oesophageal glands of 0 of 4 mTHPC and 2 of 2 Photofrin animals were 
found to contain these infiltrates. 
Changes of the respiratory epithelium of the trachea consisted of increasing 
serionsness of loss of mucns producing cells, diminishing nnmber of nuc1ear 
rows, flattening of the cells, loss of cilia and denudation and influx of Po-
lyMorphoNuc1ear(PMN) cells. The seromucinous SUblllucosal glands lining 
the trachea were also involved in therapy related damage. They showed an 
increase of infiltrating lllononudear cells and, illllllediately aftel' treatment, 
of PMN eells. Loss of lllainly lllucinous cells, flattening of the epithelial 
cells and widening of acini is refel'l'ed to as atrophy of submucosal glands. 
Mainly the deep SUblllucosal blood vessels (near the cartilage) showed hy-
perelllia. Damage of blood vessels in the lamina propria and SUblllucosa 
104 Light delivery alld dosimetq for EndoBl'OllChial PDT 
Photofrin 
mTHPC 
Figure 7.2: Overview picture of the dissected and fixed tme/was af animals 
sOC7'ificed 48 hOl,rs af ter treatment. The tmchea" were cut lengthwise and 
apened. The lm'ynx was located at the right side. Top: Phatofl'in treatment 
with (lejt to right) 190, 90 and 50 J/cm2 (630 nm). Boltom: mTHPC 
tl'eatment with (lejt to right) 50, 25 and 12.4 J/crn2 (652 nrn). 
sensitiser mTHPC Photofrin 
sacrificed after (days) 1 2 14 1 2 14 
total !luence (J/cm2 ) 50 25 12.5 50 25 12.5 50 c 274 133 79 190 90 50 65 c 
epithelium 
reduction of 0/' 1/1 1/2 2/0 2/1 2/2 0/1/1/1 0/0/0/0 2 2 2 2 2 2 1 0 
mucus producing cells 
acute inflammation 0/0 0/0 0/1 1/0 1/1 1/1 2/0/1/1 1/0/0/1 1 1 2 0 1 1 0 0 
submucosa 
acute inflammation 1/1 1/2 2/2 1/0 1/1 1/1 1/1/1/1 0/0/0/0 1 1 2 2 2 2 0 0 
oedema 1/1 2/1 2/0 1/1 2/1 1/1 1/1/0/0 0/0/0/1 2 2 1 2 2 1 0 0 
hyperemia 0/0 0/0 0/0 0/0 0/0 0/0 0/2/0/1 1/0/0/1 2 2 0 2 2 1 1 2 
damage of 1/0 1/0 0/0 0/0 0/0 0/0 0/1/0/0 0/0/0/0 2 2 1 2 2 0 0 0 
blood vessels 
atrophyof 1/0 1/1 0/2 1/1 2/1 2/1 0/2/0/1 0/0/0/0 2 2 2 1 1 2 1 1 
submucosal glands 
acute inflammation of 0/' 0/1 1/2 1/0 2/1 2/1 0/0/0/0 0/0/0/0 1 0 2 1 1 2 0 0 
subrnucosal glands 
fibrosis 0/0 0/0 0/0 0/0 0/0 0/0 0/1/0/1 0/0/0/0 0 0 0 0 0 0 1 0 
Table 7.3: Histological damage scores for acute and follow-up experiment. no/none = 0, light/few = 1, se-
vere/much = 2. Control values c are taken from sites in a treated trachea which received little or na light (distance 
from illumated area ;:: 10 cm). 
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Photofrin, 190 J/cm2 , Acute 
mTHPC, 25 J/cm2 , Acute 
-<> Normal tissue damage.fluence-response study 0-- 107 
mTHPC, 50 J/cm2 , Follow-up 
Figure 7.3: Histological slides oJ the acute and the Jol/ow-up experiment 
(HE stained). Top: Damage to the trachea 48 hours after il/umination 
oJ a PhotoJrin injected animal with a fiuence oJ 190 J/cm2 • The epithe-
lium is atrophic. The submucosal glands and blood vessels are damaged and 
surrounded by oedema. P MN cells are absent, only sporadic mononuclear 
cells are seen. (Magn. 25x) Middle:Damage 48 hours aftel' illumination 
(mTHPC, 25 J/cm2). The epithelium shows loss oJ mucus producing cells. 
In the submucosa some oedema and a slight diffuse infiltration oJ mono-
nuclear celts is seen. The glands show slight atrophic changes. (Arlagn. 
100x) Bottom: Damage 2 weeks aftel' illumination (mTHPC, 50 J/cm2). 
The trachea appears normal, with epithelium containing mucus prOdlJcing 
cells, seromucinous glands without atrophy and only slight Jocal infiltra-
lion with mononuclear cells as is seen in the control tissues. Fibrosis is 
lacking. (Magn. 1 OOx) 
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consisted of frank destruction of endathelium (nuclear debris and disap-
pearance of endothelium without inflammatory reaction) and stasis. Only 
very small areas with accumulation of coarse collagen bundies were seen 
occasionally near the submucosa at 2 weeks aftel' irradiation. 
mTHPC 
In the dose finding experiment no clear correlation between the applied 
fluence and severity of changes was observed in the mTHPC group. A 
quite intense inflammatory reaction with oedema and infiltrating PMN eells 
was seen in the lamina propria and submucosa for all fluences at day 1 
aftel' treatment, while the epithelium showed a slight or focal decrease of 
mucus producing cells without signs of acute inflammation. In one animal 
the submucosal blood vessels showed very slight damage. At 2 days aftel' 
treatment, inflammation and oedema were less while mucus producing cells 
were almost lacking in the epithelium. 
In the follow-up experiment the changes in the treated part of the trachea 
compared to the untreated (tabie 3) part were only slight and could be 
found only in some animals. The changes consisted only of minor loss of 
mucns producing eells in the epithelium and submucosal glands combined 
with slight acute inflammation with some oedema of the submucosa and 
some hyperemia. Small areas of fibrosis were found in the submucosa of 2 
of 4 animais. 
Photofrin 
All treated areas in the Photofrin treated animals silOwed an immediate 
severe denudation of the epithelium and loss of mucus producing cells that 
persisted during the second day of treatment. At both 1 and 2 days aftel' 
treatment the high fluences caused severe vascular damage in the lamina 
propria and submucosa with stasis, fragmentation of endothelial nuclei, 
karyolysis and severe oedema. These severe vascular changes were not ob-
served in mTHPC treated animais. One day aftel' treatment a surprisingly 
slight infiltration of PMN cells was seen in the Photofrin treated animals. 
Only at day 2 the acute inflammation was severe in all irradiated fields. 
Two weeks aftel' the treatment with 65 J/cm2 little difference was seen 
betwecn the irl'adiated spot and the control area. (The control spot of the 
Photofrin treated animal that was excluded from the experiment showed 
the same charactel'istics). A slight loss of submucosal glands and a small 
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area of fibrosis were found in the submucosa of the treated spot. 
Applied fiuences for the follow-up experiment 
The ftuences used in the follow-up experiment were 50 Jjcm2 and 65 Jjcm2 
for mTHPC and Photofrin, respectively. The ftuences with potentially 1'e-
coverable dalllage were chosen based on the effects observed in the acute 
experiment, with the observed visual and histological elamage as a guide-
line. 
For the mTHPC treatment the highest applied ftuence of the acute expe-
riment was used, because both visually and histologically no severe effects 
(such as blood vessel damage) were observed. The Photofrin ftuence was 
chosen as an average of the lowest dose applied in both animals in the acute 
experiment. In this ftuence range severe eftects started to show as a dark 
band of hemorrhage with 79 Jjcm2 in the first and no such area in the 
second animal with a ftuence of 50 Jjcm2 Histologically these dark bands 
are the result of hyperemia, severe damage to blood vessels anel oedema. 
mTHPC tissue levels 
The levels of mTHPC were deterlllined in trachea, oesophagus and belly 
skin samples, the data are shown in figure 4. The trachea sample (ring 
height: 5 mm) was taken from a distal part that received Iittle Ol' no light, 
and included cartilage as weil as mucosa. The oesophagus sample was taken 
from the same region (section of 5 mlll). The average value for the mTHPC 
level in the trachea is 44 ngjg (n=2) at 6 days and remains at a level of 
46 ngjg (n=3) at 20 days aftel' injection. The oesophagus level decreases 
from 46 ngjg (n=2) at 6 days to 20 ngjg (n=3) at 20 days. The skin drug 
level at 6 days was highly variabie with a valne of 358 anel 44 ngjg for two 
different animais. The level at 14 days is more consistent at 18 ngjg (n=3), 
comparable to the oesophagus level. 
Discussion 
Normal tissue damage with Photofrin and mTHPC 
During the acute experiment we observed a distinct elifterence in normal 
tissue damage between the Photofrin anel mTHPC treatment. The ftuences 
110 Light delivery and dosimetry [or EndoBronchial PDT 
500 
0; 
c; 400 
.s 
~ , 
~ 300 
.;4 
.é 
-;; 
> 200 ~ 
" 0. 
:I: 
f- 100 E 
0 
trachea oesophagus 
tissue type 
mTHPC concentration 
6 days aftel' injection 
20 days aftel' illjection 
trachea 
(ng/g) 
55/33 
63/26/39 
skin 
oesophagus 
(ng/g) 
26/66 
20/17/22 
.. 6 daysp.1. 
(Bi] 20 days p.l. 
skin 
(ng/g) 
358/44 
9/14/30 
Figure 7.4: mTHPC levels of pig tissues, taken from animals sacr-ificed 2 
days (animals acute 4 and 5) and 14 days af ter treatment (animals follow-
up 1, 4 and 5). 
used where based on values used for treatment of tumours in clinical prac-
tice were excessive normal tissue damage is to be avoided. Therefore such a 
distinct difference was not expected. It must be noted that the fluence used 
in the clinical QLT /Lederle Photofrin protocol was poody defined because 
it only specifies the output of the linear diffuser irrespective of the lumen 
diameter and the optical properties of the mucosa. The mTHPC total flu-
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ences chosen in this study were comparable to those employed by Savary et 
al (1994), who used fluences up to 16 J/cm2 of incident light, roughly C0111-
parabie with the 50 J/cm2 total fluence we used (with thc conversion factor 
2.5, see methods). Photofrin protocols for the treatment of skin lesions use 
total il'l'adiances (incident fluences) of 50-100 J /cm2 or higher (Wilson et al 
1992) with acceptable normal tissue response. With the convers ion factor 
of 2.5 this indicates a fluence range of 125-250 J/cm2 . These fluences are 
somewhat higher than the total fluences we measured for the illuminated 
fields treated according to the QLT /Lederle protocol , viz. 133 and 90 
J/cm2 (mid sections in the acute animals 3 anel 6). In these fielels consiele-
rable normal tissue elamage was observed at fluences that induce no severe 
side-efl'ects in the treatment of skin lesions. 0 bviously, the light elosimetrie 
conversion is just one aspect to take into account when adapting a protocol 
written for a specifie target for use in an ot her organ. 
In the mTHPC fluence fineling experiment no clear correlation between the 
applieel fluence anel the normal tissue elamage was observed. The fluence 
range that was investigateel might be below thresholel for the ineluction of 
significant effects. Abramson et al (1994) observeel an such illumination 
threshold for the ineluction of oedema anel erythema in the canine larynx. 
Unfortunately, the absolute fluence levels of Abramson's stuely anel the 
present work cannot be compared because the former only specifies the 
diffuser output. 
The fluences applieel in the follow-up experiment diel not induce severe long-
term effects (14 days) as could be observeel visually as weil as histologically. 
This result suggests that, while treating a lesion in the trachea, the normal 
(sub)mucosa of the trachea of the pig can withstaJld a fluence of "" 50 J /cm2 
for both sensitisers for the drug elose anel interval between injection and 
treatment used here. The maximum toierabie fluence for mTHPC might 
be even higher, as we tested the highest fluence from the acute experiment 
in the follow-up experiment. 50 J/cm2 fluence can be compared (with the 
reservations noted above) to an incident irradiation of "" 20 J/cm2 , which 
is a!reaely a relatively high 'light dose' for skin treatments. 
One has to bear in mineI, however, that the presence of (pre- )malignant 
tissue can alter the pharmacokinetics locally anel alter the sensitivity of the 
surrouneling tissue to PDT. The pharamacokinetics could be monitored in 
vivo by a fluorescence measurement to evaluate the influence of the presence 
of malignant tissue (Braichotte et al 1996, Monnier et al 1990). A pig 
tumour model in the trachea could give more insight in this matter, possibly 
the technique useel by Hayata et al (1983) to induce an invasive squamous 
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cell carcilloma in a canine model could be u8ed in the pig a180. 
For both sensitisers and all fluences employed, the damage was limited to 
the mucosa and the submucosa and did not extend into Ol' beyond the car-
tilage. The cartilage structure contains little blood and has therefore a low 
oxygen and photosensitiser content (Lofgren et al 1994), and is relatively 
insensitive to photodynamic therapy. Lofgren observed a concentration of 
10 ng/g of mTHPC in the cartilage as opposed to 80 ng/g in the mucosa 
of the canine larynx, 6 days aftel' injection of 0.3 mg/kg mTHPC. 
Vascular effects 
Irreversible vascular damage was observed in the acute Photofrin experi-
ment. This damage may explain the fact that the influx ofPMN cells (acute 
inflammation) seems delayed for the highest fluence rates used. At day 1, 
only for the lowest fluence applied an extensive influx of PMN cells is seen, 
while for the areas treated with higher fluences severe inflammation only 
occurs at day 2 (Tabie 3). 
Also with mTHPC vascular effects have been reported (Lofgren et al 1994). 
In our study, vascular effects seem slight and reversible. Contrary to the' 
Photofrin findings, PMN cell infiltration was at its maximum on day 1 and 
reduced on day 2. This suggests vascular spasm instead of destruction of 
the vasculature as seen in the Photofrin animals. 
Fluorescence imaging aftel' injection of mTHPC shows that the drug con-
tent of vascular endothelium reaches a peak at 96 hours and then decreases 
again (Savary et al 1997, Andrejevic et al 1996). However, Menezes da 
Silva et al (1995) showed that most extensive vascular occlusion aftel' il-
lumination occul'l'ed at 11 hoUl's aftel' mTHPC injection, independently of 
the blood serum level (peak at 3 hours). Their explanation is that vascular 
damage must result from damage to other cells than endothelial cells. Our 
illuminations were performed much later (96 hours) than this time point of 
maximum vascular sensitivity to mTHPC-PDT, thus possibly explaining 
the lacking of irreversible vascular damage in our study. 
mTHPC tissue levels 
The level of mTHPC in the trachea was determined fl'Om samples containing 
both the mucosa and the cartilage. From the fact that the cartilage contains 
little mTHPC (Lofgren et al 1994) it can be concluded that the levels in 
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the mucosa only, are higher than those indicated in figure 4. The fact that 
the mTHPC level in the trachea stays at the same level between 6 and 20 
days after hljeetion indicates that the day of treatment cau be chosen over a 
long period of time (assuming that the ratio of the cartilagejmucosa levels 
does not change). 
Dosimetry: the build-up factor (J 
The (J-values found in the experiment are lower than the values found in 
previous ex vivo experiments (Murrer et al 1995), and this ean be attributed 
to the absence of blood in the ex vivo experiment. The blood in the mucosa 
in the in vivo situation increases the absorption of the treatment light, 
thereby lowering the build-up factor. The (J-values found in this experiment 
agree with those reported in eadier in vivo experiments on pigs , while f3 
values in human volunteers are higher (average 4.7, sd 2.2, n=3)(Murrer et 
al 1997). 
The f3-values show large inter-animal variations (average 2.5, standm'd de-
viation 1.2), as was also observed in measurements in hUlImns (Murrer et 
al 1997). This shows the necessity of in situ ftuence rate measurements 
to assure equal illumination conditions. The presence of tumour tissue in 
the trachea may alter the dosimetry. Lesions often present as a region of 
whitish discoloration, representing areas with relatively low absorption of 
light, causing a locally higher build-up factor. Hemorrhages (or blood ves-
seis located near the mucosa sm-face) induce locally increased absorption 
and consequently a lower build-up factor. These inftuences of local 'colour' 
are reftected in the intra-animal variations in f3 (tabie 1). 
The difference in f3 between the acute and the follow-up group (for both 
wavelengths ) may be caused by variations in the oxygenation of the blood 
of the animais. The absorption of the light by the blood depends on the 
oxygenation of the blood (Cheong et al 1990), which is inftuenced by the 
anaesthesia. The anesthesia during the two parts of the experiments was 
conducted by different operators, which may explain the variations. 
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Abstract 
Five patients with a pleural malignancy (4 malignant mesotheliomas and 
one localised low grade carcinoid) were treated with maximal surgical re-
section of the tumour followed by intra-operative adjuvant photodynamic 
therapy (PDT). The additional photodynamic treatment was performed 
with light of 652 nm from a high power diode laser, and meta-tetrahydroxy 
phenylchlodn (mTHPC) as the photosensitiser. The light delivery to the 
thoracic cavity was monitored by in situ isotropic light detectors. The 
position of the light delivery fibre was adjusted to achieve optimal light 
dis tri but ion, taking account of reflected and scattered light in this hollow 
cavity. There was na 30 day postoperative mortality and only one patient 
suffered from a major complication (diaphragmatic rupture and haemato-
pericardium). The operation time was increased by a maximum of one 
hour to illuminate the total hemithoracic surface with 10 Jjcm2 (incident 
and scattered light). The effect of the adjuvant PDT was monitored by 
examination of biopsies taken 24 hours aftel' surgery under thoracoscopic 
guidance. Significant damage, including necrosis, was observed in the mar-
ker lesions with remaining malignancy, compared to normal tissue samples 
which showed only an infiltration with PMN eells and oedema of the std-
ated muscles cells. Of the five patients treated, four are alive with no signs 
of recurrent tumour with a follow-up of 9-11 lllonths. One patient was dia-
gnosed to have a tumour dissemination in the skin around the thoracoscopy 
scar and died of abdominal tumour spread. Light delivery to large surfaces 
for adjuvant PDT is feasible in a relatively short pedod of time «1 hoUl'). 
In situ dosimetry ensures optimal light dis tri but ion and allows tot al doses 
(incident plus scattered light) to be monitored at difl'erent positions within 
the cavity. This combination of light delivery and dosimetry is weil suited 
for adjuvant treatment with PDT in malignant pleural tumours. 
Introduction 
Pleural tumours, especially malignant mesotheliollla (MM) are considered 
to be incurable since at diagnosis the disease is usually advanced and spre-
ads diffusely in the pleural space. Radical resections can seldolll be perfor-
med. Macroscopically the resection may appeal' complete but microscopi-
cally tumour cells are often evident (Butchart and Gibbs, 1990). For those 
cases which are considered sUl'gical candidates, adjuvant treatments have 
mostly been given in the form of radiation therapy (DaValle et al , 1986; 
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Hilaris et al , 1984) and chemotherapy (Rusch et al , 1994; Sugal'baker et 
al, 1991). Despite some positive results from these studies, overall survival 
was not significantly improved, whereas side effects were increased. Irradia-
tion of a large field inclnding organs Iike the spinal cord, heal·t, oesophagus 
and Iiver makes it difficult for the radiation oncologist to give an adequate 
radiation dose without exceeding normal tissue tolerante. Chemotherapy 
has so far shown to be of only Iimited use in the primary treatment of 
malignant mesothelioma (Chahinian et al , 1982,1993; Sfrensen et al 1985; 
Krarup-Hansen and Hansen, 1991; Ruffie, 1993), but the most active com-
pounds (e.g. doxorubicin) might be of use for the treatment of minimal 
residual tumour. Postoperative chemotherapy is, however, associated with 
Iiver and kidney toxicity and it may be difficult to achieve adequate drug 
concentration in the areas with reduced perfusion aftel' resection. 
Photodynamic therapy (PDT) has been used by several investigators as an 
adjuvant treatment for MM but in most cases the conditions were not op-
timal (Pass et al , 1994; Lofgren 1991; Takita et al , 1994; Ris et al , 1991, 
1996). Lack of high power lasers and effective photosensitisers with a high 
singlet oxygen yield, plus a lack of knowledge of the dosimetric aspects of 
light distribution and scattering in a hollow cavity, Iimited the general use-
fulness of this form of treatment. Haematoporphyrin derivatives were used 
in most studies but the excitation wavelength (630 nm) has only a Iimited 
penetration in tissue and the singlet oxygen yield is low for these sensitisers. 
Ris and colleagues (1996) were the first to publish a study using a second ge-
neration photosensitiser, m-THPC (meta-tetrahydroxyphenylchlorin), for 
the treatment of MM. m-THPC has a longel' excitation wavelengtIl (652 
nm), resulting in somewhat better tissue penetration, and a much higher 
singlet oxygen yield than haematoporphyrin derivative sensitisers. One 
potential problem in this study was that the light was administered se-
quentially to fields in the thoracic cavity by using a cut-off fibre and micro-
lens. This technique inevitably resulted in overlapping iIIumination fields. 
In addition, no account was taken of the contribution of scattered light to 
the total light dose. The doses quoted, based on incident light alone, will 
therefore be an underestimate of the light dose to tissues in the iIIuminated 
cavity. 
In this feasibility study we have tested a new method of light application 
using a high power diode laser and real time, in situ measurement of light 
delivery to the tissue in the thoracic cavity aftel' macl'Oscopically complete 
resection of the tumour. 
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Material and Methods 
Patient selection 
In the period of January to June 1996, patients with a histological diagnosis 
of malignant mesothelioma were asked to partieipate in this study. In 
addition to extensive surgieal and pulmonary work up they had to fulfil the 
following criteria: Performance Status <1 (ECOG), age < 75 year, weight 
loss < 10 % in the preceding three months, adequate cardiac function to 
accept a pneumonectomy and a calculated pulmonary rest capacity of > 
1 I/sec expiration aftel' resection. The slll'gical work up consisted of a CT 
scan to exdude possible ingrowth in major organs Iike the vertebrae, the 
hemt and Iymph nodes. All patients had a thoracoscopie examination and 
mediastinoscopy for optimal diagnosis and staging. The new staging criteria 
according to the IMIG (International Mesothelioma Interest Group) were 
used (1995). Patients with positive Iymph nodes at mediastinoscopy or 
distant metastasis were exduded from the study. Details of patient and 
tumour characteristics are given in table 1. 
Surgical procedure 
Patients were selectively intubated by a double lumen tube and placed in. 
a lateral decubites position. The previous entrance port of thoracoscopy or 
thoracotomy was excised and an extra pleural resection was initiated. To 
reduce the chance of sunburn by the theatre lights, these were out of focus 
and the normal skin was completely covered by sheets. The pleural tumour 
was resected extra-pleurally on the side confined to the ribs and medias-
tinum; resection of tumour from the pericardium and the diaphragm was 
more difficult. To facilitate the pleural resection and to limit blood loss, 
a CUSA (Cavitron Ultrasound Surgical Aspirator) was used. In patients 
with extensive involvement of the visc€l'al pleura a pneumonectomy was 
perfonued. The surgieal aim was to achieve macroscopie tumour resection, 
but in areas whieh were unsuitable for radieal resection, tumour reduc-
tion to :::: 5 mm thickness was performed. To prevent local tumour spread 
beyond the thoracic cavity, the normal boundaries (like pericardium and 
diaphragm) of the thoracic cavity were left intact. An ipsilateral Iymph 
node dissection was part of the pleural pneumonectomy procedure. The 
bronchial stump was dosed by staples (TA 55, AutosutureR ). To obtain 
histological specimens aftel' the combined treatment, a thoracoport (Thora-
coport, AutosutureR ) was inserted in the upper part of the anterior chest 
wall and covered with steriIe adhesive tape. A small marker lesion, ea-
sily accessible by thoraeoscopy, was left behind and indicated by a suture. 
Patient diagnosis TNM side comments l age sex !;' 
no (years) after resection ~ 
1 37 M epitheloid T 3NIMo right extensive tumour mass on ~ 
diaphragm and mediastinum, .g f! 
pretreatment with one 05 ~ 
course of Mitomycin C, 
~. 
;§ 
Vinblastin and Cisplatin tg 
2 40 M carcinoid TxNoMo left localised tumour in the >-cl 
parietal pleura (9 cm diameter) Cl' 
w bich was fust diagnosed as a 
.., 
~ MM at thoracoscopy 
-3 59 M epitheloid T2NIMO right large tumour mass on parietal "". Ol 
pleura, diaphragmatic sinuses and g 
~ 
in the diaphragm ~ 4 41 F epitheloid TIbNOMo left tumour located especially at the Co 0 
diaphragmatic sinuses ~ b-
5 54 M epitheloid T3NoMo right tumour diffusely located in the f!.. ~. 
thorax with location in the top ~ 
'" wbich was difficult to remove surgically I 
Table 8.1: Patient and tumour characteristics. Tx : primary tumour cannot be assessed; Tib : tumour extending on 
both visceral and parietal pleura; T2 : tumour with ingrowth of the lung or diaphragm; T3 : tumour encompassing 
the pericardium; No : no lymph nodes; NI : positive lymph nodes within the visceral pleura; Mo : no distant 
metastases .... 
"" .... 
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Patients were detubated illllllediately post-operatively and mOllitored on 
the ICU. Oxygen saturation was measured for a few minutes every hour, 
using a fingel' c1amp (red light). Fluid replacement was administered ac-
cOl'ding to vital signs, blood pressure and urinary output balanced with the 
anticipated perspiration. 
Photodynamic procedure 
Patients were injected with 0.1 mg/kg ofmTHPC (meta-tetrahydl'Oxyphenyl 
chlorin, supplied by Scat ia Pharmaceuticals, Guilford, England) 4 days be-
fore the operation. Twenty milligrams of the dl'llg were dissolved in 5 mi 
solvent containing ethanol, polyethylene glycol and water and shaken for 
5 minutes. The dl'llg was given intravenously as a slow push injection (4 
mg/ml). Aftel' administration patients were l1ursed in subdued light for a 
minimum of 2 weeks. 
The thoracic cavity was integrally illumil1ated with a spherical diffusing 
fibre (bulb diameter 3 mm, Rare Earth Medical lnc., West Yarmouth MA, 
USA). If necessary, a micro- lens fibre (PDT inc., Santa Barbara CA, USA) 
was used for additional local illumination. The fibre was coupled to a 
diode laser (Applied Optl'Onics, 6W) that provides 6 Watts of light at 652 
nanometer. During a pilot experiment, in which we measured the fluence 
rate distribution in the thoracic cavity of a (non-sensitised) patient aftel' 
pneumonectomy, we observed that the regioll near the diaphragm posed 
a pl'Oblem for illumination. Due to the absence of the lung mass, the 
diaphragm folds into the thoracic cavity and farms a region (sinus) where 
the light is shadowed. A trallsparent stm'ile plastic bag (Steri-Drape™, 
3M) was therefore placed in the thoracic cavity and filled with saline (at 
body temperature) to stretch the diaphragm. This resulted in a bet ter 
distribution of the light. Before placing and fitting the transparent steriIe 
bag, optimal haemostasis was obtained and the thoracic cavity was cleaned 
thol'Oughly to prevent light absOl'ption by blood. The light sOurce was 
introduced via a steriIe tube (Stomach Catheter 18 G) in the cent re of the 
filled bag. The surgical wound was appl'Oximated during the illumination 
to maximise back scattering of light due to reflections in the cavity. This 
procedure was performed to obtain a uniform light distribution. Before 
and aftel' illumination the presence of blood pockets was easily verified by 
visual inspection thl'Ough the saline in the bag. 
The distribution and total dose of the light delivered was monitored with 
isotl'Opic light detectors (probes) with an accuracy of +/- 15%, (Van Sta-
veren et al , 1995), manufactured in the Clinical Physics Department of the 
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Daniel den Hoed Cancel' Centre. The probes (diameter 1 mm) wcre eon-
nected to photodiodes (Photop UDT-455, Graseby Electronics, Orlando 
FL, USA), whose output was AjD converted and displayed and stored on 
a PC. This system allowed us to do real-time fluence-rate and integrated 
fluence measurements. The isotropic probes measure the totallight fluence 
delivered to the tissue, including both direct incident and scattered light 
from the tissue bulk. The latter is not measured when flat photodiodes are 
used, as in some previous studies of PDT in malignant mesothelioma (Pass 
et al, 1994). The probes were calibrated in air in an integrating sphere with 
a weil defined diffuse light field (Van Staveren et al, 1995). The integrating 
sphere and the photodiodes are incorporated in one device that can be con-
nected to the printer port of any regular Personal Computer. The probes 
were then placed in a sterile polyethylene lockable extension tube (inner 
diameter 1-2 mm, Vygon, Ecouen, France) filled with saline to match the 
refractive index of the surronnding medium (saline and tissue), resulting in 
a proper calibration of the isotropic pro bes. For further details on these 
calibrations see also Marijnissen and Star, 1996. Four probes were used to 
monitor the treatment. The probes (in the tubes) were sutured at strategie 
spots in the thoracic cavity before the sterile bag with saline was placed 
in position. One probe was always situated in the sinus, and one in the 
top of the thoracic cavity. The third and the fourth probe were positioned 
to cover representative areas of the cavity, including critical structures like 
the oesophagus, the pericardium or the lung surface if only a pleurectomy 
was performed. 
At the start of the treatment, the spherieal diffuser was placed in the eentre 
of the cavity and the position of the difl'user was manually adjusted until 
the fluence-rate readings on all detector probes were approximately equal. 
If the detectors showed an imbalanee in fluence rate during the treatment, 
the diffuser was manually repositioned to regain the desired distribution. If 
a region (e.g. the sinuses) received insufficient light, this region was given 
top np iIIumination using a micro-lens fibre aftel' removal of the saline filled 
bag. The four probes were recalibrated (software-wise) for the absence of 
the saline (which causes a refractive index mismatch), and left in place to 
measure the scattered light at other than the directly iIIuminated regions. 
The ilIumination was continued until the required total dose of 10 Jjcm2 
was reached, averaged over all measured sites. Sometimes an imbalanee 
between the totallight dose on the four spots was allowed, for instance when 
the probe was on a spot with a visible tumonr mass. Twenty-four hours 
aftel' treatment a thoracoscopy was performed (4 patients) through the 
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thoracoport with a 0° rigid optie held in a forceps device (Wolf, Germany). 
Biopsies were taken from apparently normal tissue and from the marked 
indicator lesions. The tissue was collected in formaldehyde and processed 
for histology. The thoracoport was replaced by a transparent tube and 
additional illumination (20 J/cm at 400 mW lcm using a 2 cm cylindrical 
diffuser) was given to the tract in order to kill any remaining tumour cells. 
Results 
Five patients were suitable for the combined surgical/PDT treatment. The 
mediastinoscopy was normal in these patients, there were no contra-indi-
cations for a pleuropneumonectomy and written informed consent was ob-
tained. Four of the patients had diffuse mesothelioma (confirmed by an 
expert panel) for which a pleuropneumonectomy was indicated. The chest 
X-ray of the first patient is shown in Figure 1. 
One patient with a localised lesion was treated with excision of the pleural 
tumour and was illuminated with the lung in situ. This patient proved 
to have a carcinaid tumour instead of a malignant mesothelioma when 
the excised tumour was analysed (Tabie 1). A sixth patient referred for 
the adjuvant PDT therapy, proved to be irresectable at operation. The 
operation was therefore terminated and na additional PDT was given. 
The total PDT-treatment time was (maximally) one hour, including place-
ment of the probes and the bag. The integrated cumulative dose (J/cm2 ) is 
shown as a function of time for all patients in Figure 2 a-e and the delivered 
dose to all sites of measurement is given in Table 2. 
In patient 1 the fluence rates on all but one probe were balanced (Figure 
2a). The probe in the sinus showed a low fluence rate, indicating that the 
diaphragm was not properly stretched. The total light dose to the sinus 
was less than 1 J I cm 2 . Two additional illuminations using a micro-lens 
were therefore given. The bag was removed and the diaphragm stretched 
manually, leaving the other probes in situ. The probe near the oesophagus 
registered an additionallight dose of 2.5 J/cm2 as a result of the scatte-
red light from the micro-lens illuminations, the other probes showed an 
additional dose of 1.5 J/cm2 . The probe located in the sinus was used to 
measure the additional dose given by the micro-lens. The total dose on 
the diaphragm, outside the areas which were additionally illuminated, is 
estimated to be about 1 J/cm2 higher than the initial dose of 8.6 J/cm2 . 
The average dose for the enth'e cavity was 10.1 J/cm2 . 
Light dose (J / cm2) 
Probe position Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 
top of thoracic cavity 9.8 9.9 8.5 8.5 8.5 
lung surface 10.5 
retro-sternal 10.2 
oesophagus/mediastinum 11.7 7.8 
tumour 12.8 
pericard 8.5 10.4 
thorax surgical entrance 10.5 9.1 10.2 
diaphragmatic sinus <1.0 9.0 14.4 9.4 8.5 
extra sinus illumination 
anterior and posterior 8.6 
Average 10.1 10.0 10.3 8.9 9.4 
Table 8.2: Total cumulative light doses delivered to various sites in the thoracic cavity 
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Figure 8.1: Ghest X-my (postero-anterior' view) oJ this patient beJore ope-
mtion. The arTOWS indicate the cont01lrs oJ the mesothelioma on the r'ight 
side. 
In patient 2 the (deflated) lung was still present in the thoracic cavity. 
The dose on the IUllg surface was monitored to avoid excessive normal 
tissue damage (Figure 2b). The flllence rate on the probes was balanced, 
except for the probe on the tumour located on the lateral thoracic wall. 
The tumour surface was additionally illuminated with a micro-lens. In this 
sitllation the scattered light contributed little extra dose to the other sites 
of measurement. The diaphragm was well-stretched and the light dose in 
the sinus was sufficient. The tumour received 12.8 J /cm2 , the average for 
the cavity was 10.6 J/cm2. 
In patient 3 well-balanced fluence-rates were established on all probes (Fi-
gure 2c), with, intentionally, a higher fluence rate on the sinus, which re-
ceived 14.4 J /cm2 to the remainder of tumour mass on the diaphragm. The 
average dose delivered was 10.3 J/cm2. 
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Figure 8.2: Cumulative light dose (J/cm2) plotled in time (minutes) for different 
probes located on different places in thc thoracic cavity. The prescribed average light 
dose on all probes was 10 J/cm2 • a Illumination of patient 1. The probe in the 
sinus received only 1 J/cm2 in the 25 minutes of illumination. Additiollal illumi-
nation, u.sing a micro-lens, was th ere/are given to the diaphragm in two successive 
sessions while fhe afhel' ]Jrobes were left in situ. During fhis additional illumina-
tion the other probes registered an extra fluenee of 1 to S J/cm2 • b Illumination 
of patient 2 in whom the lung was left in situ. After rcnwval of the pleural tumour 
an addiUonal illuminalion was given to fhe l'esected area. In this case minimal 
additional light dose was reeorded on the other probes. c IlIumination of patient 
3 slwwing that all probes received a constant fluence rate, with preferenee to the 
diaphmgm where most of the tumour had been resected. d and e mumination of 
patients 4 and 5 showing equal distribution of light throughout the thoraeie cavity. 
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Figure 8.3: Fluence rate (m W/cm2 ) recorded in time (minutes) du1'ing 
the iltumination of the thoracic cavity of patient 4. Smalt changes in flu-
ence rate occur during iltumination due to respiration and the man ua I 1'e-
positioning of the light souree. 
In patients 4 and 5 the fluence rat es on all probes were weil balanced (Figure 
2d and el. Average doses for the cavity were 8.9 and 9.4 J/cm2 , respecti-
vely. Changes in fluence rate during the iIIumination period for patient 4 is 
iIIustrated in Figure 3. Apart from the fluctuations caused by the manual 
repositioning of the spherical diffuser, the fluence rate on all pro bes was 
kept stabie at 3-4 mWatts/cm2 . 
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Post treatment complications and follow-up 
There was no 30 day mortality and the duration of the hospital stay was 
less than 3 weeks for patients 1,2,3 and 5 (TabIe 3). In patient 1, skin 
photosensitivity occured in the intensive care due to monitoring with a 
plllse-oximeter on the index fingel'. A small grade 2 sllnburn reslllted from 
the measurement (whieh lasted 4 hours). (Other patients were monitored 
intermittently for several seeonds on different fingers). Bleven months aftel' 
operation patient 1 was in good clinical condition and had resumed work-
ing full time. On CT scanning, there was no evidenee of tumour reeurrence 
in the thoracic cavity. Patient 2 had recovered fully from the operation 
and resumed working part time at 10 months aftel' operation. Physical 
and radiological examination did not reveal any recurrences and the lung 
function parameters (spirometry and diffusion) were unchanged. The third 
patient suffered from constipation related to the post-operative pain medi-
cation. Reduction of the opiates and oral and rectallaxatives resolved this 
complication. Sixteen weeks post-operatively, diffuse tumour spread was 
diagnosed in the superficial skin vessels originating from the thoracoscopic 
scar. He died of local and abdominal tllmo\ll' spread at 7 months aftel' 
treatment. No pqst mor tem was performed. 
In patient 4, the diaphragm was elevated one day aftel' surgery and thora-
coscopic examination was difficult. On day 2 signs of a diaphragmatic 
rupture had become apparent and a rethoracotomy had to be performed to 
replace the stomach in the abdominal cavity and to close the diaphragmatic 
rllpt\ll'e. The margins of the rupture were biopsied and a Marlex covering 
was used to strengthen the diaphragm. Increased lIuid production in the 
thoracic cavity resulted in shifting of the mediastinum to the right, ham-
pering respiration. Repeated punctures (thoracentheses ) were necessary to 
remove the superlluous pleural lIuid. Ten days aftel' treatment the patient 
had increased dyspnea and a pulsus paradoxus was noted. On radiological 
examination (chest X-ray and ultra sound) a pericardial effusion was noted 
and 500 cc of haemorrhagic lIuid was removed. Cytological examination 
revealed no tumour cells and the post operatively initiated anticoagulant 
therapy was withdrawn. F\lrther recovery was uneventful and on day 40 af-
tel' admission she was discharged. Ten months aftel' treatment she was weil 
with no signs of tumour reCllrrences on CT scan examination. Patient 5 
experienced post-operative pain which cOllld be controlled with analgetics. 
Nine months aftel' treatment he was still tired but had no ot her complaints. 
The radiologic examination did not show any signs of reCllrrences. None of 
the patients experienced any generalised sllnbllrn effects aftel' discharge. 
l 
ti"' 
~ 
~=7==~==~7=======~==~==================~~====================~========~ Patient hospital stay complication follow-up current tumour status and ~ 
no. (days) (post-operative) (months) long term side effects ~ . 
.., 
1 18 grade 2 sunburn on index finger ll,alive no evidence of tumour recurrence '" 
2 16 no complications 10,alive no evidence of tumour recurrence tg 
3 18 
4 41 
5 20 
constipation on basis of opiates 7,death 
fatigue since operation ~ 
diffuse vascular metastasis originating g 
from the thoracoport leading to ~ 
abdominal metastasis and death 
rupture of diaphragm requiring 1O,alive no evidence of tumour recurrence 
-c§" 
~ 
~ rethoracotomy, increased effusion in limited exercise tolerability 
operated cavity treated with multiple fatigue ~ 
thoracentheses, haematopericardium lower back pain with normal MRI ~ 
requiring drainage 1[ 
grade 2-3 skin burn on a 5 cm area 9,alive no evidence of tumour recurrence Sr 
in the surgical scar increased susceptibility for infections ~ 
Table 8.3: Post-surgical complications and follow-up 
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Histologie examination 
In the 4 patients who underwent pleuropneumonectomy, a thoracoscopy was 
performed one day aftel' PDT and tissue was taken from apparently normal 
and indicator lesions. In Table 4 details of the histological specimens are 
given. In all specimens obtained, an infiltration with poly-morphonuc1ear 
eells and oedema was observed. This was more marked in the tumour tissue 
than in the samples obtained from the chest wall where the tumour had been 
resected completely. Figure 4a shows an example of vital mesothelioma in 
the resection specimen of patient number 1. In the biopsies of the target 
les ion (Figure 4b), sampled 24 hours aftel' the combined treatment, necrotic 
residual mesothelioma with an increased number of polymorphonuclear cells 
was found. The patient who was re-operated for the diaphragmatic rupture 
also had tissue sampling 48 hours aftel' the PDT. Biopsies taken from the 
diaphragm at the site of rupture showed a thin muscle layer but nO evidence 
of (PDT induced) necrosis was found. 
Discussion 
From time of diagnosis of MM the mean survival is generally 9-14 months 
despite agressive treatment. It is weil recognised that surgery alone is in-
sulficient for the majority of malignant pleural mesothelioma cases and 
(adequate) adjuvant therapies are limited by their toxicity and damage to 
normal tissue or the inability to cover all sites of the resection areas. Various 
chemotherapeutic regimens containing mitomycin-C, doxorubicin and adri-
amycin have been investigated but their effectiveness has not clearly been 
demonstrated. Although some long term survivors have been reported, the 
overall effect has been disappointing (Krarup-Hansen and Hansen, 1991). 
The addition of radiotherapy to the operated hemithorax has also failed 
to demonstrate an increase in survival (DaValle et al , 1986; Hilaris et al , 
1984). One of the major problems is the planning of the radiation field to 
ad minister a tumouricidal dose without excessive normal tissue toxicity. 
The primary objective of this study was to develop a suitable illumination 
and dosimetry procedure for intra-thoracic PDT. Photodynamic therapy 
offers some advantages as alocal adjuvant treatment since it has a res-
tricted normal tissue toxicity which is related to the depth of penetration 
of the light used and the concentration of photosensitiser. For optimal elfi-
cacy, the photosenstiser should preferentially concentrate in tumour tissue 
and/or its vasculature, and its singlet oxygen product ion should be high 
Patient 
1 
2 
3 
4 
4 at 
48 hrs 
5 
tumour sample 
partly necrotic, partly viabie tumour cells 
infiammatory cells and oedema 
no data 
no tumour cells identifiabie 
infiammatory cells 
no tumour identifiabie 
inflammatory cells, oedema 
no tumour cells identifiabie 
necrosis of tumour cells 
infla=ation 
normal tissue 
fat tissue, muscle cells, partly necrotic, 
oedema 
no data 
inflammatory cells and muscle cells 
infla=atory cells and oedema in 
striated muscle cells 
no necrosis of diaphragm biopsies or 
of cbest wall biopsies 
fat tissue and muscle cells with some 
necrosis 
Table 8.4: Tumour and normal tissue response to PDT after 24 hours 
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(a) 
(b) 
Figure 8.4: a. Pleural mesothelioma, epithe/ial type (HE, 10x, pleuropneu-
monectomy specimen) of patient 1. b. Necmtic mesothelioma, 24 hours 
after combined treatment (HE, 20x, biopsy of target lesion) of patient 1. 
at illumination. A second important aspect is optimal light delivery and 
dosimetry, especially when larger areas are treated. 
Promising results on the use of PDT in MM have been reported in the 
literature. In the largest study (Pass et al , 1994) 42 patients were treated 
with haematoporphyrin derivative and illumination in a phase I study, but 
no increased survival (mean 12.4 months) was observed. The illumination, 
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2 days aftel' sensitisation, was performed with two Argon dye lasers. The 
output of each laser at 630 nm was 5 Watt inaximally and the average 
additional time to perform the PDT was 89 minutes (including placement 
of fibers). The actual laser time was 68 minutes to achieve a total light 
dose of 25 Jfcm2. Since light dosimetry was performed with flat photo-
diodes, which do not measure all scattered light, the totallight delivery to 
the tissue was underestimated. Ris et al (1996) performed a pilot study 
in 8 patients using 0.3 mgfkg m-THPC and 10 Jfcm2 aftel' an interval of 
48 hours. Seven patients had good local control of their thoracic disease 
but developed distant metastasis aftel' 4-18 months. One patient died of 
pulmonary embolism 8 days aftel' resection. Post-mortem examination sho-
wed extensive necrosis in the remaining tumour but no damage to normal 
structures like the hem't and the oesophagus. 
In all previous studies with PDT its potential has been weil recognised, 
but the lack of understanding of dosimetry and the inability to administer 
adequate light doses in a short period of time has prevcnted a more general 
use of PDT. The development of second generation photosensitisers, with 
a higher singlet oxygen yield, have made PDT treatment more attractive, 
especially for largel' areas. The higher activity of the photosensitisers and 
the new types of high power diode lasers now available enables the t.reat-
ment period t.o be considerably short.ened. We have been able to apply this 
adjuvant. phot.odynamic treatment in 40 to 60 minutes. The sllOrter half 
life Ol' reduced retention in t.he skin of such photosensitisers also greatly 
reduces the skin photosensitivity for the patients. 
The cumulative light dose (fluence) to the tissues of the thoracic cavity can 
be measured by isotropie probes in real time. This is independent of the 
optical properties of the tissues in the cavity, which may vary considerably 
between patients. These diffm'ences are enhanced by mult.iple reflections in 
a closed cavity with walls of scattering tissue (Van Staveren et al , 1994). 
The prescribed light dose, based on the use of isotropic probes for in situ 
dosimetry, will be lower than the same dose specified with the use of flat 
detectors, because the lat ter do not detect all the light in the tissue. It 
is therefore impossible to compare results from different studies on basis 
of incident light dose alone. To overcome this problem generally accepted 
methods of light delivery and measurement should be developed for specific 
clinical settings. The totallight dose received by the target tissue should be 
described by in situ dosimetry measurements. With the simple iIIumination 
technique as used in this study, one spherical diffuser occasionally supple-
mented with a micro-lens iIIumination, it was possible to achieve a control-
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led distribution of the light delivered to the thoracic cavity. The on-line 
measurement allows for repositioning of the diffuser during the treatment, 
thereby correcting for asymmetry in the Iluence rate distributions and pre-
venting under- or overillumination of same areas. Great care must be taken 
when iIluminating the cavity sequentially with adjoining Iight-fields, as has 
been done in several studies (e.g. Ris et al, 1996), since the scattered light 
contributes a considerabie amount to the dose received on locations that 
are not directly illuminated. This could lead to overdosing of same areas, 
unless this is continually monitored during iIlumination. 
In this study we have shown that the combi nat ion of PDT and surgical 
resection for pleural tumours is feasible and that in situ light dosimetry 
greatly impraves the repl'Oducibility and controllability of this combined 
treatment. The operation time increased by less than one hour (on an 
average of 5 hours surgery alone) in the current set-up and the duration of 
the hospital stay was generally na langer than expected for sugery alone. 
Largel' numbers of patients and langer follow-up will be required to deter-
mine whether this type of adjuvant treatment ollers a benefit in terms of 
local control and survival. The absence of tumour recurrenee and survival 
observed in four of five patients sa far is pram is ing. In the patient who died 
with recurrence aftel' 7 months, tumour cells may have been spread from 
the thoracoscopic entrance. We have therefore abandoned the practice of 
leaving an indwelling thoracoport for 24 hours biopsy sampling. 
Tissue specimens, taken 24 hours aftel' treatment showed extensive damage 
to the tumour tissue and only minor damage to striated muscle of the 
chest wall aftel' a light dose of only 10 J/cm2 . Clearly the light dose 
and/or the drug dose could be escalated or the time interval between drug 
administration and iIlumination could be reduced in an attempt to achieve 
better results. 
The improvements in methads of light administration and dosimetry greatly 
improves the possibility to safely apply PDT on largel' sUl'faces. Using this 
information as a starting point wc are now planning further dose escalation 
and phase Ir studies. 
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Overview 
The wark in this thesis is an attempt ta develap light delivery and calculate 
and measure the light distributian during Endo-Bronchial Photadynamic 
therapy (EB-PDT). The fluence rate distribution resulting fram illumina-
tian of the lumina of the trachea-bronchial tree has been investigated. The 
influence of the fallawing parameters was studied: 
-0 linear diffuser output characteristics 
-0 an- or off-axis positioning of the diffuser in the lumen 
-0 length of the diffuser 
-0 diameter of the treated lumen 
-0 wavelength of light used far illumination 
-0 aptical proper ties of the brollchial mucosa 
An applicatol' for in situ light delivery and light dosimetry has been de-
veloped and been used to perfarm the first fluence rate measurements in 
humans. The applicator has been used to determine a fluence-response 
relationship of the healthy bronchial mucasa in pigs. 
Finally, the techniques of in vivo fluence rate measurements have been 
applied to the integral illuminatian of the thorax aftel' resectian of the 
pleura and/or the lung. 
Ex vivo fluence rate measurements and Monte Cm'lo simulations 
In chapter 2, the light distribution during Photodynamic Therapy of the 
branchial tree has been estimated by measuring the fluence rate in ex vivo 
experiments on dissected pig bronchi. The trachea was illuminated (630 
nm) with a linear diffuser and the fluence rate was measured with an isotro-
pic probe. The results from ex vivo experiments and Monte Carlo simulati-
ons of the experiment were faund to agree within the error of measurement 
(±15%), indicating that the Monte Cal'lo technique can be used to estimate 
the light distribution for varying geametries and aptical properties. 
The results showed that the light fluence rate in the-Jllucosa of the (ex vivo) 
trachea may increase by a factor of 6 compared ta the fluence rate in air 
(in the absence of tissue), caused by mnltiple (diffuse) backscattering from 
the tissue bulk alld multiple specular reflections in the trachea. 
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Further experiments showed that the positioning of the diffuser is critical 
for the fluence rate in the les ion to be treated. When the position of the 
diffuser was changed from the central axis to nearby the lesion, the fluence . 
rate in the mucosa increased significantly by several orders of magnitude 
as compared to the initial (central) illumination. The inter- and intra- spe-
cimen variations in this increase were large (± 35 %) because of variations 
in optical and geOlnetrical properties and light source positioning, respecti-
vely. These variations might eause under- or overdosage resulting in either 
insufllcient tumour-necrosis or exeessive nonnal-tissue damage. These re-
sults indicate that it may be wiser to illuminate the lumen always with 
on-axis positioning of the diffuser. 
Light delivery by linear diffusers 
The distribution of the light emitted by linear light diffusers commonly em-
ployed in PhotoDynamic Therapy (PDT) has been investigated in chapter 
3. A device is presented whieh measures the angular distribution of the exi-
ting light at each point of the diffuser. With these data the fluenee rate in 
air or in a cavity at some distance from the diffuser can be predicted. The 
results show that the light is scattered from the diffuser predominantly in 
the forward direction. Experiments andealculations show that the fluence 
rate in air and in a cavity of scat tering tissue at some distance from the 
diffuser has a maximum near the tip of the diffuser, instead of near the 
middle. However, the fluence rate resulting from an interstitial diffuser in a 
purely se at tering tissue phantom shows a maximum in the bisecting plane 
of the diffuser as would be predicted when each element of the difl'user 
emitted light isotropieally. The scattering nature of the tissue is expected 
to cancel the anisotropy of the light emitted by the diffuser. 
In chapter 4 the angular radiance distribution of several linear diffusers 
used for PhotoDynamic Therapy (PDT) was measured. The forward scat-
tering found previously (chapter 3) was not observed in these designs. The 
improved isotropy leads to a bet ter agreement between intended treatment 
site and actualmaximum of the fluence rate profile when the linear diffuser 
is used in a hollow, cylindrical, organ . 
. Applicator for endobronchial light delivery and light dosÎlnetry 
A design of an applicatol' for light delivery and light dosÎlnetry during Endo-
Bronchial PhotoDynamic Therapy (EB-PDT) is presented in chapter 5. 
The design incorporates a linear difl'user that is fixed in the centre of the 
lumen by a steel spring basket that does not block the air flow. The fixation 
system ensures central positioning of the diffuser for optimal light dis tri-
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but ion (chapter 2). An isotropie probe is a part of the design, to measure 
the light fluence actually delivered to the bronchial mucosa snrface. The 
applicatol' is designed for use with common bronchoscopy equipment, and 
can be used with bronchoscopes with a large biopsy chalmel ('" 3 mm). 
The first clinical measurements were performed and caused no additional 
discomfort to the bronchoscopy of (non-photosensitized) patients. 
The data showed a considerable inter-patient variability of the flnence rate 
measnred for a given ontput power of the diffuser. This fact and the ex-
pected strong dependence of the fluence rate on the lumen diameter stress 
the importance of in situ fluence rate measnrement for a proper evaluation 
of the relationship between light fluence and biologicalresponse of EB-PDT. 
Monte Car'lo calculations for varying geometry, optical properties 
and diffuser characteristics 
In chapter 6 a Monte Carlo model is presented for the illumination of a 
cylindrical cavity by a Iinear diffuser. It is employed to compute the fluence 
rate distribution dnring endo-bronchial PhotoDynamic Therapy. The influ-
ence of geometrical parameters such as the diameter of the treated lumen, 
the length of the Iinear diffuser and the pos si bie ofl~axis position of the dif-
fuser on the fluence rate have been investigated, as weIl as the consequences 
of varying output characteristics of the diffusel's. For on-axis isotropie dif-
fusers some simple practical rules are derived to estimate the fluence rate 
profile on the wall for varying diffuser length and lumen diameter. 
With Iinear diffusers that ean be modelled as a row of isotropie point sonr-
ces, a constant fluence rate build-up factor can be employed for varying 
diffuser lengths and lumen diameters. Extreme off-axis placement of the 
diffuser causes a highly variabie, considerable increase in the maximum 
fluence rate as weIl as a highly asymmetrical fluence rate profile on the 
circumference of the illuminated lumen (as already observed in chapter 2). 
The measured radiance profiles of real diffusers can be incorpol'ated in the 
model, which provides a means of evaluating thc fluence rate distribution 
resulting from realistic (non-ideal) light sonrces. 
The influence of the optical properties of the bronchial mucosa on the flu-
ence rate build-up factor was also investigated. The changes in fluence rate 
could be accounted for by diffusion theory. 
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Fluence-response experiment for normal tissue damage of the 
bronchial mucosa in pigs . 
In chapter 7 the damage to normal pig brollchial mncosa caused by Photo-
Dynamic Therapy (PDT) using mTHPC and Photofrin as photoscnsitisers 
has been evaluated. The endobronchial applicatol' from chapter 5 was used 
to deliver the light with a linear diffuser and to measnre the light fiuence 
in sitiL. The applied fiuences were varied, based on existing protocols. A 
fiuence finding experiment with short-term (1-2 days) response as an end-
point showeel considerable elamage to the mucosa with the use of Photofrin 
(fiuences 50-275 J/cm2 , drug elose 2 mg/kg) with oedema anel blood vessel 
elamage as most important features. In the short-term mTHPC experi-
Illent thc damage found was slight (fiuences 12.5-50 J/cm2 , elrug dose 0.15 
mg/kg). For both sensitisers atrophy and acute infiammation of the epithe-
lium anel the submucosal glands was observeel. The elamage was confined 
to the mucosa anel submucosa leaving the cartilagc intact. A long-term 
experiment showed that fiuences of 50 J/cm2 for mTHPC anel 65 J/cm2 for 
Photofrin treateel animals caused damage that recovereel within 14 elays, 
with sporaelic slight fibrosis anel occasional infiammation of thc submucosal 
glands. Limiteel elata on the pharmacokinetics of mTHPC show that drng 
levels in the trachea are similar at 6 and 20 elays post injection. Thc impor-
tance of in situ light elosimetry was stressed by the inter-animal variations 
in fiuence rate for comparable iIIumination conditions. 
Intra-operative adjuvant Photodynamic Thel'apy for Malignant 
Mesothelioma 
Chapter 8 elescribes the treatment of five patients with a pleural malig-
nancy with maximal surgical resection of the tumour followeel by intra-
operative aeljuvant photoelynamic therapy (PDT). The aelelitional photo-
dynamic treatment was performeel with mTHPC as photosensitiser. The 
light elelivel'Y to the thoracic cavity was monitoreel by in sit.t isotropic light 
detectors. The position of the spherical diffuser was aeljusteel to achieve 
optimallight distribution, taking account of refiecteel anel scattered light in 
this hollow cavity. 
There was no 30 elay postopCl'ative mortality anel only one patient suffereel 
from a major complication (eliaphragmatic rupture and haematopericar-
elium). The op€l'ation time was increaseel by a maximum of one hour to 
illuminate the tot al hemithoracic surface with 10 J/cm2 (incident plus scat-
tered light). The effect of the aeljuvant PDT was monitored byexamination 
of biopsies taken 24 hours aftel' surgery uneler thoraeoscopic guielance. Sig-
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nificant damage, including necrosis, was observed in the marker lesions with 
remaining malignancy, compared to normal tissue samples which showed 
only an infiltration with PMN cells and oedema of the striated muscles 
cells. 
Of the five patients treated, four are alive with no signs of recurrent tumour 
with a follow-up of 9-11 months. One patient was diagnosed to have a 
tumour dissemination in the skin around the thoracoscopy scar and died of 
abdominal tumour spread. 
Concluding Remarks 
The fluence rate distribution during EB-PDT (and all other applications of 
PDT) depends on many factors, some of which are difficult to determine in 
situ in a routine maJlIler (eg. the optical properties of the tissue). Therefore 
it essential that an in situ measurement is performed during each treatment 
to ensure that a repl'Oducible light fluence is delivered to the tissue. Only 
in this way one can hope to obtain a correlation between the amount of 
applied light and the observed therapeutic efl'ect. 
In this thesis two ways of performing in situ light dosimetry are presented, 
one for the trachea-bronchial tree and one for the integral illumination of 
the thorax. The fluence rate measurements can be used to estimate the' 
fluence rate distribution although the number of measurement sites is Ii-
mited especially in the bronchus applicatol'. Monte Carlo models can help 
to expand those few measurement points to an es ti mate of the distribution 
at the tissue surface and in the tissue. The latter is very important, be-
cause invasive measurements are seldom performed, and one has to rely on 
measurements on the surface. 
The dimensions of the isotropic probes used for the measurements are such 
that they can be applied for dosimetry in virtually any area. Every target 
organ for PDT will require a specific device for light delivery and light 
dosimetry. The knowledge of the pharmacokinetics of the photosensitiser is 
also very important for the final therapeutic efl·eet. Combination of in situ 
light dosimetry with measurement of the fluorescence of the photosensitiser 
before and during treatment will give a better prediction of the therapeutic 
effect. 
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Inleiding 
Het werk in dit proefschrift beschreven is een poging om de lichtapplicatie te 
ontwikkelen en de lichtverdeling te meten en berekenen tijdens Fotodynami-
sche Therapie van de bovenste luchtwegen. De fluentie tempo verdeling als 
gevolg van de belichting van een van de lumina van de bovenste luchtwegen 
werd onderzocht. De invloed van de volgende parameters werd bestudeerd: 
-{) emissie profielen van de lineaire diffuse lichtbron (diffuser) 
-{) de positionering van de diffuser in het lumen (gecentreerd of excen-
trisch) 
-{) de lengte van de gebruikte diffuser 
-{) de diameter van het behandelde lumen 
-{) de golflengte van het licht waarmee behandeld wordt 
-{) optische eigenschappen van het longslijmvlies 
Voor in situ licht applicatie en dosimetrie is een applicatol' ontwikkeld, en 
deze is gebruikt om de eerste fluentie tempo metingen uit te voeren in de 
mens. De applicator is vervolgens gebruikt om een fluentie('licht-dosis')-
schade relatie te bepalen in het gezonde longslijmvlies van het varken. 
Tenslotte zijn de technieken voor in vivo fluentie tempo metingen toegepast 
bij het integraal belichten van de thorax na resectie van het longslijmvlies 
en/of de long. 
Ex vivo fluentie tempo metingen en Monte Cat'lo simulaties 
In hoofdstuk 2 wordt de licht verdeling tijdens Fotodynamische Therapie 
van de bronchi bestudeerd door middel van meting van het ex vivo fluentie 
tempo in de trachea van een varken. De trachea wordt belicht (rood licht, 
630 nm) met een lineaire difl'user en het fluentie tempo wordt gemeten 
met een isotrope detector. De resultaten van de metingen komen binnen 
de meet font (±15%) overeen met die van een Monte Cal'lo simulatie van 
het experiment. Dit geeft aan dat de Monte Cat'lo techniek gebruikt kan 
worden om een schatting te doen van de lichtverdeling voor verschillende 
geometrieën en optische eigenschappen. 
De resultaten laten zien dat het fluentie tempo in het slijmvlies van de ex 
vivo trachea een factor 6 meer kan zijn dan het fluentie tempo op die plaats 
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in lucht. Dit wordt veroorzaakt door meervoudige (difruse) terugstrooiing 
uit het weefsel en meervoudige spiegelende reflecties in de trachea. 
Verdere experimenten tonen aan dat het positioneren van de lineaire difl'user 
bepalend is voor het fluentie tempo in de te behandelen laesie. Bij een 
verplaatsing van de diffuser van de centrale as tot dichtbij de laesie stijgt het 
fluentie tempo enkele orden van grootte vergeleken met de begintoestand. 
De inter- en intra- trachea variaties in deze toename waren groot (± 35%) 
door variaties in respectievelijk de optische eigenschappen en geometrie en 
de positionering van de lineaire diffuser. Deze variaties kunnen over- en 
onderdosering tot gevolg hebben met als consequentie onvoldoende tumor-
necrose of te veel schade aan het normale weefsel. De resultaten geven 
aan dat het verstandiger lijkt om de belichting altijd uit te voeren met de 
lineaire diffuser op de centrale as. 
Licht applicatie met lineaire diffusers 
De verdeling van het licht uitgezonden door lineaire diffusers die gebruikt 
worden voor Fotodynamische Therapie werd onderzocht in hoofdstuk 3, 
waarin een apparaat wordt gepresenteerd dat de hoekverdeling meet van 
het uitgezonden licht op ieder punt van het diffuseroppervlak. Met deze 
gegevens kan het fluentie tempo in lucht of in een holte op zekere afstand 
van de diffuser voorspeld worden. De resultaten laten zien dat het licht 
van de difl'user voornamelijk in de voorwaartse richting uitgezonden wordt. 
Experimenten en berekeningen tonen aan dat het fluentie tempo in lucht 
en in een holte in verstrooiend weefsel op enige afstand van de diffuser een 
maximum heeft nabij de voorkant van de diffuser, in plaats van tegenover 
het midden. Een meting van het fluentie tempo met de diffuser interstitieel 
in een puur verstrooiend weefsel fantoom laat zien dat het maximum ligt 
tegenover het midden van de diffuser, hetgeen te verwachten is indien ieder 
element van het diffuseroppervlak het licht isotroop uit zou zenden. De 
verstrooiing van het weefsel zelf zal er voor zorgen dat de anisotropie van 
het uitgezonden licht teniet wordt gedaan. 
In hoofdstuk 4 werd de radiantie-hoekverdeling gemeten van enkele li-
neaire diffusers die voor Fotodynamische Therapie gebruikt worden. De 
voorwaartse verstrooiing die voorheen gevonden werd (hoofdstuk 3) was 
afwezig in deze diffusers. De verbeterde isotropie leidt tot een beter over-
eenstemming tussen de bedoelde en de werkelijke plaats van behandeling 
in het geval van een belichting van een hol, cylindervormig orgaan. 
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Applicator voor endobronchiale licht applicatie en licht dosimetrie 
In hoofdstuk 5 wordt een applicatol' gepresenteerd voor het toedienen en 
het in situ meten van licht tijdens EndoBronchiale Fotodynamische thera-
pie. Dit ontwerp bevat een lineaire diffuser die middels een mandje van 
stalen veren gecentreerd wordt in het te behandelen lumen, zonder dat de 
luchttoevoer geblokkeerd wordt. De centrale positionering van de diffuser 
zorgt voor een optimale lichtverdeling (hoofdstuk 2). Een isotrope detector 
i~ onderdeel van de applicator. Deze meet het fluentie tempo dat daadwer-
kelijk toegediend wordt aan het longslijmvlies. De applicator is ontworpen 
voor gebruik met gangbare bronchoscopen, en kan gebruikt worden met 
bronchoscopen met een groot (:::; 3 mm) werkkanaal. De eerste klinische 
metingen werden uitgevoerd en veroorzaakten geen extra ongemakken bij 
de standaard bronchoscopie van niet-lichtgevoelige gemaakte vrijwilligers. 
De gegevens laten een aanzienlijke variatie tussen de patiënten zien van het 
gemeten fluentie tempo voor een vast uitgangsvermogen van de lineaire dif-
fuser. Dit gegeven gecombineerd met de te verwachten afhankelijkheid van 
het fluentie tempo van de lumen diameter benadl'tlkken het belang van in 
situ fluentie tempo metingen voor een verantwoorde evaluatie van de relatie 
tussen licht fluentie en biologisch effect bij Endobronchiale Fotodynamische 
Therapie. 
Monte Carlo berekeningen voor variaties in geometrie, optische 
eigenschappen en diffuser emissie karakteristieken 
In hoofdstuk 6 wordt een Monte Cat'lo model gepresenteerd voor de be-
lichting van een cylindrische holte in weefsel door een lineaire diffuser. Het 
model wordt gebruikt om de fluentie tempo verdeling te berekenen tijdens 
Endo-Bronchiale Fotodynamische Therapie. De invloed van geometrische 
parameters zoals de diameter van het behandelde lumen en de lengte van de 
lineaire diffuser en de mogelijke excentrische positionering van de diffuser 
worden onderzocht. Ook wordt er gekeken naar de invloed van variaties 
in de emissie karakteristieken van de lineaire diffusers. Voor een centraal 
geplaatst diffuser worden enkele vuistregels afgeleid om de fluentie tempo 
verdeling op de wand van de trachea te schatten bij verschillende diffuser 
lengtes en lumen diameters. 
Voor lineaire diffusers die gemodelleerd kunnen worden als een reeks van 
isotrope puntbronnen kan een constant fluentie tempo opbouwfactor ge-
bruikt worden voor verschillende diffuser lengtes en lumen diameters. Ex-
treme excentrische plaatsing van de diffuser veroorzaakt een aanzienlijke en 
zeer variabele toename in het maximum van het fluentie tempo evenals een 
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zeer asymmetrische flueutie tempo verdeling langs de omtrek van het lumen 
(zoals reeds gezien tijdens metingen in hoofdstuk 2). De gemeten emissie 
karakteristieken van lineaire diffusers kunnen worden ingebouwd in het mo-
del zodat de fluentie tempo verdelingen bij belichting met een niet-ideale 
lineaire diffuser onderzocht kunnen worden. 
De invloed van de optische eigenschappen van het longslijll!vlies op de flu-
ent ie tempo opbouwfactor werd ook onderzocht. De variaties in het fluentie 
tempo konden verklaard worden met behulp van diffusie theorie. 
Fluentie-respons experiment voor normaal weefsel schade aan het 
longslijmvlies in varkens 
In hoofdstuk 7 wordt onderzocht welke schade er ontstaat aan het longslijm-
vlies van varkens na Fotodynamische Therapie met mTHPC en Photofrin 
als lichtgevoelige stof. De applicatol' uit hoofdstuk 5 werd gebruikt om het 
licht toe te dienen in de trachea en om een in situ meting van de fluentie uit 
te voeren. De fluenties die toegediend werden waren afgeleid van bestaande 
protocollen. 
Een fluentie-bepalings experiment met korte-termijn schade (1-2 dagen) als 
eindpunt liet zien dat er aanzienlijke schade ontstaat wanneer Photofrin 
gebruikt wordt als lichtgevoelige stof (fluenties 50-275 J jcm2 , Photofrin 
dosis 2 mgjkg). Hierbij waren schade aan de bloedvaten en oedeem de 
belangrijkste verschijnselen. In het korte-termijn mTHPC experiment was 
de gevonden schade slechts gering (fluenties 12.5-50 Jjcm2 , mTHPC dosis 
0.15 mgjkg). Voor beide lichtgevoelige stoffen werd atrofie en acute ontste-
king van zowel het epitheel als de kliertjes in de submucosa gevonden. De 
schade bleef beperkt tot het slijmvlies, waarbij het kraakbeen intact bleef. 
Een lange-termijn experiment liet zien dat fluenties van 50 Jjcm2 voor de 
mTHPC en 65 Jjcm2 voor de Photofrin behandelde dieren schades veroor-
zaakten die binnen 14 dagen hersteld was, met sporadisch lichte fibrose en 
af en toe ontsteking van de kliertjes. 
Een beperkte set metingen van de farmaco-kinetiek van mTHPC laat zien 
dat de niveaus van de lichtgevoelige stof in de trachea vergelijkbaar zijn 
op 6 en 20 dagen na injectie. Het belang van in situ licht dosimetrie werd 
onderstreept door grote variaties in gemeten fluentie tempo tussen de dieren 
in vergelijkbare belichtingsomstandigheden. 
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Intra-operatieve adjuvante Fotodynamische Therapie voor Ma-
ligne Mesotheliomen 
Hoofdstuk 8 beschrijft de behandeling van vijf patiënten met kanker aan 
het longslijmvlies met maximale chirurgische resectie van de tumor gevolgd 
door intra-operatieve adjuvante Fotodynamische Therapie. De Fotodyna-
mische Therapie werd uitgevoel'd met mTHPC als lichtgevoelige stof. De 
licht applicatie in de thorax werd gecontroleerd met in situ isotrope licht 
detectors. De positie van de spherische diffuser werd handmatig gevarieerd 
om een optimale lichtverdeling te verkrijgen, waarbij ook alle bijdragen van 
verstrooid licht in de thorax holte gemeten worden. 
Er was geen postoperatieve mortaliteit na 30 dagen en slechts een patiënt 
ondervond een ernstige complicatie (scheuring van het middenrif en bloe-
ding in het hartzakje). De operatietijd werd verlengd met maximaal een 
uur om de hele thoraxwand te belichten met een gemiddelde !luentie van 
10 J/cm2 • Het effect van de adjuvante therapie werd onderzocht door het 
nemen van biopten 24 uur na de operatie middels een thoracoscopie. Signi-
ficante schade (waaronder necrose) werd waargenomen in resterende tumor, 
terwijl bij normaal weefsel alleen acute ontstekingsinfiltraten en oedeem van 
het dwarsgestreepte spierweefsel gevonden werden. 
Van de vijf behandelde patiënten zijn er nog 4 in leven zonder tekenen 
van terugkerende tumorgroei, met een opvolg tijd van 9-11 maanden. Een 
patiënt ontwikkelde tumor rond het litteken van de thoracoscopie, en over-
leed aan tumorgroei in de buikholte. 
Afsluitende Opmerkingen 
De !luentie tempo verdeling tijdens Endobronchiale Fotodynamische the-
rapie (en alle andere toepassingen van PDT) wordt beïnvloed door vele 
factoren, waarvan sommige moeilijk in situ en routinematig te bepalen zijn 
(bijvoorbeeld de optische eigenschappen van het weefsel). Daarom is het 
essentieel dat er een in situ meting wordt gedaan tijdens de behandeling 
om er zeker van te zijn dat er een reproduceerbare licht fluentie aan het 
weefsel wordt toegediend. Alleen op deze manier zal het mogelijk zijn om 
een goede correlatie te verkrijgen tussen de hoeveelheid toegediend licht en 
het waargenomen therapeutische effect. 
In dit proefschrift worden twee methodes voor in situ licht dosimetrie ge-
presenteerd, een voor de bovenste luchtwegen en een voor de belichting van 
de thorax. De fluentie tempo metingen kunnen gebruikt worden om een 
schatting te maken van de hele !luentie tempo verdeling, zij.het met behulp 
van een beperkt aantal meetpunten (met name in het geval van de endo-
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bronchiale applicatol') . Monte Carlo modellen ktmnen helpen om met de 
enkele meetpunten toch een schatting van de hele lichtverdeling op en in 
het weefsel te maken. Het laatste is belangrijk omdat invasieve metingen 
niet goed mogelijk zijn en er van metingen aan het oppervlak uitgegaan 
moet worden. 
De afmetingen van de isotrope detectors zijn zodanig dat ze gebruikt kun-
nen worden voor licht dosimetrie in vrijwel elk gebied. Voor ieder doelor-
gaan voor Fotodynamische Therapie is er een op dat orgaan toegesneden 
instrumentatie voor licht applicatie en licht dosimetrie nodig. De kennis van 
de farmaco-kinetiek van de lichtgevoelige stof is ook belangrijk voor het uit-
eindelijke therapeutische effect. De combinatie van in situ licht dosimetrie 
en meting van de fluorescentie van de lichtgevoelige stof voor en tijdens de 
behandeling zal een betere voorspelling geven van het te verwachten effect. 
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